cleaned_up_drug,class_drug_info,class_umls
BR55,,
SGT-53,,
Irinotecan,"Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
Temozolomide,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Mutation Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Bevacizumab,"Antineoplastic|Monoclonal Antibody|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Antineoplastic Agents, Immunological",
PVSRIPO,,
Pembrolizumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
anti-PSMA,,
BKM120,,
darolutamide,,
APG-2575,,
Gemcitabine,"Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antiviral Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Noxae|Radiation-Sensitizing Agents",
anti-Mesothelin,,
INC280,,
erlotinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
Platinum/pemetrexed,,
Vinorelbine,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Antineoplastic Agents|Antimitotic Agents|Tubulin Modulators",
Letrozole,"Antineoplastic Agents|Enzyme Inhibitors|Aromatase Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
Pimonidazole,Radiation-Sensitizing Agents,
M7824,,
HER2+,,
Chemotherapy,,
anti-,,
MESO,,
CAR-T,,
Fludarabine,Antineoplastic Agents|Mutation Data,
Cyclophosphamide,"Agricultural Chemical|Alkylating Agents|Antineoplastic Agents, Alkylating|Antirheumatic Agents|Drug / Therapeutic Agent|Experimental Pesticide|Human Data|Immunosuppressive Agents|Mutagens|Mutation Data|Reproductive Effect|Tumor Data|Unspecified / Unclassified Pesticide|Antineoplastic Agents|Immunologic Factors|Myeloablative Agonists|Noxae",
Cyclophosphamide,"Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antirheumatic Agents|Immunologic Factors|Immunosuppressive Agents|Mutagens|Myeloablative Agonists|Noxae",
Fluorine-18,,
1-amino-3-fluorocyclobutane-1-carboxylic,,
FACBC,,
18F-DCFPyL,,
18F-Fluciclovine,,
CNCT19,,
FPA150,,
Vitamin,,
BTG-002814,,
vandetanib-eluting,,
radiopaque,Contrast Media|Drug / Therapeutic Agent|Mutation Data|Tumor Data|Diagnostic Uses of Chemicals,
ET019002-,,
18F-fluciclovine,,
radium-223,,
lapatinib,Tyrosine Kinase Inhibitors|Antineoplastic Agents|Dual EGFR/erbB2 Inhibitors|Enzyme Inhibitors|Protein Kinase Inhibitors,
ditosylate,,
paclitaxel,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
albumin-stabilized,,
nanoparticle,,
Talimogene,,
laherparepvec,,
Atezolizumab,Antineoplastic Agents,
Cisplatin,Antineoplastic Agents|Cross-Linking Reagents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Indicators and Reagents,
Erlotinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
Trametinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Paclitaxel,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
Durvalumab,,"ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker"
Medi4736,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
pd-1,,
dc-cik,,
DC-NK,,
F-18,,
irinotecan,"Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
temozolomide,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Mutation Data|Alkylating Agents|Antineoplastic Agents|Noxae",
bevacizumab,"Antineoplastic|Monoclonal Antibody|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Antineoplastic Agents, Immunological",
alkylator,,
Denosumab,Bone Density Conservation Agents,
MG/1.7,,
Subcutaneous,,
XGEVA,Bone Density Conservation Agents,
Eluting,,
Transarterial,,
Chemoembolization,,
Nivolumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Sorafenib,Protein Kinase Inhibitors|Antineoplastic Agents|Enzyme Inhibitors,
ET140202-T,,
AB-101,,
Abemaciclib,,"Protein kinase inhibitors|Kinase Inhibitor|ANTINEOPLASTIC,OTHER|Kinase Inhibitors"
LCAR-C182A/LCAR-C182B/LCAR-C182C,,
anti-MESO,,
CLL1-CD33,,
cCAR,,
sunitinib,Protein Kinase Inhibitors|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Enzyme Inhibitors,
rapamycin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Immunosuppressive Agents|Mutation Data|Natural Product|Anti-Bacterial Agents|Antifungal Agents|Anti-Infective Agents|Antineoplastic Agents|Immunologic Factors",
CB-03-10,,
Eribulin,Antineoplastic Agents,
Mesylate,,
Trastuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
pertuzumab,"Monoclonal Antibody|HER-2-Targeting Antibody|Antineoplastic Agents|Antineoplastic Agents, Immunological",
Ipilimumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Bexarotene,Anticarcinogenic Agents|Antineoplastic Agents|Protective Agents,
Entinostat,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
SR-T100,,
Solanum,,
undatum,,
GSK1120212,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
GSK1120212,Antineoplastic Agents,
sorafenib,Protein Kinase Inhibitors|Antineoplastic Agents|Enzyme Inhibitors,
tosylate,,
P15-041,,
Sitravatinib,,
GVAX,,
IMC-CS4,,
Daratumumab,Antineoplastic Agents,
Porfimer,Antineoplastic Agents|Dermatologic Agents|Photosensitizing Agents|Radiation-Sensitizing Agents,
Sodium,,
IFx-Hu2.0,,
Sunitinib,Protein Kinase Inhibitors|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Enzyme Inhibitors,
Avelumab,,"ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker"
CD137,,
Interleukin-2,"Analgesics|Analgesics, Non-Narcotic|Antineoplastic Agents|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents",
Interleukin-2,Anti-HIV Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents,
ET1402L1-ARTEMIS,,
#NAME?,,
#NAME?,,
Carvedilol,Adrenergic alpha-Antagonists|Antihypertensive Agents|Drug / Therapeutic Agent|Reproductive Effect|Vasodilator Agents|Adrenergic beta-Antagonists|Adrenergic Agents|Adrenergic Antagonists|Cardiovascular Agents|Neurotransmitter Agents|Adrenergic alpha-1 Receptor Antagonists|Antioxidants|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Membrane Transport Modulators|Protective Agents,
VM4-037,,
Nicotine,Agricultural Chemical|Ganglionic Stimulants|Human Data|Insecticide|Mutation Data|Natural Product|Nicotinic Agonists|Reproductive Effect|Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Smoking Cessation Agents,
Anti-Smoking,,
Vemurafenib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Autologous,,
EBV-CTL,,
SFG-CNA12,,
SFG-CNA8,,
Anti-BCMA,,
BCMA,,
Lenalidomide,Antineoplastic Agents|Growth Substances|Angiogenesis Modulating Agents|Angiogenesis Inhibitors|Immunologic Factors|Growth Inhibitors,
Dexamethasone,"Antiemetics|Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Immunomodulator|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents",
MEDI-551,,
PU-AD,,
RGD-K5,,
Intra-lesional,,
nivolumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
ODSH,,
Fimepinostat,,
extracorporeal,,
photopheresis,,
Calcipotriene,Dermatologic Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect,
recMAGE-A3,,
AS15,"Agricultural Chemical|Drug / Therapeutic Agent|Germicide, Bactericide, Disinfectant|Human Data|Mutation Data|Reproductive Effect",
ASCI,,
Doxorubicin,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
CD19-TriCAR-T/SILK,,
MB-CART20.1,,
GPA-TriMAR-T,,
Xylocaine,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant,
Xylocaine,"Anesthetics, Local|Anti-Arrhythmia Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Anesthetics|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents|Membrane Transport Modulators|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",
bortezomib,Antineoplastic Agents|Protease Inhibitors|Enzyme Inhibitors,
G-CSF,,BLOOD FORMATION PRODUCTS|Receptor Protein Kinase Interactions|Colony stimulating factors|Leukocyte Growth Factor|Receptor Activity Modifying Protein Agonists
Rituximab,"Antineoplastic Agents|Antirheumatic Agents|Immunologic Factors|Antineoplastic Agents, Immunological",
Bendamustine,"Antineoplastic Agents|Alkylating Agents|Antineoplastic Agents, Alkylating|Noxae",
Spartalizumab,,
Canakinumab,,Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
Topotecan,Antineoplastic Agents|Enzyme Inhibitors|Antineoplastic|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,
Gadolinium,Tumor Data,
DTPA,Antidotes|Chelating Agents|Iron Chelating Agents|Protective Agents|Sequestering Agents,
Sacituzumab,,
Govitecan,,
Tadalafil,Phosphodiesterase 5 Inhibitors|Enzyme Inhibitors|Phosphodiesterase Inhibitors|Cardiovascular Agents|Vasodilator Agents|Urological Agents,
Ixazomib,Antineoplastic Agents|Enzyme Inhibitors|Protease Inhibitors,
Tasigna,Antineoplastic|Antineoplastic Agents,"Protein kinase inhibitors|Bcr-Abl Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor"
Tasigna,,"Protein kinase inhibitors|Bcr-Abl Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor"
ipilimumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
GAA/TT-peptide,,
vaccine,,
poly-ICLC,Interferon Inducers|Immunologic Factors,
CD19-CD22,,
Anti-CD19/CD22,,
Anti-CD19,,
iCAR,,
Anti-CD22,,
ET190L1-ARTEMIS,,
Romidepsin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Natural Product|Antineoplastic Agents",
Burosumab,,"Other drugs affecting bone structure and mineralization|IMMUNOLOGICAL AGENTS,OTHER"
SNX-5422,,
Paclitaxel+Reparixin,,
DS-8201a,Antineoplastic Agents,
Urelumab,,
AZD2281,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
enzalutamide,,"ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor"
anastrozole,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Enzyme Inhibitors|Aromatase Inhibitors|Antineoplastic Agents|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
exemestane,"Antineoplastic Agents|Enzyme Inhibitors|Antineoplastic|Aromatase Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
fulvestrant,"Antineoplastic Agents|Estrogen Antagonists|Antineoplastic Agents, Hormonal|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Estrogen Receptor Antagonists",
MSB0011359C,,
Evofosfamide,,
AGS-1C4D4,,
AB928,,
IPI-549,,
liposomal,,
doxorubicin,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
albumin-bound,,
CTX-471,,
ASG-5ME,,
Ritonavir,Protease Inhibitor|Antiretroviral|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|HIV Protease Inhibitors|Protease Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Metabolic Side Effects of Drugs and Substances,
Itraconazole,"Antifungal Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anti-Infective Agents|14-alpha Demethylase Inhibitors|Enzyme Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
MEDI-575,,
INCB028060,,
WT2725,,
Triciribine,Mutation Data,
Monohydrate,,
TBI-1401,,
HF10,Mutation Data|Tumor Data|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Nab-paclitaxel,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
TS-1,"Antimetabolites, Antineoplastic|Antimetabolites|Antineoplastic Agents|Noxae",
Belinostat,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
Warfarin,Agricultural Chemical|Anticoagulants|Human Data|Reproductive Effect|Rodenticide|Rodenticides|Hematologic Agents|Pesticides,
SAR441000,,
Cemiplimab,,"ANTINEOPLASTIC,OTHER"
REGN2810,,
Hydrochloride,Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data,
Liposome,,
eRapa,,
grapiprant,,
pembrolizumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
R306465,Enzyme Inhibitors|Histone Deacetylase Inhibitors,
PalloV-CC,,
MDV3100,,
AR-67,,
DB-67,,
CVA21/pembrolizumab,,
OMP-21M18,,
M4344,,
Carboplatin,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Cross-Linking Reagents|Indicators and Reagents,
TB-403,,
Hu5F9-G4,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Hu5F9-G4,,
Demcizumab,,
Abraxane®,,
Volitinib,,
Docetaxel,Antineoplastic Agents|Drug / Therapeutic Agent|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators,
Docetaxel,Antineoplastic Agents|Tubulin Modulators|Mitosis Modulators|Antimitotic Agents,
GM-CSF,,
Pemetrexed,"Antineoplastic Agents|Enzyme Inhibitors|Antimetabolites|Antimetabolites, Antineoplastic|Folic Acid Antagonists|Noxae|Nucleic Acid Synthesis Inhibitors","Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues"
Pemetrexed,,"Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues"
GB226,,
Fruquintinib,,
Ridaforolimus,,
ODM-201,,
REGN3767,,
cemiplimab,,"ANTINEOPLASTIC,OTHER"
mogamulizumab,Antineoplastic Agents,
MEDI4736,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
tremelimumab,Antineoplastic Agents,
rSIFN-co,,
Anastrozole,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Enzyme Inhibitors|Aromatase Inhibitors|Antineoplastic Agents|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
AVE0005,,
Binimetinib,,"Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER"
Oxaliplatin,Drug / Therapeutic Agent|Antineoplastic|Antineoplastic Agents,
Oxaliplatin,Antineoplastic Agents,
Leucovorin,Growth Substances|Micronutrients|Vitamin B Complex|Vitamins|Antidotes|Protective Agents,
5-Fluorouracil,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
Cabiralizumab,,
nanoparticulate,,
SAR405838,,
Pimasertib,,
Galunisertib,,
HMPL-523,,
SRT501,"Anticarcinogenic Agents|Antimutagenic Agents|Antineoplastic Agents, Phytogenic|Antioxidants|Enzyme Inhibitors|Platelet Aggregation Inhibitors|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antineoplastic Agents|Antirheumatic Agents|Hematologic Agents|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents",
Aflibercept,,
XRP6976,Antineoplastic Agents|Drug / Therapeutic Agent|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators,
XRP6976,Antineoplastic Agents|Tubulin Modulators|Mitosis Modulators|Antimitotic Agents,
Prexasertib,,
Cetuximab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
BAY94-9343,,
mg/kg,,
Enzalutamide,,"ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor"
PCI-32765,Antineoplastic Agents,
enfortumab,,
vedotin,,
Laherparepvec,,
TLD1433,,
photodynamic,,
therapy,,
MCLA-158,,
SHR3680,,
SHR3162,,
REGN421,,
SAR153192,,
E7386,,
Clarithromycin,Drug / Therapeutic Agent|Human Data|Protein Synthesis Inhibitors|Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Metabolic Side Effects of Drugs and Substances,
CYAD-101,,
LY2624587,,
Ramucirumab,Antineoplastic Agents,
Necitumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Osimertinib,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors"
EOC202,,
Brivanib,,
Brivanab,,
JX-594,,
E7389,Antineoplastic Agents,
Exemestane,"Antineoplastic Agents|Enzyme Inhibitors|Antineoplastic|Aromatase Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
OMP-54F28,,
Nab-Paclitaxel,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
Vantictumab,,
MVT-5873,,
CC-95251,,
GRN163L,Enzyme Inhibitors,
MSC1936369B,,
talazoparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
SRF231,,
cis-UCA,,
Entrectinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
TAS-114/capecitabine,,
CPX-351,Antineoplastic Agents,
Cytarabine,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
INCMGA00012,,
NK012,"Mutation Data|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
5-FU,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
LY2780301,,
Alecsat,,
LY2523355,,
pegfilgrastim,Antineoplastic Agents|Pegylated Protein,
olaparib,,"Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor"
BLZ-100,,
Xentuzumab,,
Fulvestrant,"Antineoplastic Agents|Estrogen Antagonists|Antineoplastic Agents, Hormonal|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Estrogen Receptor Antagonists",
sphingosine,,
kinase-2,,
inhibitor,,
ABC294640,,
MGAH22,,
Comparator,,
MM-121,,
ABT-888,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
EC20,,
LY900009,,
Escalation,,
PF-03084014,,
Veliparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
tivantinib,,
omeprazole,Anti-Ulcer Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Gastrointestinal Agents|Proton Pump Inhibitors,
s-warfarin,,
caffeine,Central Nervous System Stimulants|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Phosphodiesterase Inhibitors|Reproductive Effect|Tumor Data|Central Nervous System Agents|Enzyme Inhibitors|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists,
digoxin,Anti-Arrhythmia Agents|Cardiotonic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Protective Agents,
midazolam,"Adjuvants, Anesthesia|Anesthetics, Intravenous|Drug / Therapeutic Agent|GABA Modulators|Human Data|Mutation Data|Reproductive Effect|Anesthetics|Anesthetics, General|Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|Hypnotics and Sedatives|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents",
NEO-PV-01,,
Anetumab,,
ravtansine,,
Liposomal,,
Ad/PNP,,
fludarabine,Antineoplastic Agents|Mutation Data,
monophosphate,,
Herceptin,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
CS-7017,,
LY3076226,,
imexon,,
ES414,,
ARN-509,,
Prednisone,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
FOLFOX,,
AbGn-7,,
ADI-PEG,,
AdV-tk,,
aglatimagene,,
besadenovec,,
valacyclovir,Anti-Infective Agents|Antiviral Agents,
AZD6244,,
Olaparib,,"Other antineoplastic agents|Poly(ADP-Ribose) Polymerase Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Poly(ADP-Ribose) Polymerase Inhibitor"
FS118,,
Nerofe,,
CM082,,
TVB-2640,,
TAS3681,,
IMMU-130,,
Telatinib,,
entinostat,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
LTX-315,,
IPI-926,,
FPA144,,
mFOLFOX6,,
PF-05082566,,
MK-3475,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
mg/m2,,
AB-16B5,,
AZD8330,,
SHR-1701,,
OCV-103,,
OCV-104,,
ADH300004,,
PWT33597,,
mesylate,,
Dalotuzumab,,
diclofenac,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents",
TKI258,,
CC-90002,,
Angiocal®,,
PRS-050-PEG40,,
Pyrotinib,,
TRC105,,
chimeric,,
anti-CD105,,
antibody,,
MLN0128,,
trastuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
MEDI3726,,
Post-Chemo,,
Pre-Chemo,,
Combo,,
CPGJ602,,
MKC-1,,
ETBX-021,,
TRC093,,
IgG1k,,
AZD2014,,
PF-04554878,,
BBI608,,
Levofolinate,,
chemotherapy,,
MEN1611,,
Caffeine,Central Nervous System Stimulants|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Phosphodiesterase Inhibitors|Reproductive Effect|Tumor Data|Central Nervous System Agents|Enzyme Inhibitors|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists,
Dextromethorphan,Antitussive Agents|Drug / Therapeutic Agent|Excitatory Amino Acid Antagonists|Human Data|Central Nervous System Agents|Excitatory Amino Acid Agents|Neurotransmitter Agents|Respiratory System Agents,
CRA-24781,,
Amphinex,,
TPCS2a,,
Bleomycin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents",
enzastaurin,,
hydrochloride,Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data,
Afuresertib,,
Ibrutinib,Antineoplastic Agents,
SOM230,"Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
ALT-P7,,
HM2-MMAE,,
BEZ235,Antineoplastic|Antineoplastic Agents,
AZD5438,,
carboplatin,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Cross-Linking Reagents|Indicators and Reagents,
BP-C1,,
Tivozanib,,
AV-951,,
FOLFOX6,,
EC1456,,
99mTc-Etarfolatide,,
ABT-263,Antineoplastic Agents,
IMGN853,,
FS-1502,,
Fluorouracil,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
LY3023414,,
Oshadi,,
Pioglitazone,Hypoglycemic Agents,
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors|Anticholesteremic Agents|Antimetabolites|Enzyme Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents,
Trabectedin,"Antineoplastic Agents|Alkylating Agents|Antineoplastic Agents, Alkylating|Noxae",
APR-246,,
KN026,,
ABI-011,,
Denenicokin,,
RX108,,
Perifosine,,
Capecitabine,"Antineoplastic Agents|Antimetabolites|Antimetabolites, Antineoplastic|Noxae",
Apatinib,,
rivoceranib,,
CEP-37440,,
BMS-754807,,
AVB-620,,
Digoxin,Anti-Arrhythmia Agents|Cardiotonic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Protective Agents,
DN-101,,
DN-101,Calcium Channel Agonists|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Bone Density Conservation Agents|Cardiovascular Agents|Growth Substances|Membrane Transport Modulators|Micronutrients|Vasoconstrictor Agents|Vitamins|Calcium-Regulating Hormones and Agents,
MVA-BN-PRO,,
Nanoparticle,,
Phenelzine,Antidepressive Agents|Drug / Therapeutic Agent|Human Data|Monoamine Oxidase Inhibitors|Mutation Data|Reproductive Effect|Central Nervous System Agents|Enzyme Inhibitors|Psychotropic Drugs,
neratinib,Antineoplastic Agents,
E7974,,
PSA-Activated,,
PSA-PAH1,,
Lapatinib,Tyrosine Kinase Inhibitors|Antineoplastic Agents|Dual EGFR/erbB2 Inhibitors|Enzyme Inhibitors|Protein Kinase Inhibitors,
anti-cancer,,
KU-0059436,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
PARP,,
SGN-LIV1A,,
Epacadostat,,
INCB050465,,
JNJ-212082,,
Pemigatinib,,
LJM716,,
TT-00420,,
OMP-313M32,,
BAY1251152,,
Mobilan,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Gout Suppressants|Human Data|Mutation Data|Reproductive Effect|Tocolytic Agents|Tumor Data|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Cardiovascular Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Reproductive Control Agents|Sensory System Agents",
M-VM3,,
deruxtecan,,
cisplatin,Antineoplastic Agents|Cross-Linking Reagents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Indicators and Reagents,
triapine,,
FG-3019,,
MVA-BN-HER2,,
JNJ-56021927,,
IMAB027,,
Gedatolisib,Enzyme Inhibitors|Protein Kinase Inhibitors,
Palbociclib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
AZD3514,,
AUY922,,
BYL719,,
ALECSAT,,
GDC-0077,,
Metformin,Drug / Therapeutic Agent|Hypoglycemic Agents|Mutation Data|Reproductive Effect,
ARV-110,,
RAD001,Immunosuppressant|Immunologic Factors|Immunosuppressive Agents|Antineoplastic Agents,
BP31510,Drug / Therapeutic Agent|Reproductive Effect|Growth Substances|Micronutrients|Vitamins,
monotherapy,,
Gefitinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
PX-12,,
CTT1403,,
CTT1057,,
68Ga-PSMA-11,,
GM102,,
XMT-1107,,
Farletuzumab,Antineoplastic Agents,
Minnelide,,
LY2495655,,
Abraxane,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
PSB205,,
GSK2636771,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
AZD2171,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
ABBV-011,,
ABBV-181,,
ARX788,,
Poziotinib,,
T-DM1,"Antineoplastic Agents|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators|Antineoplastic Agents, Immunological",
MEDI3617,,
JTX-4014,,
PF-05212384,Enzyme Inhibitors|Protein Kinase Inhibitors,
gedatolisib,Enzyme Inhibitors|Protein Kinase Inhibitors,
Dacomitinib,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER"
JNJ-64041809,,
M8891,,
GDC-9545,,
Ipatasertib,,
hMAb,,
BIWA,,
unlabelled,,
INCB024360,,
E7080,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
KHK2375,,
TK006,,
SAR439859,,
EC90,,
KLH-FITC,,
GPI-0100,,
EC17,,
Folate-FITC,,
Interferon-alpha,,
Interferon-alpha,Drug / Therapeutic Agent|Human Data,
LEE011,Antineoplastic Agents,
Everolimus,Immunosuppressant|Immunologic Factors|Immunosuppressive Agents|Antineoplastic Agents,
EPC2407,,
crinobulin,,
Tykerb,Tyrosine Kinase Inhibitors|Antineoplastic Agents|Dual EGFR/erbB2 Inhibitors|Enzyme Inhibitors|Protein Kinase Inhibitors,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|HER2/Neu/cerbB2 Antagonists|Protein Kinase Inhibitors|Kinase Inhibitor"
Tykerb,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|HER2/Neu/cerbB2 Antagonists|Protein Kinase Inhibitors|Kinase Inhibitor"
Tykerb,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|HER2/Neu/cerbB2 Antagonists|Protein Kinase Inhibitors|Kinase Inhibitor"
Hemay022,,
Pegfilgrastim,Antineoplastic Agents|Pegylated Protein,
"CP-751,871",,
ALN-VSP02,,
MK-8353,,
GEM3PSCA,,
Anthracycline,,
M3541,,
DHES0815A,,
D-0502,,
palbociclib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
HuC242-DM4,,
MM-111,,
AK112,,
MEDI-573,,
P1446A-05,,
Pazopanib,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors"
GW786034,,
Epirubicin,"Drug / Therapeutic Agent|Mutation Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
BCD-115,,
ABT-414,,
Pasireotide,"Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
IMC-11F8,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
omaveloxolone,,
Avapritinib,,
CUDC-101,,
BAY94-9392,,
Aromatase,,
Inhibitor,,
Glucocorticoid,,
Olaratumab,Antineoplastic Agents,
Vincristine,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
Ifosfamide,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Immunotherapeutic,,
SB719125,,
AZD9833,,
Imetelstat,Enzyme Inhibitors,
BVAC-B,,
Resiniferatoxin,,
PDR001,,
OPB-51602,,
NOX66,,
AS703569/gemcitabine,,
Patupilone,Antineoplastic Agents|Tubulin Modulators|Antimitotic Agents|Mitosis Modulators,
mFOLFOX,,
Emtansine,,
LY2940680,,
LHRH,Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
GDC-0927,,
TTI-621,,
GSK525762,,
Abiraterone,,Other hormone antagonists and related agents|Cytochrome P450 2C8 Inhibitors|Cytochrome P450 17A1 Inhibitors|ANTINEOPLASTIC HORMONES|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 17A1 Inhibitor
Venetoclax,Antineoplastic Agents,
ethinyl,,
estradiol/levonorgestrel,,
LY2835219,,
Tamoxifen,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Estrogen Antagonists|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
Pertuzumab,"Monoclonal Antibody|HER-2-Targeting Antibody|Antineoplastic Agents|Antineoplastic Agents, Immunological",
Loperamide,Antidiarrheals|Drug / Therapeutic Agent|Gastrointestinal Agents,
HQP1351,,
OBP-301,,
VM206DNA,,
VM206Ad,,
ASP1951,,
LY3007113,,
I-8H9,,
KX2-361,,
BAY2010112,,
ABBV-621,,
FOLFIRI,Antineoplastic Agents,
U3-1402,,
INCB001158,Enzyme Inhibitors,
LY3295668,,
Erbumine,Human Data,
Midazolam,"Adjuvants, Anesthesia|Anesthetics, Intravenous|Drug / Therapeutic Agent|GABA Modulators|Human Data|Mutation Data|Reproductive Effect|Anesthetics|Anesthetics, General|Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|Hypnotics and Sedatives|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents",
LY3164530,,
ALIMTA,"Antineoplastic Agents|Enzyme Inhibitors|Antimetabolites|Antimetabolites, Antineoplastic|Folic Acid Antagonists|Noxae|Nucleic Acid Synthesis Inhibitors","Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues"
ALIMTA,,"Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues"
folic,,
huMNC2-CAR44,,
RP2D,,
l/Phase,,
CNTO,,
E7046,,
capecitabine,"Antineoplastic Agents|Antimetabolites|Antimetabolites, Antineoplastic|Noxae",
folinic,,
acid/5-FU/oxaliplatin,,
mFOLFOX-6,,
BOS172722,,
bivatuzumab,Monoclonal Antibody|Immunomodulator,
mertansine,,
MAG-TN3,,
TTAC-0001,,
123-I-MIP-1072,,
111-In,,
capromab,,
pendetide,,
Combretastatin,"Antineoplastic Agents, Phytogenic|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
Diphosphate,,
OXi4503,,
ABI-007,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
hydrobromide,,
Theophylline,Bronchodilator Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Phosphodiesterase Inhibitors|Reproductive Effect|Tumor Data|Vasodilator Agents|Anti-Asthmatic Agents|Autonomic Agents|Cardiovascular Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Respiratory System Agents|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists,
Theophylline,Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Enzyme Inhibitors|Neurotransmitter Agents|Peripheral Nervous System Agents|Phosphodiesterase Inhibitors|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Respiratory System Agents|Vasodilator Agents,
Niraparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
LY2090314,,
pemetrexed,"Antineoplastic Agents|Enzyme Inhibitors|Antimetabolites|Antimetabolites, Antineoplastic|Folic Acid Antagonists|Noxae|Nucleic Acid Synthesis Inhibitors","Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues"
pemetrexed,,"Protein Synthesis Inhibitors|Thymidylate Synthetase Inhibitors|Dihydrofolate Reductase Inhibitors|Folic Acid Metabolism Inhibitors|ANTINEOPLASTICS,ANTIMETABOLITES|Folate Analog Metabolic Inhibitor|Folic acid analogues"
ZD6474,Antineoplastic,
Zactima,Antineoplastic,
LY2157299,,
RMC-4630,,
DS-1123,,
EPO906,Antineoplastic Agents|Tubulin Modulators|Antimitotic Agents|Mitosis Modulators,
patupilone,Antineoplastic Agents|Tubulin Modulators|Antimitotic Agents|Mitosis Modulators,
trastuzumab-MCC-DM1,"Antineoplastic Agents|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators|Antineoplastic Agents, Immunological",
mRNA-4157,,
losartan,Anti-Arrhythmia Agents|Antihypertensive Agents|Drug / Therapeutic Agent|Human Data|Angiotensin II Type 1 Receptor Blockers|Cardiovascular Agents|Angiotensin Receptor Antagonists,
dextromethorphan,Antitussive Agents|Drug / Therapeutic Agent|Excitatory Amino Acid Antagonists|Human Data|Central Nervous System Agents|Excitatory Amino Acid Agents|Neurotransmitter Agents|Respiratory System Agents,
rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors|Anticholesteremic Agents|Antimetabolites|Enzyme Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents,
bupropion,"Drug / Therapeutic Agent|Antidepressive Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Dopamine Agents|Dopamine Uptake Inhibitors|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Membrane Transport Modulators|Metabolic Side Effects of Drugs and Substances|Smoking Cessation Agents",
encorafenib,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|BRAF Serine/Threonine Kinase Inhibitors"
binimetinib,,"Protein kinase inhibitors|Protein Kinase Inhibitors|ANTINEOPLASTIC,OTHER"
modafinil,Central Nervous System Stimulants|Central Nervous System Agents|Neuroprotective Agents|Protective Agents|Cytochrome P-450 CYP3A Inducers|Wakefulness-Promoting Agents|Metabolic Side Effects of Drugs and Substances,
Regorafenib,Antineoplastic Agents,
Stivarga,Antineoplastic Agents,
Stivarga,,
BAY73-4506,Antineoplastic Agents,
BAY73-4506,,
Cixutumumab,,
LSZ102,,
Rovalpituzumab,,
tesirine,,
AZD8835,,
Danvatirsen,,
Oleclumab,,
dalotuzumab,,
MK0646,,
emtansine,,
MGD013,,
margetuximab,,
anticancer,,
IC01,,
LY3022855,,
PTC299,,
GSK2110183,,
AZD8931,,
MLN1117,Enzyme Inhibitors,
ASP1948,,
Lumretuzumab,,
SPI-2012,,
GSK1795091,,
GSK3174998,,
GSK3359609,,
BGJ398,,
pyrotinib,,
DOXIL/CAELYX,,
gemcitabine,"Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antiviral Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Noxae|Radiation-Sensitizing Agents",
Sulfatinib,,
MGCD516,,
TQB2450,,
Anlotinib,,
Hydrochioride,,
RAD1901,,
E7820,,
cetuximab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
PRO95780,,
AG-221,,
rhPSMA-7.3,,
ENMD-2076,,
Tucatinib,,
anti-HER2,,
injection.R,,
CVA21,,
Mitomycin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Cross-Linking Reagents|Enzyme Inhibitors|Indicators and Reagents|Noxae|TSCA Flag S (Substance is Identified in a Final Significant New Use Rule)","ANTINEOPLASTIC ANTIBIOTICS|ANTIGLAUCOMA,OTHER|Other cytotoxic antibiotics|Alkylating Activity|Nucleic Acid Synthesis Inhibitors|Alkylating Drug"
Mitomycin,,"ANTINEOPLASTIC ANTIBIOTICS|ANTIGLAUCOMA,OTHER|Other cytotoxic antibiotics|Alkylating Activity|Nucleic Acid Synthesis Inhibitors|Alkylating Drug"
TAS-102,,
CPT-11,"Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
CBL0137,,
RAD140,,
LBH589,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
RG1507,,
GDC-0980,,
Bavituximab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
everolimus,Immunosuppressant|Immunologic Factors|Immunosuppressive Agents|Antineoplastic Agents,
panitumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
ABX-EGF,,
Panitumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
spartalizumab,,
LAG525,,
NIR178,,
capmatinib,,
MCS110,,
canakinumab,,Interleukin 1 Receptor Antagonists|Interleukin inhibitors|IMMUNE SUPPRESSANTS
AZD1775,,
Trifluridine,Antimetabolites|Antiviral Agents|Mutation Data|Anti-Infective Agents|Noxae,
Tipiracil,,
KPG-121,,
escalation,,
Taselisib,,
Nexavar,Protein Kinase Inhibitors|Antineoplastic Agents|Enzyme Inhibitors,
Nexavar,,
BAY43-9006,Protein Kinase Inhibitors|Antineoplastic Agents|Enzyme Inhibitors,
TTC-352,,
Fluzoparib,,
Buparlisib,,
POL6326,,
ONO-4538,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
AZD3759,,
AZD9291,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
ABBV-155,,
Cediranib,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
ALT-803,,
Humanized,,
Bispecific,,
Antibody,,
MBS301,,
panobinostat,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
XELOX,Antineoplastic Agents,
vatalanib,Protein Kinase Inhibitors|Enzyme Inhibitors,
vorinostat,Antitumor Agent|Histone Deacetylase Inhibitor|Antineoplastic Agents|Enzyme Inhibitors|Anticarcinogenic Agents|Histone Deacetylase Inhibitors,
Platinum-based,,
LY01005,,
Zoladex,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Human Data|LHRH Agonist|Reproductive Effect|Antineoplastic Agents",
CriPec®,,
docetaxel,Antineoplastic Agents|Drug / Therapeutic Agent|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators,
docetaxel,Antineoplastic Agents|Tubulin Modulators|Mitosis Modulators|Antimitotic Agents,
Rucaparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
Etoposide,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|DNA Topoisomerase II Inhibitors|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
OTS167IV,,
Ixabepilone,Antineoplastic|Antineoplastic Agents,
ZEN003694,,
oxaliplatin,Drug / Therapeutic Agent|Antineoplastic|Antineoplastic Agents,
oxaliplatin,Antineoplastic Agents,
GDC-0941,,
L-DOS47,,
ASP9801,,
OMP-336B11,,
MTIG7192A,,
MEK162,,
degarelix,GnRH Antagonists|Peptides|Gonadotropin-Releasing Hormone Antagonist|Treatment of Prostate Cancer,
INO-5150,,
electroporation,,
CELLECTRA®-5P,,
INO-9012,,
AMN107,Antineoplastic|Antineoplastic Agents,
STI571,Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Antroquinonol,,
GSK2141795,,
EP2101,,
Elesclomol,,
FOR46,,
RGX-104,,
Pictilisib,,
dulanermin,,
pLADD,,
AZD5363,,
Gimatecan®,,
ST-1481,Antineoplastic,
ST-1481,,
XMT-1536,,
SPARC1613,,
Reference1613,,
Sutent,Angiogenesis Inhibitors|Antineoplastic Agents|Growth Substances|Angiogenesis Modulating Agents,
Sutent,Protein Kinase Inhibitors|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Enzyme Inhibitors,
SHR9549,,
Ficlatuzumab,,
PF-06755992,,
PF-06755990,,
Tremelimumab,Antineoplastic Agents,
PF-06801591,,
OB318,,
AGS67E,,
NEV801,,
GW572016,Tyrosine Kinase Inhibitors|Antineoplastic Agents|Dual EGFR/erbB2 Inhibitors|Enzyme Inhibitors|Protein Kinase Inhibitors,
ALT-836,,
HPN424,,
RUTI®,,
P276-00,,
SYN004,,
VXM01,,
INO-3106,,
SU011248,Angiogenesis Inhibitors|Antineoplastic Agents|Growth Substances|Angiogenesis Modulating Agents,
SU011248,Protein Kinase Inhibitors|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Enzyme Inhibitors,
axitinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
MUC1-gene-DC-CTL,,
MUC1-peptide-DC-CTL,,
GX-188E,,
NIZ985,,
Cirmtuzumab,,
Custirsen,,
ANG1005,,
MEHD7945A,,
Cobimetinib,Antineoplastic Agents,
ridaforolimus,,
MK-0752,,
MK-2206,,
LErafAON,,
BN83495,,
MCLA-145,,
JNJ-26481585,,
ABBV-399,,
PSMA,,
veliparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
P16-093,,
STA-9090,,
ganetespib,,
LErafAON-ETU,,
Dasatinib,Antineoplastic|Enzyme Inhibitors|Protein Kinase Inhibitors,
Dasatinib,Protein Kinase Inhibitors|Enzyme Inhibitors|Antineoplastic Agents,
DMUC4064A,,
mg/m^2,,
Glufosfamide,,
LY3434172,,
KO-947,,
SCT200,,
AGEN1181,,
Vorinostat,Antitumor Agent|Histone Deacetylase Inhibitor|Antineoplastic Agents|Enzyme Inhibitors|Anticarcinogenic Agents|Histone Deacetylase Inhibitors,
LEP-ETU,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
Taxol,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
PD-L1,,
t-haNK,,
DM-CHOC-PEN,,
AGS-22M6E,,
ASG-22CE,,
PG545,,
Monotherapy,,
pegol,,
Therapy,,
BPX-201,,
AP1903,,
SHR-1501,,
goserelin,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Human Data|LHRH Agonist|Reproductive Effect|Antineoplastic Agents",
goserelin,"Antineoplastic Agents|Antineoplastic Agents, Hormonal",
nab-paclitaxel,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
BIBF,,
ABBV-151,,
AZD9496,,
AMC303,,
MASCT-I,,
Chemophase,,
Biologicals,,
Tesmilifene,Histamine Antagonists|Platelet Aggregation Inhibitors|Hematologic Agents|Histamine Agents|Neurotransmitter Agents,
MP-470,,
amuvatinib,,
IBI318,,
AZD4547,,
Vistusertib,,
AZD9150,,
Selumetinib,,
tivozanib,,
IMF-001,,
Clostridium,,
novyi-NT,,
ABBV-368,,
FOLFOX-4,,
TAB08,,
PF-06939999,,
DSTP3086S,,
Pyruvate,,
CA102N,,
LONSURF,,"Unknown Cellular or Molecular Interaction|ANTINEOPLASTIC,OTHER|Thymidylate Synthetase Inhibitors|Nucleoside Metabolic Inhibitor|Antivirals|Nucleoside Analog Antiviral|Thymidine Phosphorylase Inhibitor|Nucleic Acid Synthesis Inhibitors|Thymidine Phosphorylase Inhibitors"
Cabazitaxel,,"Tubulin Interactions|Microtubule Inhibitor|ANTINEOPLASTIC,OTHER|Taxanes"
Ensartinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
XRP6258,,
prednisolone,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
afatinib,Antineoplastic Agents|Radiation-Sensitizing Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
OTS167PO,,
BMS-641988,,
ModraDoc006/r,,
SHR-1316,,
bengal,Culture Media|Natural Product|Tumor Data|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
disodium,,
SAR408701,,
dexamethasone,"Antiemetics|Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Immunomodulator|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents",
naphazoline,Adrenergic alpha-Agonists|Drug / Therapeutic Agent|Nasal Decongestants|Adrenergic Agents|Adrenergic Agonists|Cardiovascular Agents|Neurotransmitter Agents|Respiratory System Agents|Vasoconstrictor Agents,
diphenhydramine,"Anesthetics, Local|Anti-Allergic Agents|Antiemetics|Drug / Therapeutic Agent|Histamine H1 Antagonists|Human Data|Mutation Data|Reproductive Effect|Anesthetics|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Hypnotics and Sedatives|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Sleep Aids, Pharmaceutical",
SAR428926,,
CA-4948,,
TJ004309,,
Anti-PD-L1,,
HM95573,,
cobimetinib,Antineoplastic Agents,
autologous,,
Cetrelimab,,
PCA062,,
regorafenib,Antineoplastic Agents,
Xeloda®,,
OMP-52M51,,
brontictuzumab,,
trifluridine/tipiracil,,"Unknown Cellular or Molecular Interaction|ANTINEOPLASTIC,OTHER|Thymidylate Synthetase Inhibitors|Nucleoside Metabolic Inhibitor|Antivirals|Nucleoside Analog Antiviral|Thymidine Phosphorylase Inhibitor|Nucleic Acid Synthesis Inhibitors|Thymidine Phosphorylase Inhibitors"
DCC-3014,,
NBM-BMX,,
softgel,,
NPI-0052,,
AutoSynVax,,
DPX-Survivac,,
cyclophosphamide,"Agricultural Chemical|Alkylating Agents|Antineoplastic Agents, Alkylating|Antirheumatic Agents|Drug / Therapeutic Agent|Experimental Pesticide|Human Data|Immunosuppressive Agents|Mutagens|Mutation Data|Reproductive Effect|Tumor Data|Unspecified / Unclassified Pesticide|Antineoplastic Agents|Immunologic Factors|Myeloablative Agonists|Noxae",
cyclophosphamide,"Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antirheumatic Agents|Immunologic Factors|Immunosuppressive Agents|Mutagens|Myeloablative Agonists|Noxae",
Relatlimab,,
SHR2554,,
Promitil,,
Elacestrant,,
KRN330,,
MGCD265,,
ADXS31-142,,
Platinum-doublet,,
DS-6051b,,
ES101,,
mg/mL,,
Ketoconazole,"Antifungal Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Anti-Infective Agents|14-alpha Demethylase Inhibitors|Enzyme Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
PVX-410,,
HSP990,,
EP-100,,
TSR-022,,
TSR-042,,
anti-PD-1,,
TSR-033,,
anti-LAG-3,,
XL184,,
KTN3379,,
vemurafenib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
TAK-659,,
BPX-501,,
rimiducid,,
Copanlisib,Antineoplastic Agents,
BAY80-6946,Antineoplastic Agents,
Rifampin,"Antibiotics, Antitubercular|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Leprostatic Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Anti-Bacterial Agents|Anti-Infective Agents|Antitubercular Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inducers|Metabolic Side Effects of Drugs and Substances",
MLN0264,,
pbi-shRNA,,
STMN1,,
Chlorogenic,,
5-fluorouracil,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
malate,,
malate,Skin / Eye Irritant,
ALT-801,,
ZD4054,,
Zibotentan,,
Bortezomib,Antineoplastic Agents|Protease Inhibitors|Enzyme Inhibitors,
Imatinib,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
SAR302503,Antineoplastic,
TG101348,Antineoplastic,
Panolosetron,,
OSI-930,,
Crizotinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
IBI188,,
L19TNFa,,
atezolizumab,Antineoplastic Agents,
Mitoxantrone,Analgesics|Antineoplastic Agents|Mutation Data|DNA Topoisomerase II Inhibitor|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
Mitoxantrone,Drug / Therapeutic Agent|Human Data|Mutation Data|DNA Topoisomerase II Inhibitor,
EnGeneIC,,
LY2228820,,
LY2875358,,
trametinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
AGS15E,,
Lenvatinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Nanoplatin,,
NC-6004,,
"CP-675,206",Antineoplastic Agents,
DS-1205c,,
PAN-301-1,,
TRX-818,,
AZD4635,,
M3814,,
Avastin,"Antineoplastic|Monoclonal Antibody|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Antineoplastic Agents, Immunological",
Xeloda,"Antineoplastic Agents|Antimetabolites|Antimetabolites, Antineoplastic|Noxae",
Tarceva,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Radium-223,,
Dichloride,,
VX15/2503,,
SAR245408,Antineoplastic Agents,
ABT-767,,
Liposomes,,
SAR125844,,
cediranib,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
RECENTIN,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
EGEN-001,,
phIL-12-005/PPC,,
TOK-001,Enzyme Inhibitors,
IMC-1121B,Antineoplastic Agents,
bendamustine,"Antineoplastic Agents|Alkylating Agents|Antineoplastic Agents, Alkylating|Noxae",
DFP-14927,,
PCUR,,
Sevacizumab,,
MABp1,,
methyl,,
VCN-01,,
MLN2704,,
MLN591,,
Navitoclax,Antineoplastic Agents,
ZL-2306,,
niraparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
SAR245409,,
REOLYSIN®,,
Merck,,
GS-9820,,
Iniparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
SAR240550-BSI-201,,
Placlitaxel,,
U3-1565,,
selumetinib,,
Lirilumab,,
IDH305,,
PM02734,,
Talazoparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
Tanibirumab,,
4SC-202,,
CA-18C3,,
7-t-butyldimethylsilyl-10-hydroxycamptothecin,,
MEDI0680,,
AMP-514,,
aflibercept,,"Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Inhibitors|OPHTHALMICS,OTHER|Vascular Endothelial Growth Factor Inhibitor|Antineovascularisation agents"
P501-AS15,,
MK-1697,,
PAC-1,,
SAR260301,,
GT0918,,
pimasertib,,
PI3K,,
mTOR,,
LDK378,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
ONC1-0013B,,
PF-00299804,,
NKR-2,,
OPB-111077,,
Intuvax,,
ilixadencel,,
Ribociclib,Antineoplastic Agents,
Ceritinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
SAR566658,,
MK2461,,
DS-7423,,
SLC-0111,,
INCB040093,,
itacitinib,,
KHK2455,,
Mogamulizumab,Antineoplastic Agents,
Tirabrutinib,,
Idelalisib,Antineoplastic Agents|Enzyme Inhibitors,
Entospletinib,,
Obinutuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
CYP1A2,,
CYP2C19,,
CYP3A,,
Kytril,Drug / Therapeutic Agent|Mutation Data|Reproductive Effect,
granisetron,Antiemetics|Serotonin Antagonists|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin Agents,
Wee-1,,
kinase,,
liposome,,
Tivantinib,,
M200,Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances,
Volociximab,Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances,
defactinib,,
AVE8062,,
OMP-305B83,,
nab-Paclitaxel,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
AZD1208,,
crizotinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Kadcyla,"Antineoplastic Agents|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators|Antineoplastic Agents, Immunological",
KPT-330,,
ANX-514,,
Foxy-5,,
RDEA119,,
PF-04449913,,
RO6874281,,
Selicrelumab,,
SB-485232,,
interleukin,,
Intratumoral,,
Poly,,
ICLC,,
Intramuscular,,
TAK-385,,
OSI-774,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
VEGF,,
alaninate,,
BN80927,,
Ivosidenib,Antineoplastic Agents|Enzyme Inhibitors,
MSC2156119J,,
#NAME?,,
Anti-HER2,,
VHH1,,
PF-03446962,,
MEDI4276,,
pazopanib,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Receptor Inhibitors|Cytochrome P450 2C8 Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Cytochrome P450 2D6 Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor|Cytochrome P450 3A4 Inhibitors"
DMOT4039A,,
tislelizumab,,
pamiparib,,
JNJ-61186372,,
XmAb18087,,
BGB-3111,,
ASP5878,,
NJH395,,
Margetuximab,,
ZIO-201,"Antineoplastic Agents, Alkylating|Alkylating Agents|Antineoplastic Agents|Noxae",
Chiauranib,,
OMBRABULIN,,
Ombrabulin,,
Sym013,,
BBI503,,
NKTR-214,,
alisertib,,
Cabozantinib,,"Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor"
CNF2024,,
IPH5401,,
nesvacumab,,
REGN910/,,
SAR307746,,
ombrabulin,,
CT-2103,Antineoplastic Agents,
Samarium-153,,
Androgen,,
Bicalutamide,"Androgen Antagonists|Antineoplastic Agents|Drug / Therapeutic Agent|Reproductive Effect|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
androgen,,
Goserelin,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Human Data|LHRH Agonist|Reproductive Effect|Antineoplastic Agents",
Goserelin,"Antineoplastic Agents|Antineoplastic Agents, Hormonal",
Itacitinib,,
BPX-101,,
BEL-X-HG,,
IXAZOMIB,Antineoplastic Agents|Enzyme Inhibitors|Protease Inhibitors,
E7050,,
Cellcristin®,,
pharm®,,
imatinib,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
ceritinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Oraxol,,
Calcium,Calcium-Regulating Hormones and Agents,
Amor,,
CBDCA,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Cross-Linking Reagents|Indicators and Reagents,
AUC5,,
mg/mL*min,,
MLN2480,,
Alisertib,,
ADU-S100,,
Genexol-PM,,
CS-1008,,
mRNA-2752,,
durvalumab,,"ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker"
AMG820,,
FP-1039,,
IMP4297,,
etoposide/cisplatin,,
Intravenous,,
MK-3475/,,
Intravesical,,
belinostat,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
Keytruda,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Trimix,,
BIND-014,,
Neratinib,Antineoplastic Agents,
LYC-55716,,
XMT-1001,,
RRx-001,,
Temsirolimus,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor"
Ferumoxytol,Mutation Data,IRON|Parenteral Iron Replacement|Electrolyte Activity
Ferumoxytol,,IRON|Parenteral Iron Replacement|Electrolyte Activity
MM-398,,
SU014813,,
RO7051790,,
HM30181AK,,
TPX-0022,,
SHR9146+SHR-1210,,
SHR9146+SHR-1210+Apatinib,,
F0002-ADC,,
IMC-TR1,,
CMP-001,,
CBP501,,
rHuPH20,,
SPARC-08-038,,
Ref-08-038,,
MLN4924,Enzyme Inhibitors,
PTK787,,
LY2334737,,
rovalpituzumab,,
Docetaxel-PNP,,
Carfilzomib,,"Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER"
CCI-779,,
temsirolimus,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor"
XL765,,
APG-1252,,
enoblituzumab,,
PTK/ZK222584,,
LDE225,,
BIIB022,,
XL147,Antineoplastic Agents,
ACY-241,,
TAK-228,,
isomaltoside,,
GM-CT-01,,
OCPM,,
Vaccine,,
AS703569,,
SAR256212,,
Anti-OX40,,
CV301,,
TAK-733,,
alpelisib,,"ANTINEOPLASTIC,OTHER"
buparlisib,,
PTK787/ZK222584,,
iNeo-Vac-P01,,
BMS-690514,,
AGS-8M4,,
AC0010MA,,
LY3039478,,
HS-10241,,
EMB-01,,
PF-06952229,,
Enadenotucirev,,
PRS-343,,
AVX701,,
SF1126,,
Alectinib,Antineoplastic Agents,
PGV001,,
NBF-006,,
famitinib,,
Oprozomib,,
MEDI6469,,
MORAb-003,Antineoplastic Agents,
AZD7648,,
BMK120,,
Malate,,
Malate,Skin / Eye Irritant,
AB0024,,
Sym022,,
Sym023,,
imiquimod,"Adjuvants, Immunologic|Interferon Inducers|Antineoplastic Agents|Immunologic Factors",
GRASPA,,
TAK700,,
Lomustine,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
RO5323441,,
Anti-Macrophage,,
Inhibitory,,
Anti-MIF,,
FOLIRI,,
lurbinectedin,,
PM01183,,
DMUC5754A,,
Ad-RTS-hIL-12,,
veledimex,,
Rifampicin,"Antibiotics, Antitubercular|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Leprostatic Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Anti-Bacterial Agents|Anti-Infective Agents|Antitubercular Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inducers|Metabolic Side Effects of Drugs and Substances",
CC-115,,
PU-H71,Antineoplastic Agents,
TRASTUZUMAB,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
123-I-MIP-1095,,
INCB086550,,
Oratecan,,
AXL1717,Natural Product,
13-cis-retinoic,,
celecoxib,"Anti-Inflammatory|Analgesic|Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Cyclooxygenase 2 Inhibitors|Antirheumatic Agents",
leucovorin,Growth Substances|Micronutrients|Vitamin B Complex|Vitamins|Antidotes|Protective Agents,
Dovitinib,,
Dexanabinol,Antiemetics|Excitatory Amino Acid Antagonists|Anti-Arrhythmia Agents|Autonomic Agents|Cardiovascular Agents|Central Nervous System Agents|Excitatory Amino Acid Agents|Gastrointestinal Agents|Neuroprotective Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Protective Agents,
PF00562271,,
DPX-0907,,
tumor-specific,,
HLA-A2-restricted,,
peptide,,
polynucleotide,,
Montanide,,
ISA51,,
IHL-305,,
epothilone,,
Dinaciclib,,
SV-BR-1-GM,,
Interferon-alpha-2b,Drug / Therapeutic Agent|Human Data,
FCN-437,,
Linifanib,,
AV-299,,
GSK3745417,,
Aliqopa,Antineoplastic Agents,
Aliqopa,,
forodesine,,
E7090,,
MSB0010718C,,
Axitinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
AG-013736,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Gimatecan,Antineoplastic,
XMT-1522,,
Tergenpumatucel-L,,
Indoximod,,
BMS-599626,,
PF-02341066,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
TG01,,
131I-MIP-1095,,
MEDI0562,,
NPI-2358,,
rituximab,"Antineoplastic Agents|Antirheumatic Agents|Immunologic Factors|Antineoplastic Agents, Immunological",
sodium,,
Child-Pugh,,
NSCLC,,
PledOx,,
µmol/kg,,
DNIB0600A,,
ARGX-111,,
Sym021,,
DS-8895a,,
MBP-426,,
PD-0332991,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Photofrin,Antineoplastic Agents|Photosensitizing Agents|Dermatologic Agents|Radiation-Sensitizing Agents,
porfimer,Antineoplastic Agents|Dermatologic Agents|Photosensitizing Agents|Radiation-Sensitizing Agents,
ARRY-334543,,
EGFR/ErbB2,,
JNJ-26483327,,
SNDX-6352,,
AZD0530,Antineoplastic Agents|Enzyme Inhibitors,
LCL161,,
SGT-94,,
AK-104,,
Eribulin-LF,,
ID-LV305,,
Trifluridine/tipiracil,,
mg/min/mL,,
SKI-606,Antineoplastic (Src Kinase Inhibitor)|Antineoplastic Agents,
AB122,,
BMS-354825,Antineoplastic|Enzyme Inhibitors|Protein Kinase Inhibitors,
Erbitux,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
C225,,
MEDI0639,,
IMC-3C5,,
LY573636,,
XL820,,
CS1002,,
XL647,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Hydroxychloroquine,Antimalarials|Antirheumatic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents,
AZD1152,,
Suberoylanilide,,
Hydroxamic,,
SAHA,Antitumor Agent|Histone Deacetylase Inhibitor|Antineoplastic Agents|Enzyme Inhibitors|Anticarcinogenic Agents|Histone Deacetylase Inhibitors,
ISU104,,
Indium,,
IMP-205xm734,,
Merestinib,,
MLN9708,,
MLN9708,Antineoplastic Agents|Enzyme Inhibitors|Protease Inhibitors,
Nivolumab/Lirilumab,,
Pexa-Vec,,
E7130,,
CMD-193,,
AVID200,,
GDC-0994,,
LY2584702,,
LE-DT,,
bosutinib,Antineoplastic (Src Kinase Inhibitor)|Antineoplastic Agents,
aldesleukin,Anti-HIV Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents,
Afatinib,Antineoplastic Agents|Radiation-Sensitizing Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
clofarabine,"Antineoplastic Agents|Mutation Data|Antimetabolites|Antimetabolites, Antineoplastic|Noxae",
bsi-201,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
topotecan,Antineoplastic Agents|Enzyme Inhibitors|Antineoplastic|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,
carboplatin/paclitaxel,,
Leuprolide,"Antineoplastic Agents, Hormonal|Fertility Agents, Female|Hormone|Human Data|Reproductive Effect|Antineoplastic Agents|Fertility Agents|Reproductive Control Agents",
Casodex,"Androgen Antagonists|Antineoplastic Agents|Drug / Therapeutic Agent|Reproductive Effect|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
MEGF0444A,,
TAK-441,,
ASONEP,,
sonepcizumab/LT1009,,
IT-pIL12-EP,,
Stibogluconate,,
Interferon,Antineoplastic Agents|Antiviral Agents|Mutation Data|Anti-Infective Agents,
Alpha-2b,,
GO-203-2c,,
MORAb-202,,
Aneustat,,
OMN54,,
AZD2461,,
decitabine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Reproductive Effect|Teratogens|Antimetabolites|Antineoplastic Agents|Noxae",
genistein,"Anticarcinogenic Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Reproductive Effect|Estrogens|Estrogens, Non-Steroidal|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phytoestrogens|Protective Agents|Protein Kinase Inhibitors",
SLC-391,,
IMGN388,,
MFGR1877S,,
HLX10,,
Filgrastim,Drug / Therapeutic Agent|Human Data|Natural Product|Hematologic Agents,
#NAME?,,
gefitinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
PBF-999,,
ADG106,,
DFP-11207,"Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Noxae",
CEND-1,,
MEDI1873,,
TAK-164,,
ThermoDox,,
cilengitide,Peptides,
radiochemotherapy,,
TAK-788,,
Pegzilarginase,,
Zoledronic,,
apalutamide,,"GABA A Antagonists|Anti-androgens|ANTINEOPLASTIC,OTHER|Androgen Receptor Antagonists"
CEP-9722,,
SOR-C13,Antineoplastic Agents|Calcium Channel Blockers|Calcium-Regulating Hormones and Agents|Cardiovascular Agents|Membrane Transport Modulators,
etoposide,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|DNA Topoisomerase II Inhibitors|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Prolanta,,
prolactin,Hormone|Mutation Data|Reproductive Effect,
prolactin,,
HLX07,,
Acetaminophen,"Analgesics, Non-Narcotic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Antipyretics",
5-HT3,,
vinorelbine,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Antineoplastic Agents|Antimitotic Agents|Tubulin Modulators",
EGFR,,
IL12,,
NG-350A,,
PLX3397,,
V930,,
V932,,
Vigil,,
Quisinostat,,
ranibizumab,Growth Substances|Angiogenesis Modulating Agents|Angiogenesis Inhibitors|Antineoplastic Agents|Growth Inhibitors|Immunologic Factors,
GDC-0425,,
Pegilodecakin,,
Oxaliplatin/Leucovorin/5-Fluorouracil,,
gemcitabine/nab-paclitaxel,,
Gemcitabine/carboplatin,,
Gevokizumab,,
NG-641,,
Rapamycin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Immunosuppressive Agents|Mutation Data|Natural Product|Anti-Bacterial Agents|Antifungal Agents|Anti-Infective Agents|Antineoplastic Agents|Immunologic Factors",
EC1169,,
tucotuzumab,,
celmoleukin,Drug / Therapeutic Agent,
GSK2849330,,
Valacyclovir,Anti-Infective Agents|Antiviral Agents,
Selinexor,,
Folinic,,
OMP-131R10,,
AZD5153,,
Panobinostat,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
#NAME?,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
MEDI9447,,
CC-223,,
azacitidine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
CHR-2845,,
AbGn-107,,
GDC-0349,,
MTL-CEBPA,,
MK2206,,
BXQ-350,,
PHA-848125AC,,
5-Fluoruracil,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
IPI-504,,
SCB01A,,
5-fluorouracile,,
PCK3145,,
LFA102,,
GSK2118436,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
avelumab,,"ANTINEOPLASTIC,OTHER|Programmed Death Ligand-1-directed Antibody Interactions|Monoclonal antibodies|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker"
111In-CS-1008,,
AV-412,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
larotaxel,,
G-202,,
Farnesyl,,
Protein,,
Transferase,,
YY-20394,,
Tezacitabine,Antineoplastic Agents|Enzyme Inhibitors|Radiation-Sensitizing Agents,
FMdC,,
Azacitidine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
Melphalan,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Alkylating Agents|Antineoplastic Agents|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Noxae",
Antithymocyte,,
Globulin,,
Sirolimus,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Immunosuppressive Agents|Mutation Data|Natural Product|Anti-Bacterial Agents|Antifungal Agents|Anti-Infective Agents|Antineoplastic Agents|Immunologic Factors",
Tacrolimus,Drug / Therapeutic Agent|Natural Product|Reproductive Effect|Immunologic Factors|Immunosuppressive Agents,
Tacrolimus,Drug / Therapeutic Agent|Immunosuppressive Agents|Immunologic Factors|Calcineurin Inhibitors|Enzyme Inhibitors,
Anti-angiogenesis,,
dichloride,,
Xofigo,Antineoplastic Agents,
BAY88-8223,,
DCC-2618,,
Apaziquone,Drug / Therapeutic Agent|Antineoplastic Agents,
LM716,,
KW-2450,,
Hiltonol,Interferon Inducers|Immunologic Factors,
LY2603618,,
Valproic,,
BAY1895344,,
GEN-1,,
Indomethacin,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Gout Suppressants|Human Data|Mutation Data|Reproductive Effect|Tocolytic Agents|Tumor Data|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Cardiovascular Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Reproductive Control Agents|Sensory System Agents",
Omeprazole,Anti-Ulcer Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Gastrointestinal Agents|Proton Pump Inhibitors,
D-3263,,
NM-3,,
YL-13027,,
AK-105,,
APL-501,,
Enoblituzumab,,
naquotinib,,
AZD7762,,
EM-1421,,
PT-112,,
HDM201,,
GSK3326595,,
Ceramide,,
NanoLiposome,,
MORAb-004,,
TEM1,,
GSK3368715,,
IMGN632,,
IMA101,,
interleukin-2,"Analgesics|Analgesics, Non-Narcotic|Antineoplastic Agents|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents",
interleukin-2,Anti-HIV Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents,
AZD4785,,
NeoVax,,
MUC_1,,
Alvespimycin,,
PTC596,,
lenvatinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
NKP-1339,,
4-Demethyl-4-cholesteryloxycarbonylpenclomedine,,
LTT462,,
Cetuximab/Gefitinib,,
and/or,,
Clofarabine,"Antineoplastic Agents|Mutation Data|Antimetabolites|Antimetabolites, Antineoplastic|Noxae",
Thiotepa,"Alkylating Agents|Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Noxae",
Mycophenolate,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Natural Product|Reproductive Effect|Antineoplastic Agents|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antitubercular Agents",
mofetil,,
TrasGEX,,
GW003,,
PDL192,,
JAB-3068,,
Aroplatin,Drug / Therapeutic Agent,
hydroxamic,,
TCD-717,,
CUDC-907,,
Cloretazine,Alkylating Agents,
CGC-11047,,
5-flurouracil,,
XL092,,
Patupilone/EPO906,,
LAE001,,
BAY1143572,,
RO6839921,,
ARRY-438162,,
Birinapant,,
Conatumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
JNJ-26854165,Radiation-Sensitizing Agents,
laromustine,Alkylating Agents,
mg/mL/min,,
Paricalcitol,,"Vitamin D3 Analog|Other anti-parathyroid agents|Enzyme Interactions|VITAMIN D,OTHER"
rigosertib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
ALX148,,
89Zr-GSK2849330,,
interleukin-4,"Adjuvants, Immunologic|Antineoplastic Agents|Immunologic Factors|Antirheumatic Agents",
PE38KDEL,,
cytotoxin,,
OSI-906,,
PF-06804103,,
Sym004,,
Poliglumex,,
ng/kg,,
ng/kg-D1,,
GBR1302,,
"ng/kgD15,22",,
"D15,22",,
"doses,1200",,
LDE225+gemcitabine,,
AZD2811,,
EOC317,,
2-deoxy-D-glucose,Antimetabolites|Antiviral Agents|Reproductive Effect|Anti-Infective Agents|Noxae,
MNRP1685A,,
ONT-380,,
Tecemotide,,
L-BLP25,,
Plinabulin,,
NGR-hTNF,,
AC0010,,
JNJ-42756493,,
APO010,,
mFOLFIRI,,
CGM097,,
JNJ-74699157,,
SM04755,,
CEP-37250/KHK2804,,
PF-00337210,,
ASP3026,,
GLPG0187,,
omacetaxine,,
mepesuccinate,,
BGB-290,,
INCAGN01876,,
Herceptin®,,
ACE-041,,
PG-11047,,
Satraplatin,Antineoplastic Agents,
lorlatinib,Antineoplastic Agents,
SCT-I10A,,
ABBV-744,,
FPA008,,
BMS-936558,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
biologic,,
GS-5829,,
IMC-RON8,,
Alpelisib,,"ANTINEOPLASTIC,OTHER"
LEAC-102,,
Bevacizumab/Cetuximab,,
IMC-A12,,
MPC-3100,,
Hsp90,,
RX-3117,,
18F-AraG,,
Obatoclax,Enzyme Inhibitors,
Carboplatin/etoposide,,
tisotumab,,
OSI-027,,
XL281,,
famotidine,Anti-Ulcer Agents|Drug / Therapeutic Agent|Histamine H2 Antagonists|Human Data|Reproductive Effect|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Neurotransmitter Agents,
OBI-833/OBI-821,,
MEDI6383,Antineoplastic Agents,
IVAC_W_bre1_uID,,
IVAC_W_bre1_uID/IVAC_M_uID,,
camsylate,,
SHR7390,,
IONIS-STAT3Rx,,
PolyPEPI1018,,
esomeprazole,Anti-Ulcer Agents|Enzyme Inhibitors|Gastrointestinal Agents|Proton Pump Inhibitors,
ziv-aflibercept,,"Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Vascular Endothelial Growth Factor Inhibitors|OPHTHALMICS,OTHER|Vascular Endothelial Growth Factor Inhibitor|Antineovascularisation agents"
SC-43,,
MSC-1,,
ARGX-110,,
Tisotumab,,
Vedotin,,
GSK2256098,,
ASP8374,,
TQB3616,,
eribulin,Antineoplastic Agents,
Famitinib,,
CPI-613,,
STA-5312,,
PF-06647020,,
fluconazole,"Antifungal Agents|Drug / Therapeutic Agent|Human Data|Anti-Infective Agents|14-alpha Demethylase Inhibitors|Enzyme Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
Irosustat,,
IMC-3G3,Antineoplastic Agents,
CNTO888+DOXIL®/,,
Caelyx®,,
CNTO888,,
BLS_ILS_E710c,,
BLS_ILB_710c,,
ST1968,,
INCAGN01949,,
BAY1179470,,
SHR1459,,
Simmitecan,,
Thalidomide,Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Leprostatic Agents|Mutation Data|Reproductive Effect|Teratogens|Tumor Data|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Immunologic Factors|Noxae,
PKI-587,Enzyme Inhibitors|Protein Kinase Inhibitors,
MGN1703,,
Brigatinib,Antineoplastic Agents,
CT7001,,
LY3300054,,
Midalzolam,,
Decitabine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Reproductive Effect|Teratogens|Antimetabolites|Antineoplastic Agents|Noxae",
Vandetanib,Antineoplastic,
X-82,,
SHR-1210,,
#NAME?,,
ancillary,,
AZD5312,,
FAZ053,,
CKD-516,,
SNS-032,,
tumor,,
BTP-114,,
Anti-Androgen,,
Hormone-Releasing,,
Hormone,,
LGX818,,
OMP-18R5,,
filgrastim,Drug / Therapeutic Agent|Human Data|Natural Product|Hematologic Agents,
PR104,,
OMP-59R5,,
BOS172738,,
DCVax-Direct,,
TAK-700,,
PEGPH20,Antineoplastic Agents,
RX-5902,,
non-pegylated,,
SHR-A1403,,
Capivasertib,,
Ad5-SGE-REIC/Dkk3,,
ASA404,Antineoplastic Agents,
BEY1107,,
TEW-7197,,
BLEX,Acaricide|Agricultural Chemical|Insecticide|Mutation Data|Insecticides|Pesticides,
I-131-CLR1404,,
Glumetinib,,
MVT-1075,,
ORIC-101,,
Xtandi,,"ANTINEOPLASTIC,OTHER|Cytochrome P450 2C9 Inducers|Anti-androgens|Cytochrome P450 2C19 Inducers|Androgen Receptor Antagonists|Cytochrome P450 3A4 Inducers|Androgen Receptor Inhibitor"
PR-104,,
RXC004,,
Ulixertinib,,
COM701,,
Opdivo,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
MEDI1191,,
AEE788,,
GDC-0449,Antineoplastic Agents,
letrozole,"Antineoplastic Agents|Enzyme Inhibitors|Aromatase Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
Femara,"Antineoplastic Agents|Enzyme Inhibitors|Aromatase Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
exatecan,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
GSK2820151,,
CHR-3996,,
MEDI5395,,
TLR9,,
SD-101,,
Rexin-G,,
INCB081776,,
ATI-1123,,
ME-143,,
Intraperitoneal,,
'SMT-NK,,
allogeneic,,
RAF265,,
NeoTCR-P1,,
BAY86-9766+Gemcitabine,,
CV787,,
CG7870,,
intravenous,,
intraperitoneal,,
GPX-100,,
volasertib,,
G1T48,,
CM4307,,
AG-013726,,
INCSHR01210,,
Ricolinostat,,
MORAb-009,,
SEA-CD40,,
AZD4877,,
TP-3654,,
ixabepilone,Antineoplastic|Antineoplastic Agents,
salmonella,,
VNP20009,,
Gemcitabine-Releasing,,
GemRIS,,
/TAR-200,,
split-dose,,
SNS-314,,
MK-1248,,
AMG479,,
DJ-927,,
Vismodegib,Antineoplastic Agents,
TG6002,,
Flucytosine,Antifungal Agents|Antimetabolites|Drug / Therapeutic Agent|Human Data|Mutation Data|Anti-Infective Agents|Noxae,
5-FC,Antifungal Agents|Antimetabolites|Drug / Therapeutic Agent|Human Data|Mutation Data|Anti-Infective Agents|Noxae,
Ancotil,Antifungal Agents|Antimetabolites|Drug / Therapeutic Agent|Human Data|Mutation Data|Anti-Infective Agents|Noxae,
G3139,"Antineoplastic Agents|Molecular Probes|Oligodeoxyribonucleotides, Antisense|Oligonucleotides, Antisense",
Oblimersen,"Antineoplastic Agents|Molecular Probes|Oligodeoxyribonucleotides, Antisense|Oligonucleotides, Antisense",
Bcl-2,,
antisense,,
oligonucleotide,,
AVB-S6-500,,
Inoculation,,
CPI-1205,Enzyme Inhibitors,
Abiraterone/Prednisone,,
CR011-vcMMAE,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Dabrafenib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
KN035,,
TLC178,,
BAY1834942,,
Gemfibrozil,Drug / Therapeutic Agent|Human Data|Reproductive Effect|Tumor Data|Antimetabolites|Hypolipidemic Agents|Lipid Regulating Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Metabolic Side Effects of Drugs and Substances,
CDX-0158,,
KTN-0158,,
APX3330,,
haNK,,
cefixime,Drug / Therapeutic Agent|Anti-Bacterial Agents|Anti-Infective Agents,
cefixime,Anti-Infective Agents|Anti-Bacterial Agents,
ceftriaxone,Anti-Bacterial Agents|Anti-Infective Agents,
ciprofloxacin,Drug / Therapeutic Agent|Human Data|Mutation Data|Anti-Infective Agents|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Anti-Bacterial Agents|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors|Metabolic Side Effects of Drugs and Substances,
trimethoprim-sulfamethoxazole,"Anti-Infective Agents|Anti-Infective Agents, Urinary|Antimalarials|Drug / Therapeutic Agent|Human Data|Antiparasitic Agents|Antiprotozoal Agents|Renal Agents|Anti-Bacterial Agents",
idronoxil,,
Nilotinib,Antineoplastic|Antineoplastic Agents,
budesonide/formoterol,Anti-Asthmatic Agents|Respiratory System Agents,
budesonide/formoterol,Respiratory System Agents|Anti-Asthmatic Agents,
fumarate,,
dihydrate,,
methylation,,
genomic,,
hybridization,,
microarray,,
AT13387,,
ABT-700,,
TP-0184,,
BAY1436032,,
MSC2363318A,,
TRC102,,
Recentin,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
TAK-901,,
INCB057643,,
INCB059872,,
anti-EGFR,,
VELCADE,Antineoplastic Agents|Protease Inhibitors|Enzyme Inhibitors,
darinaparsin,,
RXDX-105,,
CT-2106,,
fluorouracil,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
IBI308,,
ALKS,,
MPC-6827,,
ABT-165,,
GSK1120212B,,
DMSO,Cryoprotective Agents|Drug / Therapeutic Agent|Free Radical Scavengers|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Solvents|Tumor Data|Antioxidants|Protective Agents,
ME-344,,
CP-4126,,
TAS-116,,
AG-120,,
AV-203,,
AMP-224,,
Albumin-bound,,
P16_37-63,,
Montanide®,,
ISA-51,,
JNJ-63898081,,
BMS-986213,,
RBN-2397,,
calcium,Calcium-Regulating Hormones and Agents,
Dacogen,,
Vectibix®,,
ONT-10,,
Genz-644282,,
28-day,,
21-day,,
palifermin,,"Keratinocyte Growth Factor Receptor Agonists|Mucocutaneous Epithelial Cell Growth Factor|Detoxifying agents for antineoplastic treatment|HORMONES/SYNTHETICS/MODIFIERS,OTHER"
EMD525797,,
BMX-001,,
Blood-stage,,
P.vivax,,
XELODA,"Antineoplastic Agents|Antimetabolites|Antimetabolites, Antineoplastic|Noxae",
Rogaratinib,,
BAY1163877,,
venetoclax,Antineoplastic Agents,
M6620,,
Tesirine,,
Defactinib,,
MGD019,,
CT-322,,
GSK923295,,
OTSGC-A24,,
mgkg,,
43-9006,,
gimatecan,Antineoplastic,
HE3235,,
AlphaMedix,,
Regimen,,
IMP321,,
TRC253,,
CK-301,,
cosibelimab,,
ZD1839,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
panHer,,
FN-1501,,
MEDI9090,,
YS-0N-001,,
Acalabrutinib,,"Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER"
IT-141,,
ZW49,,
TP-1287,,
CapeOx,Antineoplastic Agents,
MDX-010,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Theliatinib,,
Neoantigen,,
CHR-2797,Enzyme Inhibitors,
tosedostat,Enzyme Inhibitors,
Rubitecan,Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,
Rubitecan,Antineoplastic Agents,
SHR6390,,
Anti-RANKL,,
CGX1321,,
ABTL0812,,
Alfa-2b,,
ABBV-927,,
Premetrexed,,
Alimta,"Antineoplastic Agents|Enzyme Inhibitors|Antimetabolites|Antimetabolites, Antineoplastic|Folic Acid Antagonists|Noxae|Nucleic Acid Synthesis Inhibitors",
Alimta,,
Genasense,"Antineoplastic Agents|Molecular Probes|Oligodeoxyribonucleotides, Antisense|Oligonucleotides, Antisense",
SB-743921,,
TR1801-ADC,,
Rilotumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Ponatinib,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
Aldoxorubicin,Antineoplastic Agents,
ETBX-011,,
ETBX-051,,
ETBX-061,,
GI-4000,,
GI-6207,,
GI-6301,,
haNK,,
MGCD0103,Antineoplastic Agents|Histone Deacetylase Inhibitors|Enzyme Inhibitors,
MEDI5752,,
LY2801653,,
GSK3052230,,
Intermittent,,
DSP-0337,,
CYC065,,
CA4P,,
prednisone/prednisolone,,
Verteporfin,Photosensitizing Agents|Dermatologic Agents|Radiation-Sensitizing Agents,
ABBV-428,,
SYD985,,
vc-seco-DUBA,,
Omacetaxine,,Protein Synthesis Inhibitors
MK-7684,,
ISA101/ISA101b,,
ZN-c5,,
sulfatinib,,
AZD8055,,
ARRY-382,,
cFMS,,
CV9103,,
GDC-0032,,
SM-88,,
MK-4830,,
Modufolin,,
ZW25,,
BMS-986016,,
LY3405105,,
Etanercept,"Anti-Inflammatory Agents, Non-Steroidal|Gastrointestinal Agents|Immunosuppressive Agents|Antirheumatic Agents|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Immunologic Factors|Peripheral Nervous System Agents|Sensory System Agents",
BMS-813160,,
INNO-206,Antineoplastic Agents,
DSP-0509,,
PRN1371,,
INO-3112,,
BZL101,,
MK-0482,,
IMMU-107,Treatment of Pancreatic Cancer,
hPAM4,Treatment of Pancreatic Cancer,
CPI-444,,
6R-MTHF,,
Levoleucovorin,Antidotes|Protective Agents,
GSK1363089,Antineoplastic Agents,
CMB305,,
G100,,
Metronomic,,
XL880,Antineoplastic Agents,
LY3415244,,
ICP-105,,
erbitux®,,
thioureidobutyronitrile,,
SPL-108,,
LY3200882,,
F-AraG,,
AO-176,,
aldoxorubicin,Antineoplastic Agents,
MIW815,,
Xofigo®,,
ICP-192,,
Pre-Resection,,
Post-Resection,,
TTX-030,,
AZD5363when,,
RO6874813,,
DOTAP,Fluorescent Dyes|Coloring Agents|Indicators and Reagents|Luminescent Agents,
Diphenhydramine,"Anesthetics, Local|Anti-Allergic Agents|Antiemetics|Drug / Therapeutic Agent|Histamine H1 Antagonists|Human Data|Mutation Data|Reproductive Effect|Anesthetics|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Hypnotics and Sedatives|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Sleep Aids, Pharmaceutical",
SB-715992,,
Atezolizumab1200,,
Sipuleucel-T,Antineoplastic Agents,
NOV1601,,
CHC2014,,
LOAd703,,
MP0274,,
mitotic,,
subcutaneous,,
HMPL-504,,
Orteronel,,
RiMO-301,,
SC16LD6.5,,
E7389-LF,,
LZM009,,
CC-90011,,
RM-1929,,
BMS-833923,,
XL139,,
DTA-H19,,
perifosine,,
NLG802,,
NKTR-102,Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
prodrug,,
Emactuzumab,,
RO7009789,,
DLYE5953A,,
TAK-117,Enzyme Inhibitors,
INVAC-1,,
TH-302,Antineoplastic Agents,
MK-4280,,
Folinate,Growth Substances|Micronutrients|Vitamin B Complex|Vitamins|Antidotes|Protective Agents,
MK-4280A,,
CPI-100,,
HB002.1T,,
VT1021,,
JNJ-63723283,,
Erdafitinib,,"ANTINEOPLASTIC,OTHER"
SHR-1603,,
mesilate,,
PTX-100,,
BIBW,,
Onartuzumab,,
MetMAb,,
Oratopo,Antineoplastic Agents,
MPDL3280A,Antineoplastic Agents,
anti-programmed,,
death-ligand,,
DV281,,
Anti-PD-1,,
RO7121661,,
HL-085,,
MOXR0916,,
D07001-softgel,,
GL-ONC1,,
matuzumab,,
CS1003,,
MT110,,
BAY1082439,,
Rabeprazole,Anti-Ulcer Agents|Enzyme Inhibitors|Gastrointestinal Agents,
humanized,,
anti-OX40,,
ZSTK474,,
XmAb®23104,,
sargramostim,Immunologic Factors,
14C-Labeled,,
PS-341,Antineoplastic Agents|Protease Inhibitors|Enzyme Inhibitors,
prexasertib,,
ralimetinib,,
Dabigatran,Thrombin Inhibitor|Anticoagulants|Antithrombins|Enzyme Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Proteinase Inhibitors,
etexilate,,
BAY1841788,,
ARQ197,,
OBP-801,,
WXFL10030390,,
RO5458640,,
enadenotucirev,,
LPM3480226,,
itraconazole,"Antifungal Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anti-Infective Agents|14-alpha Demethylase Inhibitors|Enzyme Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
rifampin,"Antibiotics, Antitubercular|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Leprostatic Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Anti-Bacterial Agents|Anti-Infective Agents|Antitubercular Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inducers|Metabolic Side Effects of Drugs and Substances",
IPN60090,,
PS101,,
Ultra,,
Kanitinib,,
ERY974,,
Zr-BI,,
Trilaciclib,,
14C-labeled,,
poziotinib,,
IM19,,
CO-1.01,,
hPV19,,
MM-151,,
CCT301-59,,
ABBV-321,,
CS1001,,
Volasertib,,
d1q3w,,
KN046,,
LY3381916,,
Tartrate,"Adrenergic alpha-Agonists|Analgesics, Non-Narcotic|Drug / Therapeutic Agent|Human Data|Vasoconstrictor Agents|Adrenergic Agents|Adrenergic Agonists|Analgesics|Cardiovascular Agents|Central Nervous System Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Adrenergic alpha-1 Receptor Agonists|Oxytocics|Reproductive Control Agents|Serotonin Agents|Serotonin Receptor Agonists",
biosimilar,,
BEVZ92,,
Avastin®,,
PQR309,,
Myocet,,
GDC-0919,,
HLX22,,
CX-3543,,
mg/m²,,
Hemay020,,
AGEN2034,,
BMS-906024,,
RO5045337,,
RO7198457,,
LY3127804,,
Epitinib,,
HC-1119,,
FF21101,,
BTRC4017A,,
ARRY-142886,,
AsiDNA,,
HuMax-IL8,,
RO5503781,,
cabozantinib,,"Protein kinase inhibitors|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER|Protein Kinase Inhibitors|Kinase Inhibitor"
BMS-986205,,
BGB-283,,
PF-04691502,,
PEP02,,
Amatuximab,,
CCS1477,,
LY3321367,,
CKD-810,,
Taxotere,Antineoplastic Agents|Drug / Therapeutic Agent|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators,
Taxotere,Antineoplastic Agents|Tubulin Modulators|Mitosis Modulators|Antimitotic Agents,
Taxotere®,,
Hospira,,
TL32711,,
"5,10-methylenetetrahydrofolate",,
HC1119,,
BMS-907351,,
Lucitanib,,
PF-03732010,,
IL-2,"Analgesics|Analgesics, Non-Narcotic|Antineoplastic Agents|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents",
IL-2,Anti-HIV Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents,
ASP4132,,
MEDI-522,,
GS-1423,,
RO6895882,,
MK-7162,,
Ispinesib,,
OKI-179,,
KITE-718,,
U3-1287,,
TAK-285,,
TECENTRIQ,Antineoplastic Agents,
Vanucizumab,,
SBP-101,,
BAY79-4620,,
CEP-11981,,
NPC-1C/NEO-102,,
Vx-006,,
CA-170,,
mg/d,,
Co-ArgI-PEG,,
IMC-18F1,,
Refametinib,,
BAY86-9766,,
RC48-ADC,,
RO5212054,,
GDC-0810,,
Hyperthermia,,
Simmitinib,,
BPI-16350,,
LHC165,,
Lovaza,,ANTILIPEMIC AGENTS
TAPA-pulsed,,
NaCl,,"ELECTROLYTES/MINERALS,COMBINATIONS|RESPIRATORY AGENTS,OTHER|Electrolyte solutions|ELECTROLYTES/MINERALS,OTHER|IV SOLUTIONS WITHOUT ELECTROLYTES|Salt solutions|EYE WASHES/LUBRICANTS|AMINO ACIDS/PROTEINS,PARENTERAL,WITH ADDED ELECTROLYTES|HYPEROSMOTIC LAXATIVES|Sodium|Acid-Base Activity|AMINO ACIDS/PROTEINS,PARENTERAL,WITHOUT ADDED ELECTROLYTES|NASAL AND THROAT,TOPICAL,OTHER|IV SOLUTIONS WITH ELECTROLYTES|DERMATOLOGICALS,TOPICAL OTHER|PHARMACEUTICAL AIDS/REAGENTS|PERITONEAL DIALYSIS SOLUTIONS|OPHTHALMICS,OTHER|LAXATIVES,OTHER|Electrolyte Activity|SODIUM|IRRIGATION SOLUTIONS"
BAY80-6964,,
BMS-986299,,
RO5429083,,
GX15-070MS,,
BI-6727,,
repotrectinib,,
TPX-0005,,
EOS100850,,
XL999,,
NMS-1286937,,
BiCAR-NK,,
ROBO1,,
CAR-NK,,
HS-410,,
XmAb®22841,,
Keytruda®,,
RO4987655,,
RG547,,
ZIO-101,,
HLX04,,
MRTX849,,
RG4733,,
RO5126766,,
GDC-0575,,
beta-glucan,,
RG1530,,
Perjeta,"Monoclonal Antibody|HER-2-Targeting Antibody|Antineoplastic Agents|Antineoplastic Agents, Immunological",
BAY1000394,,
MK-4166,,
68-Ga,,
PSMA11,,
CPI-200,,
E7389+carboplatin,,
APG-115,,
STA-4783/paclitaxel,,
PEG20,,
Roniciclib,,
Gentuximab,,
norethindrone,"Contraceptives, Oral, Synthetic|Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Contraceptive Agents|Contraceptive Agents, Female|Contraceptives, Oral|Reproductive Control Agents",
estradiol,"Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Estrogens|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
C-0501,,
Darinaparsin,,
HKI-272,Antineoplastic Agents,
Idasanutlin,,
MK0731,,
IC83/LY2603618,,
WX-UK1,,
SP-2577,,
Seclidemstat,,
131I-F16SIP,,
Radioimmunotherapy,,
AMG888,,
AV0113,,
DC-CIT,,
KRN951,,
"CP-870,893",,
Debio,,
abnobaVISCUM,,
Fraxini,,
Larotrectinib,,
Vitrakvi,,
BAY2757556,,
bacTRL-IL-12,,
MSB2311,,
FF-10832,,
YM155,,
hGM-CSF,,
IBI308\Cisplatinum\Pemetrexed,,
IBI308\cisplatin\gemcitabine,,
IBI308\oxaliplatin\capecitabine,,
IBI308\etoposide\cisplatin,,
IBI308\irinotecan\5-FU,,
SM88,,
alpha1H,,
Immunotherapy,,
NV1020,,
phenprocoumon,Anticoagulants|Hematologic Agents,
VAL-083,,
Dianhydrogalactitol,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Mutation Data|Alkylating Agents|Antineoplastic Agents|Noxae",
acenocoumarol,Anticoagulants|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Hematologic Agents,
PM060184,,
oleclumab,,
BGB-A317,,
SGN-CD228A,,
IBI101,,
Sintilimab,,
GAd-209-FSP,,
MVA-209-FSP,,
SHR-1702,,
Camrelizumab,,
ribociclib,Antineoplastic Agents,
EF-022,,
Macrophage,,
Activator,,
isavuconazonium,,ANTIFUNGALS
donafenib,,
tosilate,,
CC-90010,,
SOM230C,,
FF-10850,,
SH-1028,,
MP0310,,
BSI-201,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
iniparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
Tizanidine,"Adrenergic alpha-Agonists|Analgesics|Anticonvulsants|Drug / Therapeutic Agent|Muscle Relaxants, Central|Parasympatholytics|Adrenergic Agents|Adrenergic Agonists|Autonomic Agents|Central Nervous System Agents|Neuromuscular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Adrenergic alpha-2 Receptor Agonists",
177Lu-PSMA-R2,,
Pexidartinib,,
Debio1347,,
CH5183284,,
govitecan,,
BAT8003,,
Sporanox,"Antifungal Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anti-Infective Agents|14-alpha Demethylase Inhibitors|Enzyme Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
GWN323,,
omeprazol,Anti-Ulcer Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Gastrointestinal Agents|Proton Pump Inhibitors,
metoprolol,Adrenergic Agents|Adrenergic Antagonists|Anti-Arrhythmia Agents|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sympatholytics|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists,
IBI310,,
mPEG-r-crisantaspase,,
RO5479599,,
zirconium-89-labeled,,
HTI-1090,,
RO5083945,,
MGD009,,
MGA012,,
Oradoxel,,
RO6958688,,
Tocilizumab,,"Interleukin-6 Receptor Antagonist|Interleukin inhibitors|Interleukin 6 Receptor Antagonists|ANTIRHEUMATICS,OTHER"
Andecaliximab,,
ABT-869,,
lovaza,,ANTILIPEMIC AGENTS
ODM-208,,
NER1006,,
Moviprep,,"Vitamin C|Unknown Cellular or Molecular Interaction|HYPEROSMOTIC LAXATIVES|Other ophthalmologicals|Electrolyte Activity|Ascorbic acid (vitamin C), plain|Salt solutions|Free Radical Scavenging Activity|Enzyme Interactions|Sodium|Acid-Base Activity|Organic acids|Osmotic Laxative|Osmotically acting laxatives|Electrolyte solutions|Potassium|Osmotic Activity"
BGB-A1217,,
Tislelizumab,,
NIRFLI,,
Alkotinib,,
Gatipotuzumab,,
Tomuzotuximab,,
Nanoliposomal,,
indibulin,,
Degarelix,GnRH Antagonists|Peptides|Gonadotropin-Releasing Hormone Antagonist|Treatment of Prostate Cancer,
IM156,,
dovitinib,,
MBG453,,
AC220,,
SNS-595,,
DN1508052-01,,
C31510,,
ODM-204,,
CH5132799,,
#NAME?,,
ADCT-601,,
Imprime,,
Isatuximab,,
HLX20,,
alfa-2b,,
PEG-interferon,,
alfa-2a,,
PEP503,,
GLS-010,,
HTI-1066,,
LY573636-sodium,,
HMPL-013,,
IMO-2055,,
68Ga-PSMA-R2,,
N-803,,
BMS-986301,,
BIBW2992,Antineoplastic Agents|Radiation-Sensitizing Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Tazemetostat,,
ABI-009,,
Cergutuzumab,,
Amunaleukin,,
AUC6,,
GDC-0068,,
paclitaxel-albumin,,
XNW7201,,
Pevonedistat,Enzyme Inhibitors,
CS3006,,
TAK-593,,
CPX-POM,,
Carboplatin/Paclitaxel/MEDI-575,,
Carboplatin/Paclitaxel,,
KA2507,,
E7016,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
E7016,,
Motexafin,,
BIIB015,,
fruquintinib+paclitaxel,,
MK-1308,,
BC-819,,
DMXAA,Antineoplastic Agents,
WNT974,Enzyme Inhibitors,
Epothilone,,
KOS-862,Antimitotic Agents|Mitosis Modulators|Tubulin Modulators,
Bacille,,
Calmette-Guérin,,
AGEN1884,,
SM08502,,
LXI-15029,,
LXI-15029+Exemestane,,
CG200745,,
Lipegfilgrastim,,Colony stimulating factors
Plitidepsin,,
X-396,,
ensartinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
NYESO-1c259,,
rhuMAb,,
GDC-0917,,
CDX-1401,,
Resiquimod,Antiviral|Treatment of Genital Herpes,
Poly-ICLC,Interferon Inducers|Immunologic Factors,
retinoic,,
ATRA,Antineoplastic Agents|Drug / Therapeutic Agent|Keratolytic Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Dermatologic Agents,
DZD9008,,
AG-270,,
3-week,,
DKY709,,
BiCAR-NK/T,,
CAR-NK/T,,
hexaminolevulinate,,
BCG+ALT-803,,
Ga-68,,
PET/CT,,
V3-P,,
GDC-0623,,
MK-4621/JetPEI,,
ABT-806,,
PSMA-CART,,
TAK-931,,
Esomeprazole,Anti-Ulcer Agents|Enzyme Inhibitors|Gastrointestinal Agents|Proton Pump Inhibitors,
warfarin,Agricultural Chemical|Anticoagulants|Human Data|Reproductive Effect|Rodenticide|Rodenticides|Hematologic Agents|Pesticides,
cabazitaxel,,
AS1411,,
dasatinib,Antineoplastic|Enzyme Inhibitors|Protein Kinase Inhibitors,
dasatinib,Protein Kinase Inhibitors|Enzyme Inhibitors|Antineoplastic Agents,
PLX038,,
BMS-663513,,
MDX-1106,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
MEN1309,,
TNO155,,
TAS-114,,
S-3304,Enzyme Inhibitors|Matrix Metalloproteinase Inhibitors|Protease Inhibitors,
XmAb20717,,
Andes-1537,,
JNJ-64457107,,
MT-5111,,
Velcade,Antineoplastic Agents|Protease Inhibitors|Enzyme Inhibitors,
MINT1526A,,
ZIO-201-T,,
nab-rapamycin,,
OPB-31121,,
PLX9486,,
Cytokine-induced,,
Mycograb,,
YE-NEO-001,,
CP-4055,,
linifanib,,
Apitolisib,,
Prednisolone,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
ONCOS-102,,
Osteodex,,
MK-1775,Enzyme Inhibitors,
Tanespimycin,,
SCH66336,Enzyme Inhibitors,
CX-188,,
PF-03814735,,
DOXIL,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
DOXIL,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data,
OBI-888,,
BCD-135,,
Ad-E6E7,,
MG1-E6E7,,
IGF-Methotrexate,,
SAR439459,,
pentamidine,Antifungal Agents|Antiprotozoal Agents|Drug / Therapeutic Agent|Human Data|Trypanocidal Agents|Anti-Infective Agents|Antiparasitic Agents,
MK0683,Antitumor Agent|Histone Deacetylase Inhibitor|Antineoplastic Agents|Enzyme Inhibitors|Anticarcinogenic Agents|Histone Deacetylase Inhibitors,
BIIB021,,
BIIB0121,,
TAK-981,,
DCVac/PCa,,
BMS-986012,,
LiPlaCis,Antineoplastic Agents|Cross-Linking Reagents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Indicators and Reagents,
RO6870810,,
Atu027,,
AZD0156,,
T-1101,Drug / Therapeutic Agent,
Tosylate,,
Rosiglitazone,Hypoglycemic Agents,
Norethindrone/ethinyl,,
PLX8394,,
Fluconazole,"Antifungal Agents|Drug / Therapeutic Agent|Human Data|Anti-Infective Agents|14-alpha Demethylase Inhibitors|Enzyme Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
IRX4204,,
vandetanib,Antineoplastic,
SAR240550,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
Nimotuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
TheraCIM,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
h-R3,Drug / Therapeutic Agent,
h-R3,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
HSV-TK,,
romidepsin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Natural Product|Antineoplastic Agents",
Claudiximab,,
NPC-1C,,
REGN5678,,
Pentamidine,Antifungal Agents|Antiprotozoal Agents|Drug / Therapeutic Agent|Human Data|Trypanocidal Agents|Anti-Infective Agents|Antiparasitic Agents,
TRQ15-01,,
NHS-IL12,,
VERU-111,,
HM781-36B,,
Endostar,Antiangiogenic Drug|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances,
Centrum,,
BMS-908662,,
BIIB028,,
HyperAcute-Prostate,,
TJ011133,,
AZD1390,,
TAK-701,,
LB-100,,
OXALIPLATIN,Drug / Therapeutic Agent|Antineoplastic|Antineoplastic Agents,
OXALIPLATIN,Antineoplastic Agents,
ABT-806i,,
HGS1029,,
Paclitaxel+HM30181,,
4SC-205,,
APG-2449,,
ABT-348,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
RO5509554,,
L-malate,,
BVAC-C,,
NC-4016,,
VMD-928,,
300-mg,,
CD3/HER2,,
bispecific,,
ReposMBZ,,
XY0206,,
Motesanib,Antineoplastic Agents,
diphosphate,,
ONO-7475,,
Revlimid,Antineoplastic Agents|Growth Substances|Angiogenesis Modulating Agents|Angiogenesis Inhibitors|Immunologic Factors|Growth Inhibitors,
BAY806946,Antineoplastic Agents,
Temodar®,,
ACTR,,
"CP-868,596",Antineoplastic Agents,
"CP-868,596",,
Hemay102,,
Amrubicin,Antineoplastic Agents,
ONO-4578,,
HyperAcute-Pancreatic,,
Relacorilant,,
Bazedoxifene,"Estrogen Receptor Modulator|Antiestrogen|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
OSI-7904L,Antineoplastic Agents|Enzyme Inhibitors|Folic Acid Antagonists,
AlloStim-7,,
AlloStim8,,
AlloStim-9,,
Z-360,,
S81694,,
Oncopore,,
MK-5108,,
CDX1307,,
Lipotecan,,
TTI-101,,
FS102,,
VB10.16,,
TLK286,,
Y-90,,
SIRT,,
Stereotactic,,
SBRT,,
HyperAcute®-Renal,,
ADXS-NEO,,
SY-1365,,
ZSP1241,,
DS-3078a,,
BPI-15086,,
Anti-MUC1,,
PD-1,,
leuprolide,"Antineoplastic Agents, Hormonal|Fertility Agents, Female|Hormone|Human Data|Reproductive Effect|Antineoplastic Agents|Fertility Agents|Reproductive Control Agents",
bicalutamide,"Androgen Antagonists|Antineoplastic Agents|Drug / Therapeutic Agent|Reproductive Effect|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
CDX-1307,,
PLB1001,,
Tripegfilgrastim,,
PF-06936308,,
Pegylated,,
MK-1454,,
MAGE-A3,,
MSC2490484A,,
Ad-P53,,
rosiglitazone,Hypoglycemic Agents,
D-0316,,
GRT-C901,,
GRT-R902,,
Oregovomab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
ABI-008,,
GX-I7,,
ETC-1922159,,
omega-3,,
ethyl,,
haNK®,,
LXH254,,
BAY1905254,,
adenovirus-p53,,
SCH-58500,,
LOR-253,,
paricalcitol,,"Vitamin D3 Analog|Other anti-parathyroid agents|Enzyme Interactions|VITAMIN D,OTHER"
KITE-439,,
VT-464,,
ECO-4601,,
Ad-MAGEA3,,
MG1-MAGEA3,,
Enzastaurin,,
Viagenpumatucel-L,,
IMO-2125,,
INCB007839,,
EGF816,Antineoplastic Agents,
VX-984,,
GSK21110183,,
MK-2118,,
Parsaclisib,,
ARA-C,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
LDAC,,
Daunorubicin,"Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Tumor Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Exisulind,"Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anticarcinogenic Agents|Antineoplastic Agents|Antirheumatic Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents",
LY3214996,,
Encorafenib,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|BRAF Serine/Threonine Kinase Inhibitors"
KPT-9274,,
Niacin,Drug / Therapeutic Agent|Human Data|Tumor Data|Antimetabolites|Cardiovascular Agents|Growth Substances|Micronutrients|Vasodilator Agents|Vitamin B Complex|Vitamins|Hypolipidemic Agents|Lipid Regulating Agents,
CYH33,,
ALRN-6924,,
AG881,,
Thymalfasin,"Adjuvants, Immunologic|Antineoplastic Agents|Immunologic Factors",
Thymosin,,
tyrosine,Mutation Data|Reproductive Effect,
radiotherapy,,
docetaxel+lapatinib,,
HER2,,
SAR650984,,
HPN536,,
Teysuno,"Antimetabolites, Antineoplastic|Antimetabolites|Antineoplastic Agents|Noxae",
epirubicin,"Drug / Therapeutic Agent|Mutation Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
vadimezan,Antineoplastic Agents,
AT-101,"Diuretics, Osmotic|Diuretics|Natriuretic Agents|TSCA Flag PMN (a Commenced PMN (Premanufacture Notice) Substance)",
AT-101,,
GPX-150,,
fluvoxamine,"Anti-Anxiety Agents|Antidepressive Agents, Second-Generation|Serotonin Uptake Inhibitors|Antidepressive Agents|Central Nervous System Agents|Central Nervous System Depressants|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Serotonin Agents|Tranquilizing Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Membrane Transport Modulators|Metabolic Side Effects of Drugs and Substances",
VAX014,,
phenoxodiol,,
PSMA/PRAME,,
PLX4032,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
PLX4032,,
custirsen,,
hormon-peptide,,
TCApF,,
suppressive,,
APG-1387,,
INCB052793,,
lenalidomide,Antineoplastic Agents|Growth Substances|Angiogenesis Modulating Agents|Angiogenesis Inhibitors|Immunologic Factors|Growth Inhibitors,
pomalidomide,Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Substances|Immunologic Factors|Growth Inhibitors,
INCB039110,,
CC-486,,
gilteritinib,,"ANTINEOPLASTIC,OTHER"
ABN401-,,
BDB001,,
NOV1501,,
ABL001,,
PF-06821497,,
HER-2/neu,,
ABBV-075,,
AZD4205,,
lifirafenib,,
PD-0325901,,
PDC*lung01,,
Injectable,,
Sapacitabine,Antineoplastic Agents,
NKTR,,
BMS-986207,,
Fostamatinib,,
TCR-T,,
DS-8273a,,
AZD5069,,
treme,,
DS-3032,,
abiraterone,,Other hormone antagonists and related agents|Cytochrome P450 2C8 Inhibitors|Cytochrome P450 17A1 Inhibitors|ANTINEOPLASTIC HORMONES|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 17A1 Inhibitor
Allogeneic,,
AR-12,,
mRNA-2416,,
M7583,,
CEP-18770,Enzyme Inhibitors|Protease Inhibitors|Proteasome Inhibitors,
MAGE,,
ASTX727,,
Rociletinib,Antineoplastic|Antineoplastic Agents,
ganitumab,,
TBI-1301,,
Imiquimod,"Adjuvants, Immunologic|Interferon Inducers|Antineoplastic Agents|Immunologic Factors",
TRK-950,,
AT-406,,
IDC-G305,,
H3B-6545,,
ABT-510,,
CRLX101,,
MVT-2163,,
ATP128,,
VTX-2337,,
TAK-165,Antineoplastic Agents|Epidermal-Growth-Factor (EGF) Receptor Inhibitors,
UB-921,,
rHSA/GCSF,,
Divalproex,,
2-hydroxyflutamide,"Androgen Antagonists|Drug / Therapeutic Agent|Reproductive Effect|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
2-HOF,,
Liproca,,
2-Hydroxyflutamide,"Androgen Antagonists|Drug / Therapeutic Agent|Reproductive Effect|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
G1T38,,
Bombesin,Mutation Data|Neurotransmitter Agents,
BAY86-7548,,
Radium,,
Sildenafil,Enzyme Inhibitors|Phosphodiesterase 5 Inhibitors|Cardiovascular Agents|Phosphodiesterase Inhibitors|Vasodilator Agents|Urological Agents,
TGR-1202,,
INCAGN02390,,
MEDI0457,,
Satoreotide,,
tetraxetan,Chelating Agents|Sequestering Agents,
trizoxetan,,
Tepotinib,,
Onvansertib,,
Cedazuridine,,
XmAb14045,,
CetuGEX,,
MK-1496,,
UCART19/ALLO-501,,
CV9201,,
ThermoDox®,,
LTLD,,
Bosutinib,Antineoplastic (Src Kinase Inhibitor)|Antineoplastic Agents,
MRx0518,,
IPH2201,,
PI-88,,
Celecoxib,"Anti-Inflammatory|Analgesic|Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Cyclooxygenase 2 Inhibitors|Antirheumatic Agents",
EZN-2208,,
Vorolanib,,
galinpepimut-S,,
MK-5890,,
dHER2,,
SDX-7320,,
Pembrolizumab/,,
Exemestane/,,
gene,,
protein,,
transcriptase-polymerase,,
Genetically,,
BAY2287411,,
Icaritin,,
CKD602,,
CKD602,Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,
Bi-Weekly,,
DSP-7888,,
ChAdOx1-MVA,,
LEQ506,,
Isotretinoin,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Teratogens|Dermatologic Agents|Noxae,
LUM015,,
PankoMab-GEX,,
marizomib,,
111-Indium-CMD-193,,
gp96,,
Adriamycin,,Topoisomerase 2 Inhibitors|ANTINEOPLASTIC ANTIBIOTICS|Anthracycline Topoisomerase Inhibitor|Topoisomerase Inhibitors|Anthracyclines and related substances
UCPVax,,
MK-4827,Poly(ADP-ribose) Polymerase Inhibitors|Enzyme Inhibitors|Antineoplastic agents,
89Zr-,,
DFO-MSTP2109A,,
Tumor,,
fluorescence,,
IMA201,,
Varlilumab,,
GCSF,,
PEG-GCSF,,
DCVac-L,,
TP-0903,,
Lupartumab,,
Amadotin,,
BAY1129980,,
ABT-751,,
BAY1075553,,
Transgenic,,
Lymphocyte,,
Immunization,,
Rivoceranib,,
REGN4018,,
interferon-gamma,Antiviral Agents|Drug / Therapeutic Agent|Natural Product|Anti-Infective Agents,
NOV140101,,
IDX1197HCl,,
KX2-391,,
EIF4E,,
APL-1202,,
dacarbazine,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
PBF-509_80,,
PBF-509_160,,
PBF-509_320,,
PBF-509_640,,
PBF-509,,
PBF-509+PDR001,,
naïve,,
PEG-BCT-100,,
BB-10901,"Antineoplastic Agents|Antineoplastic Agents, Immunological|Antineoplastic Agents, Phytogenic|Immunotoxins|Noxae",
Toripalimab,,
SN2310,,
IMA202,,
ABBV-085,,
MS201408-0005A,,
MS201408-0005C,,
MS201408-0005B,,
MORAb-066,,
Vidaza,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
CB-839,,
Pac-CB,,
CB-Erl,,
CB-Cabo,,
ACY-1215,,
INCAGN02385,,
ABR-217620,,
mapatumumab,Antineoplastic Agents,
peg-filgrastim,Antineoplastic Agents|Pegylated Protein,
MM-310,,
Bevacizumab+Carboplatin,,
vivax,,
Interferon-gamma,Antiviral Agents|Drug / Therapeutic Agent|Natural Product|Anti-Infective Agents,
Torisel,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|mTOR Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitor"
Radspherin,,
F-627,,
DS-1062a,,
Arginase,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
AZD8186,,
KW-0761,Antineoplastic Agents,
PNT2258,,
ASTX295,,
Doxil,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Doxil,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data,
ACIT-1,,
Tumor-Infiltrating,,
Lymphocytes,,
TILs,,
CAR-T/TCR-T,,
immunotherapy,,
Genistein,"Anticarcinogenic Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Reproductive Effect|Estrogens|Estrogens, Non-Steroidal|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phytoestrogens|Protective Agents|Protein Kinase Inhibitors",
ASV,,
AGEN2017,,
QS-21,"Adjuvants, Immunologic|Immunologic Factors",
Stimulon®,,
IMA203,,
Trebananib,Growth Substances|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors,
MEDI7247,,
INO-1400,,
INO-1401,,
5-Flourouracil,,
CDX-1140,,
CDX-301,,
FT500,,
Vatalanib,Protein Kinase Inhibitors|Enzyme Inhibitors,
BGT226,,
Wafarin,,
Bupropion,"Drug / Therapeutic Agent|Antidepressive Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Dopamine Agents|Dopamine Uptake Inhibitors|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Membrane Transport Modulators|Metabolic Side Effects of Drugs and Substances|Smoking Cessation Agents",
MRX-2843,,
capecitabine/oxaliplatin/bevacizumab/RAD001,,
MK-8628,,
FATE-NK100,,
BPI-7711,,
Campto,"Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
hMN14,"Monoclonal Antibody|Antineoplastic Agents|Antineoplastic Agents, Immunological",
labetuzumab,"Monoclonal Antibody|Antineoplastic Agents|Antineoplastic Agents, Immunological",
INCB062079,,
MGA271,,
Talabostat,,
CVX-060,,
CPI-006,,
BCD-100,,
NIS793,,
Imx-110,,
AK104,,
V941,,
Ribavirin,Antimetabolites|Antiviral Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Anti-Infective Agents|Noxae,
NS-9,,
NP-G2-044,,
Tirapazamine,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Radiation-Sensitizing Agents,
JNJ-64619178,,
NEO-201,,
Picoplatin,Antineoplastic,
Ruxolitinib,Antineoplastic Agents,
OBI-3424,,
cytarabine,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
CVX-045,,
apomine,Antineoplastic,
intoplicine,,
CAB-AXL-ADC,,
Camptothecin,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Natural Product|Antineoplastic Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
cyclodextrin-based,,
polymer,TSCA Flag FRI (a Polymer Containing no Free-Radical Indicator in its Inventory Name but is Made with One Regardless of the Amount Used)|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Liposome-encapsulated,,
SN38,"Mutation Data|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
Taxane,Antineoplastic Agents,
HMPL-453,,
ADXS-503,,
Tenalisib,,
LUT014,,
JTX-2011,,
CART-TnMUC1,,
Mifepristone,"Abortifacient Agents, Steroidal|Contraceptives, Oral, Synthetic|Contraceptives, Postcoital, Synthetic|Hormone|Hormone Antagonists|Human Data|Luteolytic Agents|Menstruation-Inducing Agents|Reproductive Effect|Abortifacient Agents|Contraceptive Agents|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Postcoital|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents",
MK-8776,,
Zalutumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
GSK2126458,,
Xilonix,,
Onivyde,,
REGN4659,,
AGI-134,,
DS6051b,,
Aprepitant,Substance P Antagonist|Antiemetic (in Chemotherapy-Induced Emesis)|Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Peripheral Nervous System Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents,
Ondansetron,Anti-Anxiety Agents|Antiemetics|Antipsychotic Agents|Drug / Therapeutic Agent|Human Data|Serotonin Antagonists|Antipruritics|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dermatologic Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Psychotropic Drugs|Serotonin Agents|Tranquilizing Agents,
Taporfin,,
Cidofovir,Anti-HIV Agents|Antiviral Agents|Antiviral|Anti-Infective Agents|Antineoplastic Agents|Anti-Retroviral Agents|Radiation-Sensitizing Agents,
Cidofovir,Anti-Infective Agents|Antiviral Agents|Enzyme Inhibitors,
leronlimab,,
LGK974,Enzyme Inhibitors,
MGN1601,,
SB939,,
WBRT,,
sequential,,
Depocyte,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
BAL101553,,
ASTX029,,
ASN007,,
ADP-A2M4CD8,,
glioblastoma,,
IMA950,,
Febuxostat,Gout Suppressants|Antirheumatic Agents,
PROSTVAC-V,,
PROSTVAC-F,,
EC0489,,
SGM-101,,
Vintafolide,,
L19IL2,,
MGD007,,
HuMax-TF-ADC,,
TQ-B3203,,
Sym015,,
EC0225,,
Folic,,
hydrazide,Antitubercular Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Bacterial Agents|Anti-Infective Agents|Antimetabolites|Fatty Acid Synthesis Inhibitors|Hypolipidemic Agents,
acid-technetium,,
CORT125134,,
PF-04518600,,
COTI2,,
Thiarabine,,
MLN6907,,
CDX-1127,,
RGX-202-01,,
Tegavivint,,
ODM-209,,
vantictumab,,
Talaporfin,Antineoplastic Agents|Photosensitizing Agents|Dermatologic Agents|Radiation-Sensitizing Agents,
racotumomab,,
IDE196,,
V935,,
V934-EP,,
pediatric,,
Taladegib,,
CORT125281,,
VB10.NEO,,
IMC-001,,
SRA737,,
INCB053914,,
I-DAC,,
rebastinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
LY2784544,,
NB1011,Pronucleotides|Antineoplastic,
OMO-1,,
mocetinostat,Antineoplastic Agents|Histone Deacetylase Inhibitors|Enzyme Inhibitors,
Exherin,,
Naptumomab,,
estafenatox,,
IMFINZI,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Nelarabine,Antineoplastic,
TSD-001,,
ERBITUX,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
CXD101,,
BMS-986253,,
TAS-120,,
Sagopilone,Antineoplastic Agents,
ATOR-1015,,
Nal-Irinotecan,,
PX-478,,
GZ17-6.02,,
ADCT-301,,
FP-1305,,
Rhenium,,
P2045,,
BAY86-5284,,
INBRX-105,,
PDL1x41BB,,
Enfortumab,,
BMS-986277,,
BMS-986242,,
Carboplatin/Gemcitabine,,
YN968D1,,
CAN04,,
AB154,,
MK-0646,,
Toca,,
brentuximab,,
prednisone,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
vincristine,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
REGN1400,,
PCI-24781,Enzyme Inhibitors|Histone Deacetylase Inhibitors,
THOR-707,,
Checkpoint,,
C-14,,
TPST-1120,,
ADC-1013,,
Interleukin-21,,
STRO-002,,
PT2977,,
ARRY-380,,
LOXO-292,,
2-hydroxyoleic,,
CAB-ROR2-ADC,,
BAY2731954,,
SG001,,
BVD-523,,
GR-MD-02,,
MP0250,,
GRT-C903,,
GRT-R904,,
anti-PD-,,
anti-CTLA-4,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
RV001V,,
ODM-207,,
BMS-986288,,
MG005,,
posaconazole,"Antifungal|Antibiotics, Antifungal|Trypanocidal Agents|Antifungal Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents|14-alpha Demethylase Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
JI-101,,
ZSP1602,,
131-I-TM-601,,
chlorotoxin,Neurotoxins|Noxae,
Vitravki,,
PEN-221,,
PZP115891,,
BMS-986310,,
zoledronic,,
BMS-986249,,
ASTX660,,
OGX-427,Antineoplastic,
OGX-427,,
Standard-of-care,,
BMS-986258,,
TKM-080301,,
BMS-986148,,
NAB-PACLITAXEL,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
PACLITAXEL,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
Uracil,Mutation Data|Reproductive Effect|Tumor Data,
BMS-986218,,
IDO1,,
INBRX-109,,
PV-10,Reproductive Effect|Tumor Data,
PV-10,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
PV-10,,
NC318,,
BMS-986158,,
"CP-547,632",,
DCVAC,,
IMSA101,,
checkpoint,,
Immuno-oncology,,
Cefixime,Drug / Therapeutic Agent|Anti-Bacterial Agents|Anti-Infective Agents,
Cefixime,Anti-Infective Agents|Anti-Bacterial Agents,
Cefpodoxime,Anti-Bacterial Agents|Anti-Infective Agents,
Cibisatamab,,
plerixafor,,"Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer"
osimertinib,,"Protein kinase inhibitors|ANTINEOPLASTIC,OTHER|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inducers|Kinase Inhibitor|Cytochrome P450 3A4 Inducers|Kinase Inhibitors"
BMS-986178,,
WX-0593,,
Ganitumab,,
CC-5013,Antineoplastic Agents|Growth Substances|Angiogenesis Modulating Agents|Angiogenesis Inhibitors|Immunologic Factors|Growth Inhibitors,
CTAP101,,
Rintatolimod,Antiviral Agents|Antiretroviral|Immunomodulator|Anti-Infective Agents,
PX-866,,
SB1518,Antineoplastic Agents,
BMS-986156,,
AZD6094,,
non-Asian,,
intermittent,,
MGC018,,
JAB-3312,,
GS-4224,,
carbplatin,,
cyclophophamide,,
Desipramine,"Adrenergic Uptake Inhibitors|Antidepressive Agents, Tricyclic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Adrenergic Agents|Antidepressive Agents|Central Nervous System Agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Membrane Transport Modulators",
APG-115+Pembrolizumab,,
Crotoxin,Natural Product,
Durvalumab/chemotherapy,,
Durvalumab/Tremelimumab/chemotherapy,,
Rosuvastatin10,,
syrup,,
Voruciclib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
SGN-CD47M,,
TSR-011,,
HLX07+Gemcitabine+Cisplatin,,
HLX07+Paclitaxel+Carboplatin,,
HLX07+mFOLFOX6,,
BGB-A333,,
Treosulfan,"Antineoplastic Agents, Alkylating|Mutation Data|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Pamiparib,,
roniciclib,,
TAS-119,,
BLZ945,,
Vivomixx,,
BAY1125976,,
LGH447,,
CCX872-B,,
BAY86-9596,,
Fludeoxyglucose,,
#NAME?,Agricultural Chemical|Growth Regulator / Fertilizer|Mutation Data,
CX-072,,
SL-279252,,
PD-1/PD-L1,,
calcitriol,Calcium Channel Agonists|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Bone Density Conservation Agents|Cardiovascular Agents|Growth Substances|Membrane Transport Modulators|Micronutrients|Vasoconstrictor Agents|Vitamins|Calcium-Regulating Hormones and Agents,
GEN1046,,
GC4419,,
Kanglaite,,
vinflunine,,
ketaconazole,,
2B3-101,,
Nintedanib,Antineoplastic Agents|Enzyme Inhibitors,
TAS-106,Antineoplastic Agents,
PRT543,,
TQ-B3234,,
CS7017,,
AL2846,,
ZD-1839,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
LAM-003,,
Iressa,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Anti-SEMA4D,,
Platinum,Tumor Data,
USL311,,
sonidegib,,"Other antineoplastic agents|ANTINEOPLASTIC,OTHER|Hedgehog Pathway Inhibitor|Smoothened Receptor Antagonists"
anti-fucosyl-GM1,,
ADXS31-164,,
HS-10296,,
BMS-777607,,
FF-10502-01,,
MVA-FCU1,,
flucytosine,Antifungal Agents|Antimetabolites|Drug / Therapeutic Agent|Human Data|Mutation Data|Anti-Infective Agents|Noxae,
APL-101,,
CBT-101,,
patritumab,,
CTX110,,
AZD4573,,
APS001F,,
maltose,Drug / Therapeutic Agent|Human Data|Natural Product|Reproductive Effect|Tumor Data|Flavoring Agents|Food Additives|Sweetening Agents,
ARRY-520,Antimitotic Agents|Antineoplastic Agents,
granulocyte-colony,,
Targretin®,,
Tarceva,,
Somatuline,,Somatostatin Analog|Somatostatin and analogues|ANTERIOR PITUITARY|Somatostatin Receptor Agonists
Colo-Ad1,,
BGB-A425,,
ATL001,,
ranitidine,Anti-Ulcer Agents|Drug / Therapeutic Agent|Histamine H2 Antagonists|Human Data|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Neurotransmitter Agents,
ranitidine,Human Data|Histamine H2 Receptor Antagonists,
Novantrone,Drug / Therapeutic Agent|Human Data|Mutation Data|DNA Topoisomerase II Inhibitor,
KPT-8602,,
HA121-28,,
W0101,,
APX005M,,
Tinostamustine,,
EDO-S101,,
Estramustine,"Antineoplastic Agents, Alkylating|Antineoplastic Agents, Hormonal|Mutation Data|Alkylating Agents|Antineoplastic Agents|Noxae",
CYT-0851,,
Pancrelipase,Reproductive Effect|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Pancrelipase,Gastrointestinal Agents|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
E7449,,
microinjection,,
progenitor,,
Cripec,,
hypoxia-activated,,
anti-endosialin/TEM1,,
XmAb13676,,
Erythropoiesis,,
NESP,,
darbepoetin,Hematinics|Hematologic Agents,
alfa,,
MEDI5083,,
MEID5083,,
Medi5083,,
EDP1503,,
bicarbonate,Buffers,
g/kg/day,,
Dexrazoxane,Drug / Therapeutic Agent|Human Data|Mutation Data|Antineoplastic Agents|Immunosuppressive Agents|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Protective Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,Unknown Cellular or Molecular Interaction|Chelating Activity|PROTECTIVE AGENTS|Cytoprotective Agent|Detoxifying agents for antineoplastic treatment
Dexrazoxane,,Unknown Cellular or Molecular Interaction|Chelating Activity|PROTECTIVE AGENTS|Cytoprotective Agent|Detoxifying agents for antineoplastic treatment
Simvastatin,Anticholesteremic Agents|Drug / Therapeutic Agent|Human Data|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Reproductive Effect|Antimetabolites|Enzyme Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents,
varlilumab,,
AZD6738,,
Administation,,
ado-trastuzumab,,
Rebastinib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
satoreotide,,
M2ES,,
Napabucasin,,
Antigen-Specific,,
GSK2130579A,,
Epstein-Barr,,
virus-specific,,
cytotoxic,,
DC-CIK,,
TG02,,
ACZ885,,
CJM112,,
TMT212,,
Anti-interleukin-6,,
Anti-PDL-1,,
Abexinostat,Enzyme Inhibitors|Histone Deacetylase Inhibitors,
Fexofenadine,"Anti-Allergic Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents",
Osimertininb,,
PF-01367338,,
CK-101,,
IMU-131,,
AZD5991,,
ditartrate,,
CX-2029,,
LY2787106,,
XL888,,
amifostine,Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Protective Agents|Reproductive Effect|Protective Agents,
amifostine,Protective Agents|Radiation-Protective Agents,
trihydrate,,
ABY-025,,
Cilengitide,Peptides,
MG/1,,
KEYTRUDA,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
BAY2402234,,
IPH2101,,
siG12D,,
LODER,,
VS-6063,,
CX-2009,,
Metatinib,,
Tromethamine,Buffers|Drug / Therapeutic Agent|Excipients|Pharmaceutic Aids|Pharmaceutical Vehicles,
Vinblastine,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Tumor Data|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
GP2013,,
pralsetinib,,
BLU-667,,
Methotrexate,"Abortifacient Agents, Nonsteroidal|Agricultural Chemical|Antimetabolites, Antineoplastic|Antirheumatic Agents|Dermatologic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Folic Acid Antagonists|Human Data|Immunosuppressive Agents|Insecticide|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Abortifacient Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae|Reproductive Control Agents",
Enapotamab,,
HuMax-AXL-ADC,,
Bromelain,Drug / Therapeutic Agent|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Acetylcysteine,Antiviral Agents|Expectorants|Free Radical Scavengers|Human Data|Antiretroviral|Anti-Infective Agents|Antioxidants|Respiratory System Agents,
L-377202,,
Marqibo,Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data,
AG013,,
anlotinib,,
Iso-Fludelone,,
Yervoy,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Repaglinide,Hypoglycemic Agents,
4H11-28z/fIL-12/EGFRt+,,
Genetically-modified,,
GDC-0084,,
FluMist,,
FluMist,Vaccines,
nal-IRI,,
NY-ESO-1,,
c259,,
radio-labeled,,
^14C,,
#NAME?,,
VRx-3996,,
Valganciclovir,Anti-Infective Agents|Antiviral Agents,
pancreatic,,
CB-103,,
RAV12,,
GSK2302025A,,
BAY86-5302,Antineoplastic Agents,
Karenitecin,,
BNP1350,,
CC-122,,
pVAXrcPSAv53l,,
rhesus,,
BMS-986226,,
lymphocyte,,
alloreactive,,
T-cells,,
ATIR,,
IMMU-132,,
Nelfinavir,Anti-HIV Agents|HIV Protease Inhibitors|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Protease Inhibitors,
GEN1029,,
HexaBody®-DR5/DR5,,
ICON-1,,
STRO-001,,
VEGFR/PDGFR,,
89Zr-MMOT0530A,,
MultiStem®,,
TAS0728,,
Jan-28,,
Gleevec®,,
obuense,,
IMM-101,,
Heat-killed,,
M.obuense,,
vacc,,
peptide-pulsed,,
dendritic,,
nanosomal,,
lipid,,
Mycobacterium,,
FLX475,,
AlloStim,,
Calcitriol,Calcium Channel Agonists|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Bone Density Conservation Agents|Cardiovascular Agents|Growth Substances|Membrane Transport Modulators|Micronutrients|Vasoconstrictor Agents|Vitamins|Calcium-Regulating Hormones and Agents,
sub-cutaneous,,
JCAR017,,
entolimod,,
I124-NM404,,
TC-210,,
anti-PD1,,
MM-141,,
Vosaroxin,,
Intrathecal,,
PRGN-3005,,
UltraCAR-T,,
Monalizumab,,
Anti-PD,,
PRI-724,,
Zolbetuximab,,
haplo/cord,,
PLX2853,,
5-Azacitidine,,
PEGPEM,,
fruquintinib,,
BAY85-8050,,
MTC-DOX,,
Emibetuzumab,,
Melatonin,Antioxidants|Drug / Therapeutic Agent|Hormone|Mutation Data|Reproductive Effect|Tumor Data|Central Nervous System Agents|Central Nervous System Depressants|Protective Agents,
PEN-866,,
MDG1011,,
KY1044,,
Gallium,Mutation Data,
68-labeled,,
GRPR,,
TQ-B3233,,
Moxifloxacin,Anti-Infective Agents|Anti-Bacterial Agents|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,"Quinolone Antimicrobial|DNA Gyrase Inhibitors|ANTIBACTERIALS,TOPICAL OPHTHALMIC|Fluoroquinolones|Topoisomerase 4 Inhibitors|QUINOLONES"
Moxifloxacin,,"Quinolone Antimicrobial|DNA Gyrase Inhibitors|ANTIBACTERIALS,TOPICAL OPHTHALMIC|Fluoroquinolones|Topoisomerase 4 Inhibitors|QUINOLONES"
Freund,,
A166,,
Guadecitabine,,
VGX-3100,,
Cannabidiol,Drug / Therapeutic Agent|Mutation Data|Reproductive Effect,
Floxuridine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Antimetabolites|Antineoplastic Agents|Noxae",
TRX518,,
ADH-1,,
melphalan,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Alkylating Agents|Antineoplastic Agents|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Noxae",
Glivec,Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
film-coated,,
FOLFIRINOX,,
BGB324,,
177Lu-3BP-227,,
ALVAC,,
#NAME?,,
sirolimus,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Immunosuppressive Agents|Mutation Data|Natural Product|Anti-Bacterial Agents|Antifungal Agents|Anti-Infective Agents|Antineoplastic Agents|Immunologic Factors",
Luckyvec,,
A-007,,
Carboplatin-Paclitaxel,,
Carboplatin-Nab-Paclitaxel,,
ProTmune,,
MLN8237,,
Monofer,,
Parvovirus,,
H-1PV,,
5-azacitidine,,
VAL201,,
Glutaminase,,
Peg-filgrastim,Antineoplastic Agents|Pegylated Protein,
Seviteronel,,
APG115,,
mono-therapy,,
Trioxide,,
F16IL2,,
CELLECTRA-5P,,
TG4001,,
BL-8040,,
CT053PTSA,,
DNX-2401,,
hyaluronidase,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Linagliptin,"Dipeptidyl-Peptidase IV Inhibitors|Enzyme Inhibitors|Protease Inhibitors|Hypoglycemic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Incretins",
Gliolan,,
doxorubicin-GnRH,,
AEZS-108,,
CAL-101,Antineoplastic Agents|Enzyme Inhibitors,
CAL-101,,
Telaglenestat,,
Ibrance,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
NBTXR3,,
IMRT,,
Brachytherapy,,
Mirvetuximab,,
Soravtansine,,
Camsylate,,
9-valent,,
GSK3377794,,
131I-TM-601,,
DN1406131,,
SGX201,,
"17,21-dipropionate",,
MV-NIS,,
ATR-101,,
FT-2102,,
aPD-1,,
aPD-L1,,
ImMucin,,
WT-1,,
polymerase,,
Dacarbazine,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
SGN-CD70A,,
Neomycin,Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Protein Synthesis Inhibitors|Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors,
Pralatrexate,Antineoplastic,
NKTR-262,,
bempegaldesleukin,,
ofatumumab,Antineoplastic Agents,
DKN-01,,
AMXT1501,,
DFMO,Antineoplastic Agents|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Trypanocidal Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents|Ornithine Decarboxylase Inhibitors,
GP-2250,,
azacitadine,,
IDEC-C2B8,,
Lipo-MERIT,,
Platinol,Antineoplastic Agents|Cross-Linking Reagents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Indicators and Reagents,
BR101801,,
Citarinostat,,
ACP-319,,
HM61713,,
Enasidenib,Antineoplastic Agents,
VLS-101,,
MB-002,,
AB-110,,
SPARC1028,,
ICP-022,,
MIV-818,,
zalutumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
E7070,Antineoplastic Agents|Carbonic Anhydrase Inhibitors|Enzyme Inhibitors,
QBM076,,
TG-1701,,
Umbralisib,,
Ublituximab,,
CRS-100,,
Sativex,Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents,
OTX015/MK-8628,,
FMISO,,
SHC014748M,,
BMS-986179,,
Erythromycin,Drug / Therapeutic Agent|Gastrointestinal Agents|Human Data|Mutation Data|Natural Product|Protein Synthesis Inhibitors|Reproductive Effect|Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors,
Voriconazole,"Antifungal|Antifungal Agents|Anti-Infective Agents|14-alpha Demethylase Inhibitors|Enzyme Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
IMG-7289,,
Sonazoid,Contrast Media,
Perflubutane,Contrast Media,
AVN-944,,
TregGraft,,
RP6530,,
FT-1101,,
OrcaGraft,,
AST-008,,
Pomalidomide,Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Substances|Immunologic Factors|Growth Inhibitors,
BIBW2,,
Surface-Controlled,,
Curcumin,"Anti-Inflammatory Agents, Non-Steroidal|Antineoplastic Agents|Enzyme Inhibitors|Mutation Data|Natural Product|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Coloring Agents|Peripheral Nervous System Agents|Sensory System Agents",
REGN1979,,
ibrutinib,Antineoplastic Agents,
Ataluren,,
SGN-35,,
HSC835,,
EZN-2968,,
MabThera,"Antineoplastic Agents|Antirheumatic Agents|Immunologic Factors|Antineoplastic Agents, Immunological",
anti-CEA,,
oprozomib,,
JNJ-64407564,,
JNJ-64007957,,
BMS-936564,,
Anti-CXCR4,,
ST571,Drug / Therapeutic Agent,
NT-I7,,
SPARC1023,,
TAC-101,,
Derazantinib,,
Hoffmann-La,,
Roche,,
Albumin-Stabilized,,
EphB4-HSA,,
Lonsurf,,"Unknown Cellular or Molecular Interaction|ANTINEOPLASTIC,OTHER|Thymidylate Synthetase Inhibitors|Nucleoside Metabolic Inhibitor|Antivirals|Nucleoside Analog Antiviral|Thymidine Phosphorylase Inhibitor|Nucleic Acid Synthesis Inhibitors|Thymidine Phosphorylase Inhibitors"
IMAB362,,
HPMC,,
HPV-16,,
PWT-143,Antineoplastic Agents,
Kinase,,
metronomic,,
TLPLDC,,
BPX-601,,
Rimiducid,,
INT230-6,,
AVID100,,
EVRI,,
Rivogenlecleucel,,
CD33-CAR-T,,
dinaciclib,,
ketoconazole,"Antifungal Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Anti-Infective Agents|14-alpha Demethylase Inhibitors|Enzyme Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
PXD101,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
AVI-4126,,
RESTEN-NG®,,
NiCord®,,
Zevalin,,
TQB3456,,
AGS-16M8F,,
Hydromorphone,"Analgesics, Opioid|Drug / Therapeutic Agent|Human Data|Narcotics|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
BPI-9016M,,
Pimodivir,,
Cyclosporine,Antifungal Agents|Antirheumatic Agents|Dermatologic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Tumor Data|Anti-Infective Agents|Immunologic Factors|Calcineurin Inhibitors,
Cyclosporine,Drug / Therapeutic Agent|Human Data|Tumor Data,
SCB-313,,
Pravastatin,Anticholesteremic Agents|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Antimetabolites|Enzyme Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents,
Gynoflor,,
EGFRt/19-28z/4-1BBL,,
Casopitant/Docetaxel,,
rifampicin,"Antibiotics, Antitubercular|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Leprostatic Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Anti-Bacterial Agents|Anti-Infective Agents|Antitubercular Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inducers|Metabolic Side Effects of Drugs and Substances",
11C-JNJ-63779586,,
hLL1,,
Sulforadex,,
alpha-cyclodextrin,,
HSPPC-96,,
Calcineurin,,
Camptosar,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
Camptosar,"Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Enzyme Inhibitors|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors",
A317,,
V212,,
Mibefradil,Antihypertensive Agents|Calcium Channel Blockers|Cardiovascular Agents|Membrane Transport Modulators|Vasodilator Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Metabolic Side Effects of Drugs and Substances|Calcium-Regulating Hormones and Agents,
Mibefradil,Drug / Therapeutic Agent|Reproductive Effect,
Epoetin,Mutation Data|Hematinics|Hematologic Agents,
Alfa,,
SAR442085,,
Heptapeptide,,
IMCnyeso,,
VK-2019,,
ipatasertib,,
TG4050,,
Dronabinol,"Analgesics, Non-Narcotic|Drug / Therapeutic Agent|Hallucinogens|Mutation Data|Natural Product|Psychotropic Drugs|Reproductive Effect|Tumor Data|Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Cannabinoid Receptor Agonists|Cannabinoid Receptor Modulators|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents",
GSK2857916,,
fluphenazine,Dopamine Antagonists|Drug / Therapeutic Agent|Reproductive Effect|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents,
Rasburicase,Antirheumatic Agents|Gout Suppressants,
SNS-062,,
icotinib,,
Aldesleukin,Anti-HIV Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents,
SPARC147609,,
Reference147609,,
Pentoxifylline,Drug / Therapeutic Agent|Enzyme Inhibitors|Free Radical Scavengers|Hematologic Agents|Human Data|Mutation Data|Phosphodiesterase Inhibitors|Platelet Aggregation Inhibitors|Radiation-Protective Agents|Reproductive Effect|Vasodilator Agents|Antioxidants|Cardiovascular Agents|Protective Agents,
PHY906,,
ONC201,,
Lansoprazole,Anti-Infective Agents|Anti-Ulcer Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Reproductive Effect|Gastrointestinal Agents|Proton Pump Inhibitors,
CD123CAR-CD28-CD3zeta-EGFRt-expressing,,
cyclodextrin,,
CUE-101,,
albumin,,
sEphB4-HSA,,
antigen,,
CD22,,
trabectedin,"Antineoplastic Agents|Alkylating Agents|Antineoplastic Agents, Alkylating|Noxae",
5-flucytosine,Antifungal Agents|Antimetabolites|Drug / Therapeutic Agent|Human Data|Mutation Data|Anti-Infective Agents|Noxae,
Ancotil®,,
IRX-2,,
Lymfactin®,,
FT1050,Anti-Ulcer Agents|Human Data|Reproductive Effect|Gastrointestinal Agents,
Carmustine,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Disulfiram,"Acaricide|Agricultural Chemical|Alcohol Deterrents|Drug / Therapeutic Agent|Enzyme Inhibitors|Fungicide, Bactericide, Wood Preservative|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Immunomodulator|Central Nervous System Agents|Acetaldehyde Dehydrogenase Inhibitors",
gluconate,,
IMC-C103C,,
Novyi-NT,,
Doxycycline,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Anti-Bacterial Agents|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiprotozoal Agents,
Doxycycline,Anti-Bacterial Agents|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiprotozoal Agents,
CD19-targeting,,
ET140202,,
GNS561,,
MB-CART19.1,,
artesunate,Antimalarials|Amebicides|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents|Anthelmintics|Antineoplastic Agents|Antiplatyhelmintic Agents|Antiviral Agents|Schistosomicides,
levofolinate,,
CZ48,,
MAK683,,
ADXS11-001,,
trioxide,,
ZN-e4,,
DTI-015,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
TQ-B3525,,
ASK120067,,
ZYC300,,
pre-dosing,,
GTI-2040,,
R-enantiomer,,
"1,2-dioleoyl-3-trimethylammonium-propane",,
Peptides,,
zolinza/vorinostat,,
Tefinostat,,
L19-IL2,,
177Lu-DOTA-tyr3-OCTREOTATE,,Various therapeutic radiopharmaceuticals|Somatostatin Receptor Agonists
CPI-0610,,
navitoclax,Antineoplastic Agents,
SGN-30,,
Crenolanib,Antineoplastic Agents,
methotrexate,"Abortifacient Agents, Nonsteroidal|Agricultural Chemical|Antimetabolites, Antineoplastic|Antirheumatic Agents|Dermatologic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Folic Acid Antagonists|Human Data|Immunosuppressive Agents|Insecticide|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Abortifacient Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae|Reproductive Control Agents",
hydrocortisone,Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Anti-Inflammatory Agents,
Flt3L,,
CT-P6,,
PDC-1421,,
MK-7252,,
AAV2hAQP1,,
MEDI-507,Monoclonal Antibody|Immunomodulator,
FF-10501-01,,
acalabrutinib,,"Kinase Inhibitor|Tyrosine Kinase Inhibitors|ANTINEOPLASTIC,OTHER"
vistusertib,,
SPI-1005,"Anti-Inflammatory Agents, Non-Steroidal|Antioxidants|Anti-Ulcer Agents|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Reproductive Effect|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Central Nervous System Agents|Enzyme Inhibitors|Gastrointestinal Agents|Neuroprotective Agents|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents",
TJ107,,
FGF401,,
GIC-1001,,
GIC-1002,,
equimolar,,
quadrivalent,,
papillomavirus,,
EPZ-5676,,
HuLuc63,Antineoplastic Agents,
TAEST16001,,
Octavalent,,
AAHS,,
ACTINIUM-225-LABELED,,
HUMANIZED,,
ANTI-CD33,,
ANTIBODY,,
HuM195,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Adenoviral-mediated,,
Interferon-beta,Antineoplastic Agents|Antiviral Agents|Anti-Infective Agents|Immunologic Factors,
DC/tumor,,
Mocetinostat,Antineoplastic Agents|Histone Deacetylase Inhibitors|Enzyme Inhibitors,
APN201,,
Dalteparin,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
Atorvastatin,Anticholesteremic Agents|Antimetabolites|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents,
AGS-003,,
L19TNF,,
DOXORUBICIN,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Hu3F8,,
Clofarabine/Busulfan,,
MPBC,,
INO-5151,,
Film-Coated,,
Sandoz,,
Inc.,,
Astrazeneca,,
Quizartinib,,
prophylaxis,,
GC33,,
RO5137382,,
TVEC,Antineoplastic Agents,
Electrofusion,,
intratumoral,,
Amifostine,Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Protective Agents|Reproductive Effect|Protective Agents,
Amifostine,Protective Agents|Radiation-Protective Agents,
GEN-009,,
Adjuvanted,,
DT01,,
CX5461,,
H3B-6527,,
50-mg,,
200-mg,,
Siltuximab,Antineoplastic Agents,
TBI-1201,,
NanoDoce,,
intravesical,,
IL13-PE38QQR,,
Anti-AXL,,
ASN-002,,
pbi-shRNA,,
EWS/FLI1,,
GSK461364,,
Endoxana,"Agricultural Chemical|Alkylating Agents|Antineoplastic Agents, Alkylating|Antirheumatic Agents|Drug / Therapeutic Agent|Experimental Pesticide|Human Data|Immunosuppressive Agents|Mutagens|Mutation Data|Reproductive Effect|Tumor Data|Unspecified / Unclassified Pesticide|Antineoplastic Agents|Immunologic Factors|Myeloablative Agonists|Noxae",
Leukine,Immunologic Factors,
IMA910,,
Aldara,"Adjuvants, Immunologic|Interferon Inducers|Antineoplastic Agents|Immunologic Factors",
anti-tumor,,
necrosis,,
adalimumab,Monoclonal Antibody|Anti-Inflammatory Agents|Antirheumatic Agents,
Patritumab,,
Dendritic,,
Milademetan,,
Anti-LAG-3,,
Anti-CD137,,
FT516,,
FOLFOX4,,
MCY-M11,,
Foretinib,Antineoplastic Agents,
transdermal,,
Granisetron,Antiemetics|Serotonin Antagonists|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin Agents,
RBL001/RBL002,,
Combig-DC,,
Gemzar,"Reproductive Effect|Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antiviral Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Noxae|Radiation-Sensitizing Agents",
Complex-targeting,,
Curaxin,,
IPI-145,,
CAR2,,
Anti-CEA,,
Alvocidib,Antineoplastic|Cyclin-Dependent Kinase (CDK) Inhibitors|Antineoplastic Agents|Growth Inhibitors|Kinase Inhibitors,
Alvocidib,Antineoplastic Agents|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Protein Kinase Inhibitors,
tabelecleucel,,
TTI-622,,
Proteasome-inhibitor,,
RRituximab,,
Darbepoetin,Hematinics|Hematologic Agents,
ABI-1968,,
G207,,
oncolytic,,
TNB-383B,,
ACTR087,,
SEA-BCMA,,
Jakafi,Antineoplastic Agents,
Methylprednisolone,"Antiemetics|Drug / Therapeutic Agent|Human Data|Neuroprotective Agents|Anti-Inflammatory|Immunosuppressant|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents|Protective Agents",
anti-CD19,,
anti-CD20,,
bb2121,,
Anti-CD19-CAR,,
low-dose,,
NANT-008,,
Eloxatin,Drug / Therapeutic Agent|Antineoplastic|Antineoplastic Agents,
AV-MEL-1,,
ABT-199,Antineoplastic Agents,
Carotuximab,,
OPDIVO,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Gardasil,Vaccine,
Elotuzumab,Antineoplastic Agents,
BMS-901608,Antineoplastic Agents,
SOR007,,
FCN-159,,
BT062,,
Aurixim,,
LY2127399,,
SGN-40,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
SGN-40,,
SPH1188-11,,
ADCT-402,,
anti-huCD40,,
NeoAntigen,,
CARBOPLATIN,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Cross-Linking Reagents|Indicators and Reagents,
TAK-079,,
Vorinostst/Bevacizumab/Temozolomide,,
rhIL-2,,
PNK-007,,
MPH966,,
YPEG-Filgrastim,,
Palifermin,,"Keratinocyte Growth Factor Receptor Agonists|Mucocutaneous Epithelial Cell Growth Factor|Detoxifying agents for antineoplastic treatment|HORMONES/SYNTHETICS/MODIFIERS,OTHER"
paclitaxel/carboplatin,,
carboplatin/etoposide,,
Guselkumab,,Interleukin-23 Antagonist|Antibody-Receptor Interactions|Interleukin-23 Antagonists|IMMUNE SUPPRESSANTS|Interleukin inhibitors
Axumin,,
E6201,,
Gilteritinib,,"ANTINEOPLASTIC,OTHER"
LXS196,,
KW-2478,,
AEB071,,
Busulfan,"Alkylating Agents|Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Immunologic Factors|Myeloablative Agonists|Noxae",
Thymoglobulin,Immunologic Factors|Immunosuppressive Agents,
CD4CAR,,
Anti-NY-ESO-1,,
Temferon,,
Vargatef,Antineoplastic Agents|Enzyme Inhibitors,
isatuximab,,
CC-99712,,
TAK-169,,
Descartes-11,,
CT053,,
Measles,,
Lumbar,,
HG146,,
Bisthianostat,,
MEDI2228,,
CC-93269,,
Anti-CD38,,
PBF-1129,,
SGN-CD48A,,
CC-92480,,
anti-BCMA,,
KITE-585,,
BFCR4350A,,
bb21217,,
PF-06863135,,
DARA,,
daratumumab,Antineoplastic Agents,
CKD-581,,
Lintuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Gastro-Retentive,,
GMI-1271,,
Hyaluronidase,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
JNJ-54767414,Antineoplastic Agents,
anti-PD-L1,,
Montelukast,"Anti-Asthmatic Agents|Leukotriene Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Respiratory System Agents|Cytochrome P-450 CYP1A2 Inducers|Metabolic Side Effects of Drugs and Substances",
Celgene,,
SST0001,,
Roneparstat,,
HSV1716,,
Intra-pleural,,
Tabalumab,,
JNJ-2641585,,
DFRF4539A,,
JNS002,,
AVE1642,,
YH25448,,
BI-505,,
IMGN901,"Antineoplastic Agents|Antineoplastic Agents, Immunological|Antineoplastic Agents, Phytogenic|Immunotoxins|Noxae",
JNJ-26866138,,
SPARC147709,,
Reference147709,,
SNDX-275,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
Anti-KIR,,
Vinflunine,,
Mannose-Binding,,
Lectin,Natural Product,
rhMBL,,
MBC-11,,
HCD122,,
Oxycodone,"Analgesics, Opioid|Drug / Therapeutic Agent|Narcotics|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
OxyNorm®,,
Investigational,,
JCARH125,,
ST266,,
AT7519M,,
BL-NHL,,
BLR-CLL,,
BLR-NHL,,
quizartinib,,
Idarubicin,"Drug / Therapeutic Agent|Mutation Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Polio/Rhinovirus,,
rQNestin,,
Ultratrace,,
iobenguane,Antineoplastic Agents|Enzyme Inhibitors|Indicators and Reagents|Radiopharmaceuticals|Diagnostic Uses of Chemicals,
LX4211,Hypoglycemic Agents|Sodium-Glucose Transporter 2 Inhibitors,
PTX-9908,,
X4P-001,,
CCT301-38,,
Polatuzumab,,
BCX-1777,,
IO102,,
Kabi,,
Alvogen,,
Granulocyte,,
Colony-Stimulating,,
CAR-BCMA,,
IM21,,
LCAR-B4822M,,
Re-treatment,,
nanobody,,
huCART19,,
Single-dose,,
EGFRt/BCMA-41BBz,,
DNP-modified,,
M-Vax,,
DNP-Modified,,
Melanoma,,
HyperAcute-Melanoma,Vaccines,
MT-3724,,
Lipovaxin-MM,,
Aspirin,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Platelet Aggregation Inhibitors|Reproductive Effect|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Cardiovascular Agents|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Peripheral Nervous System Agents|Sensory System Agents|Antipyretics",
Prophylaxis,,
thymoglobulin,Immunologic Factors|Immunosuppressive Agents,
DEBIO1143,,
NY-ESO-1-specific,,
CD8-positive,,
Cell-targeting,,
Lentiviral,,
MIK665,,
SKI-G-801,,
GEM333,,
iCASP9,,
KHK7580,,
CSL362,,
daunorubicin,"Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Tumor Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Etelcalcetide,Treatment of Secondary Hyperparathyroidism Associated with Chronic Kidney Disease,
Dacogen,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Reproductive Effect|Teratogens|Antimetabolites|Antineoplastic Agents|Noxae",
IMCgp100,,
Plerixafor,,"Other immunostimulants|Unknown Cellular or Molecular Interaction|BLOOD PRODUCTS,OTHER|Hematopoietic Stem Cell Mobilizer"
MEDI4736+tremelimumab,,
peginesatide,,Other antianemic preparations
4SC-201,,
Resminostat,,
efficacy,,
ifosfamide,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Tipifarnib,Antineoplastic Agents,
Monocyte,,
KRN7000,"Adjuvants, Immunologic|Antineoplastic Agents|Immunologic Factors",
APN01,,
BC-819/PEI,,
REGN5458,,
JNJ-68284528,,
Melflufen,,
Descartes-08,,
Pexastimogene,,
Devacirepvec,,
P-BCMA-101,,
AUTO2,,
TAK-573,,
BOR+DEX,,
LCAR-B38M,,
CC-220,,
MOR03087,,
hLL1-DOX,,
milatuzumab,,
BKT140,,
proteasome,,
BHQ880,,
aminolevulinate,,
DARPin®,,
Atiprimod,,
Nitroglycerin-citrate-ethanol,,
MCLA-117,,
camrelizumab,,
Tilmanocept,,
Technetium,,
Iobenguane,Antineoplastic Agents|Enzyme Inhibitors|Indicators and Reagents|Radiopharmaceuticals|Diagnostic Uses of Chemicals,
MIBG,,
Valrubicin,Drug / Therapeutic Agent|Mutation Data|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
RPH-001,,
Multi-lineage,,
AMPC,Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimicrobial|Anti-Bacterial Agents|Anti-Infective Agents,
CD123,,
OmnImmune®,,
Evomela,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Alkylating Agents|Antineoplastic Agents|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Noxae",
enasidenib,Antineoplastic Agents,
Anti-BCMA-CAR-expressing,,
CD4+/CD8+,,
T-lymphocytes,,
FCARH143,,
Daunorubicine,"Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Tumor Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
MAX-40279,,
DCLL9718S,,
UCART123,,
AMV564,,
Fosaprepitant,Neurokinin-1 Antagonists|Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents,
ASP1235,,
Freebase,,
JNJ-63709178,,
IMGN779,,
MEN1112,,
Atuveciclib,,
pidilizumab,,
SGN-CD33A,,
SGI-110,Antineoplastic Agents,
SGI-110,,
PGX-ODSH-2013-AML-1,,
IGN523,,
RO5045377,,
endoxan,"Agricultural Chemical|Alkylating Agents|Antineoplastic Agents, Alkylating|Antirheumatic Agents|Drug / Therapeutic Agent|Experimental Pesticide|Human Data|Immunosuppressive Agents|Mutagens|Mutation Data|Reproductive Effect|Tumor Data|Unspecified / Unclassified Pesticide|Antineoplastic Agents|Immunologic Factors|Myeloablative Agonists|Noxae",
OCV-501,,
Wild-type,,
Reovirus,,
Thalidomide+Melphalan,,
#NAME?,,
panobinostat/LBH589B,,
cytosine,Mutation Data,
arabinoside,,
Neukoplast,,
NK-92,,
Ascorbic,,
ABT-888/Bortezomib,,
Ganetespib,,
Trisenox,Agricultural Chemical|Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Insecticide|Mutation Data|Out-Dated Pesticide|Reproductive Effect|Rodenticide|Tumor Data,
CSL360,,
MLN518,,
midostaurin,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Ga-IMP-288,,
CX-4945,,
Posaconazole,"Antifungal|Antibiotics, Antifungal|Trypanocidal Agents|Antifungal Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents|14-alpha Demethylase Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Metabolic Side Effects of Drugs and Substances",
MEDI,,
SEL24/MEN1703,,
Voreloxin,,
ADCT-602,,
Hydrocortisone,Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Anti-Inflammatory Agents,
Minnelide,,
Filanesib,Antimitotic Agents|Antineoplastic Agents,
LY2874455,,
carfilzomib,,"Proteasome Inhibitors|Other antineoplastic agents|Proteasome Inhibitor|ANTINEOPLASTIC,OTHER"
Nirapaib,,
IL-12,,
18F-FDG,Radiopharmaceuticals|Indicators and Reagents|Diagnostic Uses of Chemicals,
Pacritinib,Antineoplastic Agents,
mitoxantrone,Analgesics|Antineoplastic Agents|Mutation Data|DNA Topoisomerase II Inhibitor|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
mitoxantrone,Drug / Therapeutic Agent|Human Data|Mutation Data|DNA Topoisomerase II Inhibitor,
selinexor,,
REOLYSIN,Antineoplastic Agents,
velcade,Antineoplastic Agents|Protease Inhibitors|Enzyme Inhibitors,
AK105,,
Ara-C,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
SCCHN,,
B-701,Drug / Therapeutic Agent,
Vofatamab,,
Gemtuzumab,"Antineoplastic Agents|Immunotoxins|Noxae|Antineoplastic Agents, Immunological",
Ozogamicin,,
Mesna,Drug / Therapeutic Agent|Protective Agents|Reproductive Effect,
CBT-1®,,
KCP-330,,
helicobacter,,
pylori,,
CART-19,Antineoplastic Agents,
HM43239,,
ECT-001,,
UM171,,
Brequinar,Antineoplastic Agents|Immunosuppressive Agents|Enzyme Inhibitors|Immunologic Factors,
anthracycline,,
cytarabine/daunorubicin,,
Annamycin,"Antibiotics, Antineoplastic|Antineoplastic Agents",
FF-10101-01,,
CWP232291,,
SPI-1620,,
WT1/PRAME,,
besylate,,
Azacytidine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
Cephalexin,Human Data|Reproductive Effect|Antibiotics|Anti-Bacterial Agents|Anti-Infective Agents,
AL3818,,
DCP-001,,
Sargramostim,Immunologic Factors,
SVN53-67/M57-KLH,,
Peptide,,
Zosuquidar,,
gemtuzumab,"Antineoplastic Agents|Immunotoxins|Noxae|Antineoplastic Agents, Immunological",
ozogamicin,,
Pixantrone,Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
Pixantrone,Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
Idarubincin,,
Amufostine,,
Ethyol,Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Protective Agents|Reproductive Effect|Protective Agents,
BNC105P,,
MDX-1401,,
BSCT,,
INXN-1001,,
INXN-3001,,
Cytoxan,"Agricultural Chemical|Alkylating Agents|Antineoplastic Agents, Alkylating|Antirheumatic Agents|Drug / Therapeutic Agent|Experimental Pesticide|Human Data|Immunosuppressive Agents|Mutagens|Mutation Data|Reproductive Effect|Tumor Data|Unspecified / Unclassified Pesticide|Antineoplastic Agents|Immunologic Factors|Myeloablative Agonists|Noxae",
LY2510924,,
Cladribine,Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Immunologic Factors,
nonpathogenic,,
polio-rhinovirus,,
ixazomib,Antineoplastic Agents|Enzyme Inhibitors|Protease Inhibitors,
Tiragolumab,,
TAK-580,,
anti-thymocyte,,
globulin,,
busulfan,"Alkylating Agents|Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Immunologic Factors|Myeloablative Agonists|Noxae",
tacrolimus,Drug / Therapeutic Agent|Natural Product|Reproductive Effect|Immunologic Factors|Immunosuppressive Agents,
tacrolimus,Drug / Therapeutic Agent|Immunosuppressive Agents|Immunologic Factors|Calcineurin Inhibitors|Enzyme Inhibitors,
CD8+,,
CD4+,,
T-cells-expressing,,
HA1-Specific,,
CDDP,Antineoplastic Agents|Cross-Linking Reagents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Indicators and Reagents,
ALT02,,
EU-licensed,,
US-licensed,,
idarubicin,"Drug / Therapeutic Agent|Mutation Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
SCM-010,,
INO-5401,,
PEP005,Antineoplastic Agents,
Ranibizumab,Growth Substances|Angiogenesis Modulating Agents|Angiogenesis Inhibitors|Antineoplastic Agents|Growth Inhibitors|Immunologic Factors,
Cinacalcet,Treatment of Hyperthyroidism|Calcimimetic|Calcimimetic Agents|Calcium-Regulating Hormones and Agents|Hormone Antagonists,
Cinacalcet,"Calcimimetic Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
CV8102,,
doxorubicin-containing,,
AAVLP-HPV,,
CCR2/CCR5,,
Vilaprisan,Treatment of Uterine Fibroids and Endometriosis,
BAY1002670,Treatment of Uterine Fibroids and Endometriosis,
Tyrosine,Mutation Data|Reproductive Effect,
PRA-027,,
Deoxycholic,,
Fecal,,
Microbiota,,
recurrent,,
malignant,,
DIPG,,
131-I-chTNT-1/B,,
BPX-701,,
Tecogalan,Angiogenesis Inhibitor,
Lintuzumab-Ac225,,
Furosemide,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Diuretics|Membrane Transport Modulators|Natriuretic Agents|Sodium Potassium Chloride Symporter Inhibitors,
Spironolactone,"Diuretics|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Tumor Data|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Natriuretic Agents|Diuretics, Potassium Sparing|Mineralocorticoid Receptor Antagonists",
#NAME?,,
talimogene,,
MEDI-565,,
GSK580299,Vaccines,
Cervarix,,
-0.888888889,,
AS04,,
Light-activated,,
AU-011,,
ING-1,,
heMAb,,
Oncoquest-CLL,,
MB07133,,
mg/m2/day,,
LY3114062,,
OROS,,
LY317615,,
BLU-554,,
Ingenol,,
mebutate,,
Zyclara®,,
Diclofenac,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents",
Solaraze®,,
mebutat,,
ingenol,,
Tolbutamide,Drug / Therapeutic Agent|Human Data|Hypoglycemic Agents|Mutation Data|Reproductive Effect|Tumor Data,
EBViNT,,
4SC-203,,
Midostaurin,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
denileukin,,
diftitox,,
E7777,,
Betalutin,,
Pelareorep,,
CM-CS1,,
T-cell,,
Quadrivalent,,
Papillomavirus,,
CTAP201,,
Doxercalciferol,Bone Density Conservation Agents|Growth Substances|Micronutrients|Vitamins,
Mebutate,,
PRV111,,
Transmucosal,,
Cutaneous,,
Ad26.HPV16,,
Ad26.HPV18,,
MVA.HPV16/18,,
VBI-1901,,
CD56-Enriched,,
Blinatumomab,Antineoplastic Agents,
MT103,Antineoplastic Agents,
AEG35156,,
Intetumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
IVAC,,
MUTANOME,,
S65487,,
TBI-1501,,
Trans,,
Crocetinate,,
AVL-292,,
EC-18,,
AFXl-assisted,,
PTX-200,,
CC-90009,,
MDX-1342,,
A-101,Drug / Therapeutic Agent|GABA Modulators|Mutation Data|Reproductive Effect|Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents,
A-101,,
Picato,Antineoplastic Agents,
Temodar,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Mutation Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Pemetrexed/cisplatin,,
Gleevec,Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Hydroxyurea,Antineoplastic Agents|Antisickling Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Hematologic Agents|Nucleic Acid Synthesis Inhibitors,
GX-30,,
THYROGEN®,,
XIAP,,
GA101,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
rivogenlecleucel,,
iC9-CAR19,,
APTO-253,,
Etexilate,,
AR-42,,
Ex-vivo,,
SAR103168,,
Imatinib/Acetaminophen,,
CT53518,,
O6-Benzylguanine,Antineoplastic Agents|Enzyme Inhibitors,
Givinostat,,
NS-018,,
anti-CD123,,
P1101,,
LDE255,,
YS110,,
DS-3201b,,
5-azacytidine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
PKC412,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
lisocabtagene,,
maraleucel,,
single-dose,,
2-dose,,
duvelisib,,"ANTINEOPLASTIC,OTHER"
WT1-sensitized,,
bystander,,
vinblastine,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Tumor Data|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
bleomycin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents",
inotuzumab,,
#NAME?,,
ozogamicin+rituximab+gemcitabine+cisplatinum+dexamethasone,,
Zarnestra,Antineoplastic Agents,
R115777,Farnesyltransferase Inhibitor,
Oblimersen-rituximab-fludarabine,,
AFM13,,
Oblimerson,,
Ulipristal,,"CONTRACEPTIVES,SYSTEMIC|Progesterone Agonist/Antagonist|Emergency contraceptives|Progesterone receptor modulators|Selective Progesterone Receptor Modulators"
TK216,,
EN3835,,
V3-X,,
cholangiocarcinoma,,
hrBMP4,,
MDX1106-04,,
AP23573,,
Ra-223,,
PF-114,,
K0706,,
TCR-transduced,,
APVAC1,,
APVAC2,,
DMB-3111,,
sulindac,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antineoplastic Agents|Antirheumatic Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents",
ME-401,,
CC-99282,,
AB-205,,
OT-82,,
AG-636,,
CD19,,
TG-1501,,
CD19-TriCAR-T,,
TRPH-222,,
Mosunetuzumab,,
RO7082859,,
APX001,,
anti-fungal,,
B001,,
C-CAR011,,
HMPL-689,,
RP4010,,
Chimeric,,
Antigen,,
tazemetostat,,
blinatumomab,Antineoplastic Agents,
HBI-8000,,
BAY1862864,,
lenzilumab,,
IGN002,,
DCDS0780A,,
PEG-asparaginase,Antineoplastic Agents,
6-Mercaptopurine,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Antineoplastic Agents|Enzyme Inhibitors|Immunologic Factors|Noxae",
Anti-B1,,
B-Cell,,
Lymphomas,,
Tositumomab,Antineoplastic Agents,
ONO/GS-4059,,
Iodine-131,,
5-drug,,
regimen,,
DCC-2036,,
SAR3419,,
L-0501,,
Inotuzumab,,
CMC-544,Antineoplastic Agents,
SEL120,,
CAT-8015,Antineoplastic Agents,
Moxetumomab,,
Pasudotox,,
Everolmus,,
CAR-GPC3,,
SBS-101,,
Dengue-1,,
melanoma,,
lysate,,
AME-133v,,
LY2469298,,
Follicular,,
Lymphoma,,
polyamine,,
PG11047,,
ADU-1604,,
UV1/GM-CSF,,
H3B-8800,,
BCD-145,,
ECI-006,,
TBX-3400,,
SX-682,,
GRN-1201,,
RO7070179,,
eftilagimod,,
PF-06840003,,
CAVATAK,,
cis-platinum,Antineoplastic Agents|Cross-Linking Reagents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Indicators and Reagents,
GLA-SE,,
COMBIG-DC,,
AGS-16C3F,,
SGN-75,,
2-OHOA,,
MB-CART2019.1,,
MDX-1203,,
Microtubule-Targeted,,
epitinib,,
succinate,,
succinate,Mutation Data|Skin / Eye Irritant,
OKN-007,,
DEDN6526A,,
BMS-982470,,
interleukin-21,,
CAN008,,
RO5185426,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
RO5185426,,
IMC-20D7S,,
5-Azacytidine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
AS1409,,
NVX-108,Contrast Media|Diagnostic Uses of Chemicals,
ICT-121,,
PTI-6D2,,
GC1008,,
_Beta,,
lomustine,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Tc99m-tilmanocept,,
PF00299804,,
trebananib,Growth Substances|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors,
Genasense®,,
oblimersen,"Antineoplastic Agents|Molecular Probes|Oligodeoxyribonucleotides, Antisense|Oligonucleotides, Antisense",
DTIC,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
CP-461,,
Xenogeneic,,
Tyrosinase,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
PEG-Intron,Antiviral Agents|Anti-Infective Agents,
Coxsackievirus,,
188Re-PTI-6D2,,
CTNX-4975,,
#NAME?,,
AK002,,
VCL-IM01,,
Electroporation,,
Synchrotope,,
TA2M,,
SNS-301,,
gp75,,
CD19-CAR-T,,
CC-8490,,
PZ01,,
ruxolitinib,Antineoplastic Agents,
AZD1480,,
Mercaptopurine,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Antineoplastic Agents|Enzyme Inhibitors|Immunologic Factors|Noxae",
Mercaptopurine,"Mutation Data|Reproductive Effect|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors",
Pegaspargase,Antineoplastic Agents,
Thioguanine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Antimetabolites|Antineoplastic Agents|Noxae",
Thioguanine,"Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Noxae",
CAR19,,
cytoplasmic,,
CD19-directed,,
R-ICE,,
R-ICE,Natural Product,
SGN-CD19A,,
semaxanib,Tyrosine Kinase Inhibitors|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Protein Kinase Inhibitors,
collagenase,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
clostridium,,
histolyticum,,
SHP-141,,
Anti-GRP78,,
PAT-SM6,,
Mapatumumab,Antineoplastic Agents,
methylprednisolone,"Antiemetics|Drug / Therapeutic Agent|Human Data|Neuroprotective Agents|Anti-Inflammatory|Immunosuppressant|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents|Protective Agents",
Perillyl,,
Donafenib,,
Ofatumumab,Antineoplastic Agents,
PEG-Asparaginase,Antineoplastic Agents,
Progenta,,
Lucron,,
ABX-1431,,
Bexxar,Antineoplastic Agents,
Alemtuzumab,"Antineoplastic Agents|Antirheumatic Agents|Antineoplastic Agents, Immunological",
Intron,,
Vancomycin,Drug / Therapeutic Agent|Human Data|Natural Product|Anti-Bacterial Agents|Anti-Infective Agents,
pretreatment,,
SER-401,,
alemtuzumab,"Antineoplastic Agents|Antirheumatic Agents|Antineoplastic Agents, Immunological",
PF-06688992,,
interferon,Antineoplastic Agents|Antiviral Agents|Mutation Data|Anti-Infective Agents,
High-dose,,
PF-06439535,,
DNX-2440,,
Anti-GITR,,
Ch14.18,Antineoplastic Agents,
KB004,,
PF-05280014,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Sylatron,Antiviral Agents|Anti-Infective Agents,
hu3F8,,
rIL-2,Anti-HIV Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents,
PolyMVA,,
Interferon-Alfa,,
GP-100,Mutation Data|Tumor Data|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
AC480,,
PeproStat,,
Anti-CD19m-CD3,,
CPI-818,,
JNJ-67856633,,
CG-806,,
Tisagenlecleucel,,
DTRMWXHS-12,,
TG-1801,,
Loncastuximab,,
JHL1101,,
MS-533,,
ET190L1,,
ARTEMIS,,
VAY736,,
ICAR30,,
ICAR19,,
CHO-H01,,
HLX01,,
ACTR707,,
Hexal,,
Gazyvaro,,
C-CAR-011,,
UCART19,,
Zanubrutinib,,
DTRM-505,,
DTRM-555,,
Chidamide,,
adriacin,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data,
KA2237,,
BCL201,,
LAM-002A,,
IPH4102,,
Cobomarsen,,
BTCT4465A,,
Chlorambucil,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
YTB323,,
ABL001+imatinib,,
ABL001+dasatinib,,
CB-Aza,,
CC-292,,
GDC-0853,,
Brentuximab,,
IMMU-114,,
SP-02L,,
TRU-016,,
Jun-20,,
idelalisib,Antineoplastic Agents|Enzyme Inhibitors,
Oct-20,,
IMGN529,,
mcg/kg/day,,
TXA127,Cardiovascular Agents|Vasodilator Agents|Antihypertensive Agents,
interferon-alfa,,
DCDT2980S,,
JNJ-67571244,,
CYC140,,
XmAb5574,,
LFB-R603,,
ISF35,,
Rituxan,"Antineoplastic Agents|Antirheumatic Agents|Immunologic Factors|Antineoplastic Agents, Immunological",
anti-CD37,,
XmAb2513,,
tositumomab,Antineoplastic Agents,
Erwinase,Antineoplastic Agents,
INNO-406,Enzyme Inhibitors|Protein Kinase Inhibitors,
BL22,,
immunotoxin,,
MK0457,Antineoplastic Agents,
CAR-CD19,,
NMS-03592088,,
MG4101,,
Rituxumab,,
BI1206,,
IDEC-152,,
TriCAR-T-CD19,,
Luitpold,,
Vidaza®,,
TQB2303,,
BP1001,,
eltrombopag,,
olamine,Agricultural Chemical|Mutation Data|Reproductive Effect|Skin / Eye Irritant,
Ocrelizumab,Immunologic Factors,
Axicabtagene,,
Ciloleucel,,
Utomilumab,,
KTE-C19,Antineoplastic Agents,
KTE-X19,,
Astarabine,,
BST-236,,
DI-Leu16-IL2,,
axicabtagene,,
ciloleucel,,
sapacitabine,Antineoplastic Agents,
lintuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Pinatuzumab,,
DA-EPOCH-R,,
ITF2357,Histone Deacetylase Inhibitors|Enzyme Inhibitors,
Cu-64,,
SARTATE,,
Cu-67,,
veltuzumab,Antineoplastic Agents,
IDEC-114,Immunomodulator|Monoclonal Antibody|Anti-Inflammatory Agents|Antineoplastic Agents,
Z650,,
ABX196,,
GT90001,,
LioCyx,,
hA20-humanized,,
O6-BG,,
omega-3-acid,,
Pexa,,
Cerebraca,,
DCB-BO1301,,
PegIFN-2b,,
epratuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
erdafitinib,,
67Cu-SARTATE,,
64Cu-SARTATE,,
Omaveloxolone,,
mg/capsule,,
Dalantercept,,
MN-166,Bronchodilator Agents|Drug / Therapeutic Agent|Platelet Aggregation Inhibitors|Reproductive Effect|Vasodilator Agents|Anti-Asthmatic Agents|Autonomic Agents|Cardiovascular Agents|Enzyme Inhibitors|Hematologic Agents|Peripheral Nervous System Agents|Phosphodiesterase Inhibitors|Respiratory System Agents,
13-Cis,,
Retinoic,,
CD20-directed,,
PF04518600,,
phase2,,
BSG-001,,
INXN-2001,,
iPD1,,
ACP-196,,
CF102,Neurotransmitter Agents|Purinergic Agents|Purinergic P1 Receptor Agonists|Purinergic Agonists,
Orantinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
TSU-68,Enzyme Inhibitors|Protein Kinase Inhibitors,
Z-208,,
DHAP,,
rIL-21,,
ch14.18,Antineoplastic Agents,
#NAME?,,
ch14.18-UTC,Antineoplastic Agents,
Granulocyte-Macrophage,,
Istodax,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Natural Product|Antineoplastic Agents",
CD5789,Dermatologic Agents,
Zalcitabine,Anti-HIV Agents|Antimetabolites|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Reverse Transcriptase Inhibitors|Tumor Data|Antiretroviral|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Noxae|Nucleic Acid Synthesis Inhibitors,
Didanosine,Anti-HIV Agents|Antimetabolites|Drug / Therapeutic Agent|Human Data|Mutation Data|Reverse Transcriptase Inhibitors|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Noxae|Nucleic Acid Synthesis Inhibitors,
CYT004-MelQbG10,,
NPC-08,,
ifosphamide,,
STA-4783,,
PRGN-3006,,
Lenalidomida,,
Detox-B,,
verteporfin,Photosensitizing Agents|Dermatologic Agents|Radiation-Sensitizing Agents,
MKC1106-MT,,
Intranodal,,
Ad-ISF35,,
CX-01,,
S64315,,
PEG-P-INF,,
alpha-2b,,
PBCAR0191,,
CART-19/22,,
LOXO-305,,
Cervarix,Vaccines,
AUTO3,,
CD19/22,,
BinD19,,
methotrexate/hydrocortisone/cytarabine,,
Momelotinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
Asparaginase,Drug / Therapeutic Agent|Human Data|Natural Product|Reproductive Effect|Tumor Data|Antineoplastic Agents,
Cal-1,,
LVsh5/C46,,
BrentuximabVedotin,,
CYT387,Enzyme Inhibitors|Protein Kinase Inhibitors,
BeEAM,,
IMO-8400,,
mg/kg/wk,,
Sorafenib-Vorinostat,,
Soludomerin,,
BCNU,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
C-1101,,
PACTN,,
Methylprednisone,Hormone|Reproductive Effect,
Methylprednisone,,
Zolinza,Antitumor Agent|Histone Deacetylase Inhibitor|Antineoplastic Agents|Enzyme Inhibitors|Anticarcinogenic Agents|Histone Deacetylase Inhibitors,
C.E.R.A,,
carmustine,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
NEOD001,,
I-131,,
MG/ML,,
VIDAZA,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
Mofetil,,
L-1101,,
Interferon-Alpha,,
Interferon-Alpha,Drug / Therapeutic Agent|Human Data,
Ibritumomab,,
tiuxetan,,
polyICLC,Interferon Inducers|Immunologic Factors,
CLOFARABINE,"Antineoplastic Agents|Mutation Data|Antimetabolites|Antimetabolites, Antineoplastic|Noxae",
CDX-3379,,
ERBB3,,
Trans-arterial,,
chemoembolization,,
APG101,,
All-Trans,,
ARRY-614,,
p38/Tie2,,
BGB324+pembrolizumab,,
BGB324+dabrafenib,,
dabrafenib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Nab-Rapamycin,,
Terameprocol,,
Ezatiostat,,
Revlimid®,,
Peginterferon,,
JNJ-30979754,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Reproductive Effect|Teratogens|Antimetabolites|Antineoplastic Agents|Noxae",
Mebendazole,Antinematodal Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Anthelmintics|Anti-Infective Agents|Antimitotic Agents|Antiparasitic Agents|Mitosis Modulators|Tubulin Modulators,
CRISPR,,
Pfu/Ml,,
"Susp,1Ml",,
Laherparep,,
Minocycline,Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Anti-Bacterial Agents|Anti-Infective Agents,
Sertraline,Antidepressive Agents|Drug / Therapeutic Agent|Human Data|Serotonin Uptake Inhibitors|Central Nervous System Agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Serotonin Agents|Membrane Transport Modulators,
Captopril,Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Cardiovascular Agents|Enzyme Inhibitors|Protease Inhibitors,
Auranofin,Human Data|Mutation Data|Reproductive Effect|Antirheumatic Agents,
Palonosetron,Serotonin Antagonists|Neurotransmitter Agents|Serotonin Agents|Antiemetics|Central Nervous System Agents|Gastrointestinal Agents|Peripheral Nervous System Agents|Serotonin 5-HT3 Receptor Antagonists,
RG7388,,
Pegasys,Antiviral Agents|Anti-Infective Agents,
Rapamune,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Immunosuppressive Agents|Mutation Data|Natural Product|Anti-Bacterial Agents|Antifungal Agents|Anti-Infective Agents|Antineoplastic Agents|Immunologic Factors",
PBCAR20A,,
ALLO-501,,
ALLO-647,,
L-0501RI,,
TAC01-CD19,,
GEN3013,,
DuoBody®-CD3xCD20,,
AUTO4,,
Avadomide,,
BNZ132-1-40,,
PCAR-019,,
anti-CD19-CAR-T,,
Ulocuplumab,,
monalizumab,,
ublituximab,,
Cerdulatinib,,
PRT062070,,
fimepinostat,,
Radotinib,,
mcg/kg,,
asparaginase,Drug / Therapeutic Agent|Human Data|Natural Product|Reproductive Effect|Tumor Data|Antineoplastic Agents,
Acadesine,,
fostamatinib,,
APO866,,
motexafin,,
gadolinium,Tumor Data,
SPC2996,,
Lumiliximab,,
IGF/MTX,,
PF-3512676,,
vosaroxin,,
Laser,Drug / Therapeutic Agent|Human Data|Reproductive Effect,
Laser,Agricultural Chemical|Herbicide,
157-165,,
gp100,Mutation Data|Tumor Data|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
MART-1,,
Oncovir,,
poly,,
Duvelisib,,
B-MAD,,
rhuFlt3L/CDX-301,,
CMC544,Antineoplastic Agents,
Oxaliplatine,,
Carboplatine,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Cross-Linking Reagents|Indicators and Reagents,
Adcetris-Levact,,
GA101/HDMP,,
azacytidine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
Solu-medrol,Drug / Therapeutic Agent|Hormone|Human Data|Reproductive Effect,
Lenograstim,"Adjuvants, Immunologic|Drug / Therapeutic Agent|Human Data|Natural Product|Immunologic Factors|Hematologic Agents",
bexarotene,Anticarcinogenic Agents|Antineoplastic Agents|Protective Agents,
DEC-205/NY-ESO-1,,
OPN-305,,
MTX110,,
Convection-Enhanced,,
MCPyV,,
TAg-specific,,
Polyclonal,,
ALDHbr,,
erythropoietin,Mutation Data|Hematinics|Hematologic Agents,
#NAME?,,
Hydrochlorine,,
Veregen,,
TLK199,,
E7727/Decitabine,,
IDH-1,,
GS-9191,,
Bendamustin,,
Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing,,
JCAR014,,
AP611074,,
Eltrombopag,,
Apixaban,Anticoagulants|Hematologic Agents|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Protease Inhibitors|Serine Proteinase Inhibitors,
Ad-CCL21-DC,,
nanoliposomal,,
IMA970A,,
MELITAC,,
lipopolysaccharide,Mutation Data|Reproductive Effect,
VORINOSTAT,Antitumor Agent|Histone Deacetylase Inhibitor|Antineoplastic Agents|Enzyme Inhibitors|Anticarcinogenic Agents|Histone Deacetylase Inhibitors,
Candida,,
R-CHOP,,
BSL_EP044,,
Lactobacillus,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule)|TSCA UVCB,
Lactobacillus,,
BSL_PS6,,
Campath-1H,"Antineoplastic Agents|Antirheumatic Agents|Antineoplastic Agents, Immunological",
treosulfan,"Antineoplastic Agents, Alkylating|Mutation Data|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Nowarta110,,
CLS003,,
Ranpirnase,Antineoplastic Agents|Enzyme Inhibitors|Protein Synthesis Inhibitors,
AS101,"Drug / Therapeutic Agent|Immunomodulator|Adjuvants, Immunologic|Anti-Infective Agents|Antineoplastic Agents|Antiviral Agents|Immunologic Factors|Protective Agents|Radiation-Protective Agents",
TN-TC11G,,
Valomaciclovir,Antivirals,
AdE1-,,
CTLs,,
hu14.18-IL2,,
LR-ESHAP,,
CD19.CAR-T,,
questionnaire,,
Lorlatinib,Antineoplastic Agents,
Trivirus,,
Adenovirus,,
Reparixin,,
NeuVax,,
gemcitabine/carboplatin,,
HSP-130,,
Bempegaldesleukin,,
Dutasteride,"Enzyme Inhibitors|5-alpha Reductase Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Urological Agents|Steroid Synthesis Inhibitors",
OSI-211,Antineoplastic Agents,
Lurtotecan,Antineoplastic Agents,
NanoPac®,,
SFX-01,,
GSK3145095,,
AE37,,
ZALTRAP®,,
Selumetinib+Docetaxel,,
TAS-108,,
Leuprorelin,"Antineoplastic Agents, Hormonal|Fertility Agents, Female|Hormone|Human Data|Reproductive Effect|Antineoplastic Agents|Fertility Agents|Reproductive Control Agents",
Leuporelin,,
MK8669,,
open-label,,
l-LV,,
Tapentadol,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Analgesics|Analgesics, Opioid|Central Nervous System Agents|Central Nervous System Depressants|Membrane Transport Modulators|Narcotics|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Sensory System Agents",
catumaxomab,Gastrointestinal Agents,
ASP1650,,
OTL38,,
G17DT,,
demcizumab,,
eFT508,,
MCLA-128,,
2X-121,,
TALAZOPARIB,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
Aromasin,"Antineoplastic Agents|Enzyme Inhibitors|Antineoplastic|Aromatase Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
BPM31510,,
Nanosuspension,,
IMUNO,,
Moreau,,
Seribantumab,,
Estetrol,,
rubitecan,Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,
rubitecan,Antineoplastic Agents,
rhApo2L/TRAIL,,
SU011248/Trastuzumab,,
FluidCrystal®,,
galeterone,Enzyme Inhibitors,
abituzumab,,
XRP9881,,
apatinib,,
ramucirumab,Antineoplastic Agents,
epidoxorubicin,"Drug / Therapeutic Agent|Mutation Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
DCVAC/PCa,,
Orteronel+Prednisone,,
Megestrol,"Antineoplastic Agents, Hormonal|Contraceptives, Oral, Synthetic|Hormone|Antineoplastic Agents|Contraceptive Agents|Contraceptive Agents, Female|Contraceptives, Oral|Reproductive Control Agents",
LY2181308,,
Phenoxodiol,,
Poly-gamma,,
Glutamic,,
TOCOSOL,,
Alcohol-free,,
Desulfated,,
Heparin,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
IRESSA,,
Icrucumab,,
BAY59-8862,Antineoplastic Agents,
Cytotoxic,,
bavituximab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
HyperAcute,,
#NAME?,,
NSAI,,
chiauranib,,
Plenaxis,"Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
GX301,,
paclitaxel-loaded,,
polymeric,,
micelle,,
ABR-215050,,
tasquinimod,,
Irofulven,"Natural Product|Alkylating Agents|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Noxae|Radiation-Sensitizing Agents",
valrubicin,Drug / Therapeutic Agent|Mutation Data|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
RO5217790,,
DHP107,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
CDX-011,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Serine,Mutation Data,
Serine,,
Proteinase,Natural Product|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
WX-671,,
necitumumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
V3-MOMMO,,
ASP3550,,
MB-6,,
Bafetinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
Neulasta,Antineoplastic Agents|Pegylated Protein,
Aranesp,Hematinics|Hematologic Agents,
YMB1002,Histamine Antagonists|Platelet Aggregation Inhibitors|Hematologic Agents|Histamine Agents|Neurotransmitter Agents,
metyrosine-derivative,,
phenytoin,Anticonvulsants|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Central Nervous System Agents|Cardiovascular Agents|Membrane Transport Modulators|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers|Cytochrome P-450 CYP1A2 Inducers|Metabolic Side Effects of Drugs and Substances,
methoxsalen,Drug / Therapeutic Agent|Mutation Data|Photosensitizing Agents|Reproductive Effect|Tumor Data|Cross-Linking Reagents|Dermatologic Agents|Indicators and Reagents|Radiation-Sensitizing Agents,
FEC75,,
apricoxib,,
Lonaprisan,,
BAY86-5044,,
BP-C2,,
Ad5CMV-p53,,
Vicriviroc,,
EndoTAG-1,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
CEP-701,,
NOV-002,,
cixutumumab,,
tamoxifen,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Estrogen Antagonists|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
arzoxifene,,
tartrate,"Adrenergic alpha-Agonists|Analgesics, Non-Narcotic|Drug / Therapeutic Agent|Human Data|Vasoconstrictor Agents|Adrenergic Agents|Adrenergic Agonists|Analgesics|Cardiovascular Agents|Central Nervous System Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Adrenergic alpha-1 Receptor Agonists|Oxytocics|Reproductive Control Agents|Serotonin Agents|Serotonin Receptor Agonists",
CBLB612,,
glutamate-paclitaxel,,
THERATOPE®,,
NX-1207,,
V3-OVA,,
ovarian,,
Lasofoxifene,Estrogen Receptor Modulator,
Carlumab,,
Tomudex,"Antimetabolites, Antineoplastic|Enzyme Inhibitors|Folic Acid Antagonists|Antimetabolites|Antineoplastic Agents|Noxae",
OCZ103-OS,,
2-hydroxyethanesulfonate,,
Desmopressin,Antidiuretic Agents|Coagulants|Hematologic Agents|Hemostatics|Natriuretic Agents,
Streptozotocin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents",
tacedinaline,,
Chemoradiation,,
Veledimex,,
Palifosfamide,"Antineoplastic Agents, Alkylating|Alkylating Agents|Antineoplastic Agents|Noxae",
sipuleucel-T,Antineoplastic Agents,
Ertafolide,,
vismodegib,Antineoplastic Agents,
Treosulfane,,
etoricoxib,"Anti-Inflammatory|COX-2 Inhibitor|Cyclooxygenase Inhibitors|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Cyclooxygenase 2 Inhibitors|Antirheumatic Agents",
pioglitazone,Hypoglycemic Agents,
lucitanib,,
PRX302,,
tavokinogene,,
telseplasmid,,
LHRHa,,
4-Demethyl-4-cholestryloxycarbonylpenclomedine,,
efaproxiral,Antisickling Agents|Hematologic Agents|Radiation-Sensitizing Agents,
efaproxiral,,
anti-FLT-1,,
ribozyme,,
Fixed-dose,,
SAR439281,,
hu3S193,,
ACT14884,,
Quinacrine,Anticestodal Agents|Antimalarials|Antinematodal Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Antiprotozoal Agents,
CPC634,,
V3-Cervix,,
Avodart,"Enzyme Inhibitors|5-alpha Reductase Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Urological Agents|Steroid Synthesis Inhibitors",
tomivosertib,,
ZARNESTRA,Antineoplastic Agents,
tipifarnib,Antineoplastic Agents,
Lyposomal,,
Lipiodol,,
Epidoxorubicin,"Drug / Therapeutic Agent|Mutation Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
taxane,Antineoplastic Agents,
Hormonal,,
Trifluridine/Tipiracil,,
KOS-1584,,
GTx-024,,
fosbretabulin,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic",
tromethamine,Buffers|Drug / Therapeutic Agent|Excipients|Pharmaceutic Aids|Pharmaceutical Vehicles,
OPT-822/OPT-821,,
SAR2405550,,
#NAME?,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
Lanreotide,Antineoplastic Agents,
Autogel,Antineoplastic Agents,
AS1404,Antineoplastic Agents,
telotristat,,
CC-4047,Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Substances|Immunologic Factors|Growth Inhibitors,
MYOCET®,,
Arimidex,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Enzyme Inhibitors|Aromatase Inhibitors|Antineoplastic Agents|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
Faslodex,"Antineoplastic Agents|Estrogen Antagonists|Antineoplastic Agents, Hormonal|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Estrogen Receptor Antagonists",
BIO-11006,,
Veru-944,,
Bemcentinib,,
Belotecan,Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,
TLD-1433,,
Photodynamic,,
Epirubicine,"Drug / Therapeutic Agent|Mutation Data|Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Somatostatin,,
Somatostatin,"Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
Fluoropyrimidine,,
5-FU/LV,,
Aromasin®,,
POMx,,
Anastrazole,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Enzyme Inhibitors|Aromatase Inhibitors|Antineoplastic Agents|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
INSTILADRIN,,
Fosbretabulin,"Antineoplastic Agents|Antineoplastic Agents, Phytogenic",
Hycamtin,,
Hycamtin,Antineoplastic Agents|Enzyme Inhibitors|Antineoplastic|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,
Relugolix,,
BIBH,,
Lonafarnib,Enzyme Inhibitors,
DOCETAXEL,Antineoplastic Agents|Drug / Therapeutic Agent|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators,
DOCETAXEL,Antineoplastic Agents|Tubulin Modulators|Mitosis Modulators|Antimitotic Agents,
Oxaliplatin+Capecitabine+Pembrolizumab,,
soblidotin,Antineoplastic Agents,
masitinib,,
CI-1033,"Anesthetics|Anesthetics, Local|Antineoplastic Agents|Cardiotonic Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents",
ARD6562,,
PRAME,,
GSK2302032A,,
rucaparib,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
ELIGARD,"Antineoplastic Agents, Hormonal|Fertility Agents, Female|Hormone|Human Data|Reproductive Effect|Antineoplastic Agents|Fertility Agents|Reproductive Control Agents",
ELIGARD,Reproductive Effect,
Ozarelix,,
CABAZITAXEL,,
alvimopan,,
alvimopan,Drug / Therapeutic Agent|Opioid Antagonist|Peripherally Restricted mu Opioid Receptor Antagonist|Gastrointestinal Agents,
torisel,,
Catumaxomab,Gastrointestinal Agents,
onartuzumab,,
mFolfox,,
Cyproterone,"Androgen Antagonists|Hormone|Reproductive Effect|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
Norzyme,Drug / Therapeutic Agent|Gastrointestinal Agents|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
eloxatin,Drug / Therapeutic Agent|Antineoplastic|Antineoplastic Agents,
lanreotide,Antineoplastic Agents,
regimen=oxaliplatin,,
Telisotuzumab,,
VRP-HER2,,
caelyx,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
caelyx,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data,
Panzem®,,
Matuzumab,,
Kevetrin,,
Dupilumab,Anti-Asthmatic Agents|Respiratory System Agents,
Sequential,,
Icotinib,,
Tilsotolimod,,
BIBF1120,Antineoplastic Agents|Enzyme Inhibitors,
EndoTAG®-1,,
erbitux,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
TNFerade,,
TORISEL,,
ILX651,,
BGB-A317and,,
Robatumumab,,
CAPEOX/XELOX,,
Panzem,Antimitotic Agents|Mitosis Modulators|Tubulin Modulators|Antineoplastic Agents,
2-methoxyestradiol,Antimitotic Agents|Mitosis Modulators|Tubulin Modulators|Antineoplastic Agents,
Edotecarin,Topoisomerase Inhibitors|Antineoplastic,
Gallium-68,,
THP-PSMA,,
Chemo,,
RX-0201,,
Enoxaparin,Anticoagulants|Fibrinolytic Agents|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
avastin,"Antineoplastic|Monoclonal Antibody|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Antineoplastic Agents, Immunological",
SR31747A,Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents,
SR31747A,,
Prednisone*,,
Anti-NGF,,
Physician,,
CD3-MUC1,,
Infusional,,
Savolitinib,,
rHuEPO,Hematinics|Hematologic Agents,
fluoropyrimidine,,
Atrasentan,Endothelin-Receptor Antagonist|Endothelin Receptor Antagonists|Antineoplastic Agents|Endothelin A Receptor Antagonists,
TNFerade,,
CMAB009,,
Irinotecan-only,,
sequential-CMAB009,,
foretinib,Antineoplastic Agents,
PELITREXOL/AG-2037,,
Prednisone/,,
GLIADEL,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
LY293111,,
Diethylstilbestrol,"Agricultural Chemical|Carcinogens|Drug / Therapeutic Agent|Estrogens, Non-Steroidal|Hormone|Human Data|Mutation Data|Natural Product|Reproductive Effect|Tumor Data|Estrogens|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Noxae|TSCA Flag S (Substance is Identified in a Final Significant New Use Rule)",
TroVax,,
Trilostane,"Abortifacient Agents, Steroidal|Antineoplastic Agents|Enzyme Inhibitors|Hormone|Human Data|Reproductive Effect|Abortifacient Agents|Reproductive Control Agents",
Polysaccharides,,
PROSTVAC®-VF/TRICOM,,
DEBIRI,,
systemic,,
ZK219477,Antineoplastic Agents,
SorCape,,
Alpha-interferon,,
JS001,,
Toremifine,,
PHA-739358,,
ART-123,,
DCVAC/OvCa,,
infusional,,
apricoxib/erlotinib,,
BLS-ILB-E710c,,
ibandronate,Bone Density Conservation Agents,
Bondronat,Bone Density Conservation Agents,
Bondronat,,
anti-virus,,
imetelstat,Enzyme Inhibitors,
Endostatin,Antiangiogenic Drug|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances,
paclitaxel-carboplatin,,
AG013736,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
MAC-321,,
KW-2246,,
fentanyl,"Adjuvants, Anesthesia|Analgesics, Opioid|Anesthetics, Intravenous|Drug / Therapeutic Agent|Human Data|Narcotics|Analgesics|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
l-Leucovorin,Growth Substances|Micronutrients|Vitamin B Complex|Vitamins|Antidotes|Protective Agents,
Colestipol,Anion Exchange Resins|Antimetabolites|Ion Exchange Resins|Hypolipidemic Agents|Lipid Regulating Agents,
injectable,,
Lung,,
plevitrexed,Antineoplastic|Antineoplastic Agents,
MUC1,,
Cvac,,
Benadryl,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antihistamine,
Ranitidine,Anti-Ulcer Agents|Drug / Therapeutic Agent|Histamine H2 Antagonists|Human Data|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Neurotransmitter Agents,
Ranitidine,Human Data|Histamine H2 Receptor Antagonists,
talabostat,,
PT-100,,
Tookad,,
Navelbine,Reproductive Effect,
CISPLATIN,Antineoplastic Agents|Cross-Linking Reagents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Indicators and Reagents,
Zytiga,"Antineoplastic Agents|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hormone Antagonists|Steroid Synthesis Inhibitors|Hormones, Hormone Substitutes, and Hormone Antagonists|Metabolic Side Effects of Drugs and Substances",
Nanocrystal,,
Colloidal,,
mouthwash,,
Levofolinic,Antidotes|Protective Agents,
CG8123,,
picoplatin,Antineoplastic,
Gastric,,
pemetrexed/carboplatin,,
gemcitabine/cisplatin,,
colorectal,,
colony-stimulating,,
Pancreatic,,
utidelone,,
Nanoparticles,,
TQ-B3101,,
Nab-paclitaxel+carboplatin,,
Gemcitabine+carboplatin,,
Pemetrexed+carboplatin,,
Gemcitabine+cisplatin,,
Pemetrexed+cisplatin,,
AMN107-,Antineoplastic|Antineoplastic Agents,
NILOTINIB,Antineoplastic|Antineoplastic Agents,
SU11248,Protein Kinase Inhibitors|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Enzyme Inhibitors,
Lovaza,,
S-8184,,
Inhibitors,,
steroideal,,
anti-PDL1,,
FOLFOX-4+cetuximab,,
OLAPARIB,,
Etoposide-Carboplatin,,
Acyclovir,Antiviral Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Anti-Infective Agents,
suberoylanilide,,
Taxus,"Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Selective Estrogen Receptor Modulators|Antineoplastic Agents, Hormonal|Bone Density Conservation Agents|Estrogen Antagonists|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
platinum,Tumor Data,
TK1258,,
estramustine,"Antineoplastic Agents, Alkylating|Antineoplastic Agents, Hormonal|Mutation Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Cabrilizumab,,
Panitumumab+irinotecan,,
Imfinzi,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Radiotherapy,,
oxalipaltin+S-1,,
oxalipaltin+capecitabine,,
ZACTIMA,Antineoplastic,
CAPEOX,Antineoplastic Agents,
Capecitabine/,,
Folfiri,Antineoplastic Agents,
Panitumumab+FOLFOX-4,,
Panitumumab+FOLFIRI,,
secoisolariciresinol,"Estrogens|Estrogens, Non-Steroidal|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phytoestrogens",
LY900003,Drug / Therapeutic Agent|Antisense Oligonucleotide,
Concurrent,,
physician,,
pictilisib,,
Flutamide,"Androgen Antagonists|Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
PD0332991,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Lurbinectedin,,
TMX-101,"Adjuvants, Immunologic|Interferon Inducers|Antineoplastic Agents|Immunologic Factors",
modifiedFOLFOX6,,
Multi-tracer,,
Fluciclovine,,
Tak-228,,
Tak-117,Enzyme Inhibitors,
Doxycline,,
Mangafodipir,,
PCI-27483,,
Neulasta®,,
Gemcitabine+erlotinib,,
Gemcitabine+erlotinib+capecitabine,,
Capecitabine+Irinotecan+Bevacizumab,,
PGG®,,
PF-06463922,Antineoplastic Agents,
platinum-based,,
abemaciclib,,
Supportive,,
Kidney,,
Gemox,,
RO4929097,,
Carboplatin-based,,
Anastrozole+Fulvestrant,,
cisplatin/carboplatin,,
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal|Drug / Therapeutic Agent|Human Data|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Peripheral Nervous System Agents|Sensory System Agents",
Reolysin,Antineoplastic Agents,
SR96669,,
OGX-011,,
/mitoxantrone,,
/docetaxel,,
Cisplatin-5FU-Afatinib,,
vargatef®,,
Diflomotecan,,
BN80915,,
T00268C,,
PTK787/,,
AXITINIB,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Cridanimod,Drug / Therapeutic Agent|Interferon Inducers|Immunologic Factors,
progestin,"Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Progestins",
Saccharomyces,,
cerevisiae-CEA,,
doxorubicine,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
BVZ+XELOX,,
BVZ+XELIRI,,
BVZ+FUIRI,,
BVZ+FUOX,,
LEE-011,Antineoplastic Agents,
GRN1005,,
18F-FLT,,
Tesetaxel,,
VELCADE,,
Anti-EGFR,,
Carboplatinum,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Cross-Linking Reagents|Indicators and Reagents,
RHUMAB,,
dalteparin,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
Trastuzumab+Docetaxel+NPLD,,
Trastuzumab+Docetaxel+NPLD+Bevacizumab,,
CPX-1,,
L-Leucovorin,Growth Substances|Micronutrients|Vitamin B Complex|Vitamins|Antidotes|Protective Agents,
Calmette-Guerrin,,
/gemcitabine,,
Disulfiram/Copper,,
Gluconate,,
Single-agent,,
Ocoxin-Viusid,,
oregovomab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Albumin,,
Rebamipide,Drug / Therapeutic Agent|Reproductive Effect|Anti-Ulcer Agents|Antioxidants|Enzyme Inhibitors|Gastrointestinal Agents|Protective Agents,
Zometa,Bone Density Conservation Agents,
zometa,Bone Density Conservation Agents,
MT-102,,
Odanacatib,,
Aranesp®,,
GTX-006,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
Acapodene,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
AFLIBERCEPT,,
Lucanix,,
tucatinib,,
Anti-Bacterial,,
Anti-Fungal,,
Anti-Protozoal,,
tirapazamine,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Radiation-Sensitizing Agents,
embolization,,
hormone-releasing,,
hormone,,
Antiandrogen,,
DD-MVAC,,
APD209,,
KD018,,
Mitomycin-C,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Cross-Linking Reagents|Enzyme Inhibitors|Indicators and Reagents|Noxae|TSCA Flag S (Substance is Identified in a Final Significant New Use Rule)",
PF-06873600,,
Domatinostat,,
Acetylsalicylic,,
EKB-569,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Randomization,,
CDP791,,
Fluorine,Skin / Eye Irritant,
Ara-G,,
Vopratelimab,,
Vinorebine,,
ET743,"Antineoplastic Agents|Alkylating Agents|Antineoplastic Agents, Alkylating|Noxae",
S-1+leucovorin,,
Pancreas,,
CRS-207,,
Lapatinib/nab-Paclitaxel,,
rhG-CSF,Drug / Therapeutic Agent|Human Data|Natural Product|Hematologic Agents,
rhG-CSF,Drug / Therapeutic Agent|Reproductive Effect,
poliglumex,,
Navarixin,,
Neoadjuvant,,
SGN-15,,
cBR96-doxorubicin,,
immunoconjugate,,
89Zr-Pembrolizumab,,
amurubicin,,
DLBS1425,,
SHR1210,,
Carboplatin/Cisplatin,,
Pentostatin,Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Reproductive Effect|Antineoplastic Agents|Adenosine Deaminase Inhibitors,
KRN23,,
Embolization,,
Crofelemer,,
FLT3,,
Ligand,,
Granulocyte-colony,,
ctDNA,,
leflunomide,Drug / Therapeutic Agent|Enzyme Inhibitors|Immunosuppressive Agents|Antirheumatic Agents|Immunologic Factors,
Anamorelin,,
BP102,,
YPEG-rhG-CSF,,
s.c.,,
PEG-rhG-CSF,,
run-in,,
concurrent,,
chemoradiotherapy,,
chemoradiation,,
"d1,8",,
Saracatinib,Antineoplastic Agents|Enzyme Inhibitors,
Paclitaxel/Carboplatin/Gefitinib,,
Paclitaxel/Carboplatin,,
I-131-1095,,
dutasteride,"Enzyme Inhibitors|5-alpha Reductase Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Urological Agents|Steroid Synthesis Inhibitors",
Naproxen,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Gout Suppressants|Human Data|Mutation Data|Reproductive Effect|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents",
Loratadine,"Anti-Allergic Agents|Antipruritics|Histamine H1 Antagonists|Dermatologic Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents",
tozuleristide,,
28-Day,,
Within,,
re-induction,,
Maleate,,
Cisplatin-based,,
neoadjuvant,,
Masitinib,,
CP-751,,
Brilacidin,,
"SU-011,248",,
Sm-EDTMP,"Analgesics, Non-Narcotic|Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents",
levo-leucovorin,Antidotes|Protective Agents,
PPP001,,
perfusion,,
Aprepitant/Ramosetron/Dexamethasone,,
UFOX,,
Triptorelin,"Antineoplastic Agents, Hormonal|Luteolytic Agents|Antineoplastic Agents|Contraceptive Agents|Contraceptive Agents, Female|Reproductive Control Agents",
Pamoate,,
Pamorelin®,,
serum,,
corticosteroid,,
ACTH,"Human Data|Natural Product|Reproductive Effect|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
ACTH,,
Adriamycine,,
Oxycodone/Naloxone,,
INGN,,
Fentanyl,"Adjuvants, Anesthesia|Analgesics, Opioid|Anesthetics, Intravenous|Drug / Therapeutic Agent|Human Data|Narcotics|Analgesics|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
Fluciclatide,,
Fluorouracile,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
preoperative,,
Mycobacterial,,
wall-DNA,,
Bisphosphonate,,
162-,,
Ferric,,
Carboxymaltose,,
CVM-1118,,
Vascular,,
Endothelial,,
VEGFR,,
Platelet-Derived,,
PDGFR,,
brigatinib,Antineoplastic Agents,
SCV-07,,
Recurrence,,
INIPARIB,Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors,
J591,,
VB-111,,
Omiganan,Peptides|Antimicrobial,
CLS001,,
Topotecan/Docetaxel,,
Trivalent,,
Influenza,,
High-Dose,,
Genexol®-PM,,
Genexol®,,
FOLFOXIRI,,
Tegafur-,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
Gimeracil-Oteracil,,
potassium,,
Aminolaevulinic,,
no-DP,,
Probiotic,Anti-Bacterial Agents|Anti-Infective Agents,
Alclometasone,,
ISA101b,,
Lu177-PSMA-617,,
First-Line,,
Second-Line,,
inodiftagene,,
vixteplasmid,,
TPIV200,,
Losartan,Anti-Arrhythmia Agents|Antihypertensive Agents|Drug / Therapeutic Agent|Human Data|Angiotensin II Type 1 Receptor Blockers|Cardiovascular Agents|Angiotensin Receptor Antagonists,
GnRH,Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Darolutamide,,
situ,,
AlloStim®,,
CG0070,,
Lipidem,,
QBKPN,,
NPC-06,,
Duavee,,
Erythropoietin,Mutation Data|Hematinics|Hematologic Agents,
ONO-7436,Substance P Antagonist|Antiemetic (in Chemotherapy-Induced Emesis)|Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Peripheral Nervous System Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents,
RC-1291,,
Panax,Drug / Therapeutic Agent|Reproductive Effect,
Herceptin+XELOX,,
TOMOX,,
Capecitabine/Cisplatin,,
EC145,,
Ilorasertib,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
SDREGN2810,,
SDREGN2810/ipi,,
HDREGN2810,,
CI-1040,,
Genexol-PM®,,
AUC2,,
GEFITINIB,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
perioperative,,
nab-paclitaxel/gemcitabine,,
siG12D-LODER,,
Gemcitabine+nab-Paclitaxel,,
LV5FU2,,
Cabazitaxel-XRP6258,,
5-week,,
RO5490258,,
PF-06747775,,
4-weekly,,
racemic,,
ICOS,,
octreotide,"Antineoplastic Agents, Hormonal|Gastrointestinal Agents|Antineoplastic Agents",
ATEZOLIZUMAB,Antineoplastic Agents,
PERTUZUMAB,"Monoclonal Antibody|HER-2-Targeting Antibody|Antineoplastic Agents|Antineoplastic Agents, Immunological",
Fluorescein,Contrast Media|Mutation Data|Coloring Agents|Fluorescent Dyes|Indicators and Reagents|Luminescent Agents|Diagnostic Uses of Chemicals,
Dinutuximab,Antineoplastic Agents,
lapatinib/herceptin,,
P53-SLP,,
AVI-014,,
versus,"Anti-Inflammatory Agents, Non-Steroidal|Drug / Therapeutic Agent|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Peripheral Nervous System Agents|Sensory System Agents",
versus,,
PTC-Pz,,
Elsiglutide,,
Necitumumab-Gemcitabine-Cisplatin,,
HP802-247,,
Bacitracin,"Anti-Infective Agents, Local|Drug / Therapeutic Agent|Mutation Data|Anti-Bacterial Agents|Anti-Infective Agents",
1-day,,
Titration,,
3-day,,
Surufatinib,,
Zalypsis,,
EC-paclitaxel,,
G17DT-Irinotecan,,
Gleevec,,
Tesevatinib,,
CT-011,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
abatacept,Immunosuppressive Agents|Antirheumatic Agents|Antirheumatic|Immunologic Factors,
elotuzumab,Antineoplastic Agents,
Sublingual,,
EBV-specific,,
ONM-100,,
Romiplostim,,
Carbo/cyclo,,
PROSTVAC-V/F,,
Ado-Trastuzumab,,
F-Ara-G,,
cypionate,,
mDCF,,
Morphine,"Analgesics, Opioid|Drug / Therapeutic Agent|Human Data|Mutation Data|Narcotics|Reproductive Effect|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
Sulphate,,
Biosimilar,,
mFOLFIRINOX,,
StemEx,,
dextran,Anticoagulants|Drug / Therapeutic Agent|Human Data|Plasma Substitutes|Reproductive Effect|Tumor Data|Blood Substitutes|Hematologic Agents|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
vinca,Antihypertensive Agents|Drug / Therapeutic Agent|Natural Product|Vasodilator Agents|Cardiovascular Agents,
Lifileucel,,
LN-145,,
rHSA-GCSF,,
dexmethylphenidate,Central Nervous System Stimulants|Dopamine Uptake Inhibitors|Dopamine Agents|Neurotransmitter Agents|Central Nervous System Agents|Membrane Transport Modulators|Neurotransmitter Uptake Inhibitors,
d-mph,Central Nervous System Stimulants|Dopamine Uptake Inhibitors|Dopamine Agents|Neurotransmitter Agents|Central Nervous System Agents|Membrane Transport Modulators|Neurotransmitter Uptake Inhibitors,
eniluracil,Enzyme Inhibitors,
Methylphenidate,Central Nervous System Stimulants|Dopamine Agents|Dopamine Uptake Inhibitors|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Central Nervous System Agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Membrane Transport Modulators,
D0316,,
GEMOX,,
Telotristat,,
Ethyl,,
CliniMACs,,
estriol,Drug / Therapeutic Agent|Hormone|Mutation Data|Reproductive Effect|Tumor Data,
germline,,
tezacitabine,Antineoplastic Agents|Enzyme Inhibitors|Radiation-Sensitizing Agents,
Xalkori,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
telapristone,,
cisplatin/docetaxel,,
cisplatin/vinorelbine,,
STI-3031,,
Belotaxel,,
Belloxa,,
ADV/HSV-tk,,
denosumab,Bone Density Conservation Agents,
simvastatin,Anticholesteremic Agents|Drug / Therapeutic Agent|Human Data|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Reproductive Effect|Antimetabolites|Enzyme Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents,
Sandostatin,Drug / Therapeutic Agent|Human Data,
afuresertib,,
eryaspase,,
L-asparaginase,Drug / Therapeutic Agent|Human Data|Natural Product|Reproductive Effect|Tumor Data|Antineoplastic Agents,
Clindamycin,Drug / Therapeutic Agent|Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors|Protein Synthesis Inhibitors,
clindamycin,Drug / Therapeutic Agent|Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors|Protein Synthesis Inhibitors,
triamcinolone,"Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
soln,,
gemcitabine/nab,,
NLIR+FU/FA,,
nilotinib,Antineoplastic|Antineoplastic Agents,
brivanib,,
Duravalumab,,
Methylene,,
strontium-89,,
mLV5FU2,,
mFOLFOX7,,
efatutazone,Antineoplastic Agents,
B7-1,Drug / Therapeutic Agent,
premenopausal,,
postmenopausal,,
Epirubicin+,,
JNJ-42160443,,
Simtuzumab,,
Pegteograstim,,
SPECT,,
B20-,Drug / Therapeutic Agent,
Modafinil,Central Nervous System Stimulants|Central Nervous System Agents|Neuroprotective Agents|Protective Agents|Cytochrome P-450 CYP3A Inducers|Wakefulness-Promoting Agents|Metabolic Side Effects of Drugs and Substances,
Irinotecan-Capecitabine-Oxaliplatin,,
apixaban,Anticoagulants|Hematologic Agents|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Protease Inhibitors|Serine Proteinase Inhibitors,
enoxaparin,Anticoagulants|Fibrinolytic Agents|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
medroxyprogesterone,"Contraceptives, Oral, Synthetic|Hormone|Human Data|Reproductive Effect|Contraceptive Agents|Contraceptive Agents, Female|Contraceptives, Oral|Reproductive Control Agents",
megestrol,"Antineoplastic Agents, Hormonal|Contraceptives, Oral, Synthetic|Hormone|Antineoplastic Agents|Contraceptive Agents|Contraceptive Agents, Female|Contraceptives, Oral|Reproductive Control Agents",
SipT,,
Capmatinib,,
Filgrastim-SD/01,,
empegfilrastim,,
CoFactor,,
IZN-6N4,,
CBPT,,
Pre-emptive,,
ladiratuzumab,,
TroVax®,,
Quarfloxin,,
SHR-1210+GEMOX,,
Docetaxel/Carboplatin/Bevacizumab/Erlotinib,,
Docetaxel/Carboplatin,,
Ziconotide,"Calcium Channel Blockers|Neuroprotective Agents|Analgesics|Analgesics, Non-Narcotic|Cardiovascular Agents|Central Nervous System Agents|Membrane Transport Modulators|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents|Calcium-Regulating Hormones and Agents",
Myelo001,,
Anagrelide,Drug / Therapeutic Agent|Human Data|Cardiovascular Agents|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Platelet Aggregation Inhibitors,
AH111585,,
vaccina,,
Glivec®,,
FLOT,,
Herceptin/Pertuzumab,,
Amuvatinib,,
LS11,,
Disodium,,
APC8015F,,
FK228,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Natural Product|Antineoplastic Agents",
FLOT-A,,
Immunological,,
MVA-BN-Brachyury,,
zolbetuximab,,
Ingestion,,
amantadine,"Analgesics, Non-Narcotic|Antiparkinson Agents|Antiviral Agents|Dopamine Agents|Drug / Therapeutic Agent|Mutation Data|Analgesics|Anti-Dyskinesia Agents|Anti-Infective Agents|Central Nervous System Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents",
Tasquinimod,,
TALIMOGENE,,
LAHERPAREPVEC,,
Vial,,
Eloxatin®,,
Perindopril,Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Cardiovascular Agents|Enzyme Inhibitors|Protease Inhibitors,
nintedanib,Antineoplastic Agents|Enzyme Inhibitors,
UGN-102,,
raltitrexed,"Antimetabolites, Antineoplastic|Enzyme Inhibitors|Folic Acid Antagonists|Antimetabolites|Antineoplastic Agents|Noxae",
ALD518,,
NRL0706,,
NK-DLI,,
DUK-CPG-001,,
Folate,Drug / Therapeutic Agent|Hematinics|Mutation Data|Reproductive Effect|Vitamin B Complex|Growth Substances|Hematologic Agents|Micronutrients|Vitamins,
oxaliplatine,,
de-escalation,,
5-flourouracil,,
Gamma-Interferon-1b,,
Bevacizumab-IRDye800CW,,
Ifetroban,Platelet Aggregation Inhibitors|Hematologic Agents,
Neugranin,,
F-Fluciclovine,,
Tegafur-gimeracil-oteracil,,
SR48692,,
epoetin,Mutation Data|Hematinics|Hematologic Agents,
AVOVA-1,,
ADXS-HPV,,
LBH581,,
EGFR-TKI,,
Corticosteroid,,
TG4010,,
"beta-1,3/1,6-glucan",,
APD515,,
amlexanox,Anti-Allergic Agents|Drug / Therapeutic Agent,
Diprosone,Drug / Therapeutic Agent|Hormone|Reproductive Effect|Anti-Inflammatory Agents,
LMWH,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
Mouthwash,,
Folotyn,Antineoplastic,
nonavalent,,
prinomastat,Enzyme Inhibitors|Matrix Metalloproteinase Inhibitors|Protease Inhibitors,
Adecatumumab,,
131I-MIBG,Antineoplastic Agents|Enzyme Inhibitors|Radiopharmaceuticals|Indicators and Reagents,
carboplatin/gemcitabine,,
KRN5500,Antitumor Agent|Antineoplastic Agents|Enzyme Inhibitors|Protein Synthesis Inhibitors,
Hepatitis,,
GSK2132231A,,
MVA-MUC1-IL2,,
Sunitinib-Malate,,
pTVG-HP,,
"CP-868,596-26",,
Isoquercetin,Drug / Therapeutic Agent,
ELACYT,,
MVA-BN-CV301,,
FPV-CV301,,
oraly,,
Gem/nab-Pac,,
FOLFIFINOX,,
Trivax,"Agricultural Chemical|Fungicide, Bactericide, Wood Preservative",
Euthyroid,,
intra-rectal,,
Botulinum,,
toxin,,
cartilage,,
AE-941,,
ATIR101,,
RK-0202,,
Intra-arterial,,
Chemoradiotherapy,,
pemigatinib,,
ivosidenib,Antineoplastic Agents|Enzyme Inhibitors,
AMD3100,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents,
rebombniant,,
endostatin,Antiangiogenic Drug|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances,
TAK228,,
naloxegol,Central Nervous System Agents|Narcotic Antagonists|Peripheral Nervous System Agents|Sensory System Agents,
A007,,
INCB018424,Antineoplastic Agents,
BYM338,,
S-malate,,
Perflutren,Contrast Media|Diagnostic Uses of Chemicals,
hexafluoride,,
Glesatinib,,
Salirasib,Antineoplastic Agents|Enzyme Inhibitors,
Alflutinib,,
Nivolumab/Ipilimumab,,
TQ-B3139,,
AV-GBM-1,,
VAL401,,
PF-299804,,
Tc99m,,
tilmanocept,,
optional,,
Zoledronate,Bone Density Conservation Agents,
NOX-H94,,
Aminolevulinic,,
methoxy,,
polyethylene,Biocompatible Materials|Tumor Data|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
glycol-epoetin,,
Mircera,,
Metoprolol,Adrenergic Agents|Adrenergic Antagonists|Anti-Arrhythmia Agents|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sympatholytics|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists,
Candesartan,Angiotensin II Type 1 Receptor Blockers|Antihypertensive Agents|Cardiovascular Agents|Angiotensin Receptor Antagonists,
vivo-expanded,,
cyclosporine,Antifungal Agents|Antirheumatic Agents|Dermatologic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Tumor Data|Anti-Infective Agents|Immunologic Factors|Calcineurin Inhibitors,
cyclosporine,Drug / Therapeutic Agent|Human Data|Tumor Data,
mycophenolate,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Natural Product|Reproductive Effect|Antineoplastic Agents|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antitubercular Agents",
TRAIL-R1,,
TRM-1,,
HGS-ETR1,,
supportive,,
Afinitor®,,
OSE2101,,
talaporfin,Antineoplastic Agents|Photosensitizing Agents|Dermatologic Agents|Radiation-Sensitizing Agents,
Allopurinol,Antimetabolites|Drug / Therapeutic Agent|Enzyme Inhibitors|Free Radical Scavengers|Gout Suppressants|Human Data|Reproductive Effect|Antioxidants|Antirheumatic Agents|Noxae,
i.v.,,
Acetyl-L-Carnitine,Central Nervous System Agents|Growth Substances|Micronutrients|Nootropic Agents|Vitamin B Complex|Vitamins,
HRPC,,
MDA-TIL,,
WST09,,
Removab,Gastrointestinal Agents,
Platinum-Based,,
V-Boost,,
Q-122,,
Vicinium,,
Golimumab,,
Mavrilimumab,Antirheumatic Agents,
linsitinib,,
Tomivosertib,,
eFT-508,,
Netupitant,,
Gefetinib,,
VBP-926,,
VEGF-receptor,,
FDX104,,
LDV/SOF,,
HM10460A,,
Indium-111,,
pentetreotide,,
tbo-filgrastim,,
Allovectin-7®,,
retreatment,,
Imbruvica,Antineoplastic Agents,
MOVIPREP,,
Anti-B7H1,,
resection,,
MRCP001,,
cidofovir,Anti-HIV Agents|Antiviral Agents|Antiviral|Anti-Infective Agents|Antineoplastic Agents|Anti-Retroviral Agents|Radiation-Sensitizing Agents,
cidofovir,Anti-Infective Agents|Antiviral Agents|Enzyme Inhibitors,
Melphalan/HDS,,
Vx-001,,
SB497115,,
LAR®,,
azithromycin,Anti-Bacterial Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anti-Infective Agents,
Zithromax,Anti-Bacterial Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anti-Infective Agents,
177Lu-DOTA0-Tyr3-Octreotate,,
Macimorelin,,
Octreotide,"Antineoplastic Agents, Hormonal|Gastrointestinal Agents|Antineoplastic Agents",
Pectin,Antidiarrheals|Gastrointestinal Agents|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule)|Food Additives,
Metronidazole,Anti-Infective Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Slimicide|Antiparasitic Agents|Antiprotozoal Agents|Anti-Bacterial Agents,
Actavis,,
pralatrexate,Antineoplastic,
E7337,,
Pivanex,Drug / Therapeutic Agent,
Angiostatin,Antineoplastic Agents|Drug / Therapeutic Agent|Hypotensive Agent|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Growth Inhibitors|Growth Substances,
Tagrisso,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Tagrisso,Antineoplastic Agents,
Olmutinib,,
squamous,,
savolitinib,,
Telavancin,,
rhEGF,,
povidone,Pharmaceutic Aids|Plasma Substitutes|Tumor Data|Blood Substitutes|Hematologic Agents|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
chlorhexidine,"Anti-Infective Agents, Local|Disinfectants|Mouthwashes|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Anti-Infective Agents|Cosmetics|TSCA Flag PMN (a Commenced PMN (Premanufacture Notice) Substance)",
nystatin,Drug / Therapeutic Agent|Ionophores|Mutation Data|Natural Product|Reproductive Effect|Anti-Bacterial Agents|Antifungal Agents|Anti-Infective Agents|Membrane Transport Modulators,
patients-,,
TACE,"Antineoplastic Agents, Hormonal|Estrogens, Non-Steroidal|Hormone|Human Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Estrogens|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
ACTIQ®,,
pilimumab,,
dihydroaremisinin,,
Lenalidomide-Dexamethasone-DLI,,
Flu/Bu4,,
Disease,,
prevention,,
GVHD,,
thalidomide,Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Leprostatic Agents|Mutation Data|Reproductive Effect|Teratogens|Tumor Data|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Immunologic Factors|Noxae,
Lorvotuzumab,,
Mertansine,,
milligrams/kilogram,,
Tinzaparin,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
herceptin,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Gene-modified,,
aprepitant,Substance P Antagonist|Antiemetic (in Chemotherapy-Induced Emesis)|Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Peripheral Nervous System Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents,
PET-CT,,
leukemia,,
FOLFIRI-HD,,
FOLFOX-7,,
CCRT,,
V504,,
Ursodeoxycholic,,
Doublet,,
Akynzeo,,
Lutathera,,
18-F-MISO,,
Isavuconazole,Anti-Infective Agents|Antifungal Agents,
Remetinostat,,
Tumor-Specific,,
Breakpoint,,
R-PDAC,,
BR-PDAC,,
Eflornithine,Antineoplastic Agents|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Trypanocidal Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents|Ornithine Decarboxylase Inhibitors,
hepcortespenlisimut-L,,
Adalimumab,Monoclonal Antibody|Anti-Inflammatory Agents|Antirheumatic Agents,
Ivabradine,Cardiovascular Agents,
SGX942,,
Pharmacological,,
ascorbate,Antioxidants|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Growth Substances|Micronutrients|Protective Agents|Vitamins,
ascorbate,,
anamorelin,,
Tavokinogene,,
Telseplasmid,,
tavo,,
cutaneous,,
TP-38,Skin / Eye Irritant|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
hydroxyurea,Antineoplastic Agents|Antisickling Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Hematologic Agents|Nucleic Acid Synthesis Inhibitors,
TP38,Skin / Eye Irritant|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
chemotherapy+Durvalumab+Tremelimumab,,
olaparib+cediranib,,
SCIO-469,,
ERY001,,
5-fluoro-uracil/oxaliplatin/leucovorin,,
folfox,,
DVD-R,,
MabThera/Rituxan,,
IbritumomabTiuxetan,,
SAMITAL®,,
fotemustine,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data,
obinutuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
RO5072759,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Denileukin,,
CAP-232,,
PROCRIT,,
Propylene,Tumor Data,
Glycol-Free,,
Eftilagimod,,
Vivo-Expanded,,
Progenitor,,
Hemospan,,
MP4OX,,
velafermin,,
Cell-Based,,
ACT-774312,,
AK001,,
5-Fluorouracil/Leucovorin,,
Tosedostat,Enzyme Inhibitors,
Anti-TNF-alpha,,
RO7123520,,
CDP6038,,
Actemra,,
RoActemra,,
Androxal,Human Data|Reproductive Effect,
Androxal,"Reproductive Effect|Estrogen Antagonists|Estrogen Receptor Modulators|Fertility Agents|Fertility Agents, Female|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents|Selective Estrogen Receptor Modulators",
enclomiphene,"Reproductive Effect|Estrogen Antagonists|Estrogen Receptor Modulators|Fertility Agents|Fertility Agents, Female|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents|Selective Estrogen Receptor Modulators",
Testosterone,"Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Androgens|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
ABT-494,Antirheumatic Agents|Enzyme Inhibitors|Janus Kinase Inhibitors|Protein Kinase Inhibitors,
testosterone,"Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Androgens|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
GW679769,Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents,
GW679769,,
Nicotinamide,Drug / Therapeutic Agent|Mutation Data|Growth Substances|Micronutrients|Vitamin B Complex|Vitamins,
Riboside,,
doxorubicin/cyclophosphamide,,
epirubicin/cyclophosphamide,,
Marqibo®,,
Tyrosinase/gp100/MART-1,,
hematopoietic,,
MesoPher,,
Elacytarabine,,
ATG-010,,
Dara-SC,,
TJ202,,
DARATUMUMAB,Antineoplastic Agents,
DURVALUMAB,,
GZ316455,,
Bortezomilb,,
NOX-A12,,
/Alkeran,,
Alkeran,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Alkylating Agents|Antineoplastic Agents|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Noxae",
Alkeran,Human Data|Tumor Data,
Injection/Melphalan,,
Siltuximab11,,
AB1010,,
HDAC,,
ACE-011,,
DENOSUMAB,Bone Density Conservation Agents,
Ziv-Aflibercept,,
GM-CSF-secreting,,
Tempol,Antioxidants|Mutation Data|Protein Synthesis Inhibitors|Radiation-Protective Agents|Central Nervous System Agents|Enzyme Inhibitors|Neuroprotective Agents|Protective Agents,
CDC-501,Antineoplastic Agents|Growth Substances|Angiogenesis Modulating Agents|Angiogenesis Inhibitors|Immunologic Factors|Growth Inhibitors,
MEDI2070,,
angiome,,
cfDNA,,
VVZ-149,,
LF-PB,,
PEG-G-CSF,,
VT-122,,
Post-operative,,
rasburicase,Antirheumatic Agents|Gout Suppressants,
SR29142,Antirheumatic Agents|Gout Suppressants,
leteprinim,Drug / Therapeutic Agent,
Neotrofin,,
SNX-1012,,
meclocycline,Anti-Bacterial Agents|Anti-Infective Agents,
sulfosalicylate,,
Clonidine,Adrenergic alpha-Agonists|Analgesics|Antihypertensive Agents|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Skin / Eye Irritant|Sympatholytics|Adrenergic Agents|Adrenergic Agonists|Autonomic Agents|Cardiovascular Agents|Central Nervous System Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Adrenergic alpha-2 Receptor Agonists,
Lauriad®,,
DC/myeloma,,
fusions/GM-CSF,,
chidamide,,
Collagenase,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Histolyticum,,
MEL-CFZ-TD-PACE,,
POMALIDOMIDE,Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Substances|Immunologic Factors|Growth Inhibitors,
Myeloma,,
Prevnar-13,,
clarithromycin,Drug / Therapeutic Agent|Human Data|Protein Synthesis Inhibitors|Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Metabolic Side Effects of Drugs and Substances,
thalomid,Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Leprostatic Agents|Mutation Data|Reproductive Effect|Teratogens|Tumor Data|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Immunologic Factors|Noxae,
CI-994,,
cyclophoshamide,,
Cusatuzumab,,
Dose-adjusted,,
SK-1403,,
KRN1493,"Calcimimetic Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
ASP7991,,
Naloxone,Drug / Therapeutic Agent|Human Data|Reproductive Effect|Central Nervous System Agents|Narcotic Antagonists|Peripheral Nervous System Agents|Sensory System Agents,
Naloxone,Drug / Therapeutic Agent|Mutation Data|Narcotic Antagonists|Reproductive Effect|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents,
DP001,,
ACTIQ,Drug / Therapeutic Agent|Human Data,
OTFC,,
Darzalex,Antineoplastic Agents,
S-588410,,
Panobinostat/LBH589,,
Eicosapentanoic,,
Prevnar13,,
KRdD,,
auto-HCT,,
p.DOM-WT1-37,,
p.DOM-WT1-126,,
Carfilzomib/Lenalidomide/Dexamethasone,,
IPILIMUMAB,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
cabergoline,Antineoplastic Agents|Antiparkinson Agents|Dopamine Agonists|Drug / Therapeutic Agent|Anti-Dyskinesia Agents|Central Nervous System Agents|Dopamine Agents|Neurotransmitter Agents,
Zydelig,Antineoplastic Agents|Enzyme Inhibitors,
Vascana,,
nitroglycerin,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Vasodilator Agents|Cardiovascular Agents|Explosive Agents,
saccharate,,
Venofer,Drug / Therapeutic Agent|Tumor Data|Hematinics|Hematologic Agents,
Yeast-,,
Brachyury,,
Cefepime,Anti-Bacterial Agents|Anti-Infective Agents,
Ceftolozane,Anti-Bacterial Agents|Anti-Infective Agents,
Meropenem,Drug / Therapeutic Agent|Reproductive Effect|Anti-Bacterial Agents|Anti-Infective Agents,
Meropenem,Anti-Bacterial Agents|Anti-Infective Agents,
Piperacillin-Tazobactam,Drug / Therapeutic Agent|Reproductive Effect,
Tazobactam,Drug / Therapeutic Agent,
Tazobactam,Drug / Therapeutic Agent|Reproductive Effect|Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors|beta-Lactamase Inhibitors,
BHQ990,,
tanespimycin,,
OXAL,Agricultural Chemical|Experimental Pesticide|Mutation Data|Skin / Eye Irritant|Unspecified / Unclassified Pesticide,
OXAL,Drug / Therapeutic Agent,
Amolimogene,,
volociximab,Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances,
Campath,"Antineoplastic Agents|Antirheumatic Agents|Antineoplastic Agents, Immunological",
Non-myeloablative,,
ASCT,,
flavopiridol,Antineoplastic|Cyclin-Dependent Kinase (CDK) Inhibitors|Antineoplastic Agents|Growth Inhibitors|Kinase Inhibitors,
Inecalcitol,,
Pracinostat,,
IPH2102,,
Besylate,,
Sonidegib,,
GRNVAC1,,
LCZ696,Angiotensin Receptor Antagonists,
L-Malate,,
aminopterin,Agricultural Chemical|Drug / Therapeutic Agent|Folic Acid Antagonists|Human Data|Mutation Data|Reproductive Effect|Rodenticide|Tumor Data|Enzyme Inhibitors,
high-dose,,
Mitozantrone,Analgesics|Antineoplastic Agents|Mutation Data|DNA Topoisomerase II Inhibitor|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
cenersen,,
Mylotarg,"Antineoplastic Agents|Immunotoxins|Noxae|Antineoplastic Agents, Immunological",
Cep-701,,
GEN0101,,
Pembrolizmub,,
131I-omburtamab,,
YF476,,
etiprate,,
GMCI,,
Azacitadine,,
milligram,,
CLAG,,
Verubulin,,
Azixa,,
Neupogen,Drug / Therapeutic Agent|Human Data|Natural Product|Hematologic Agents,
Cycophosphamide,,
13-cis,,
VP-102-cantharidin,,
organogel,,
BN-Brachyury,,
MIS416,,
ganglioside,,
OPT-821,,
ACCS100,,
Thrombospondin-1,,
Perioperative,,
CAPOX-bevacizumab,,
FOLFOX-bevacizumab,,
FOLFIRI-bevacizumab,,
Gemcitabine-Capecitabine,,
Gemcitabine-Erlotinib,,
dirucotide,,
Maxacalcitol,Anticarcinogenic Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Reproductive Effect|Dermatologic Agents|Protective Agents,
FLUDARABINE,Antineoplastic Agents|Mutation Data,
Pre-operative,,
post-operative,,
CG53135-05,,
crenolanib,Antineoplastic Agents,
SGN-33,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Asciminib,,
CTL019,Antineoplastic Agents,
GCS-100,,
TG-0054,,
nonpegylated,,
OMEGAVEN,,
DC/AML,,
T-VEC,Antineoplastic Agents,
HuMax-CD4,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Nanoparticulate,,
ALLN-177,,
Iloprost,Drug / Therapeutic Agent|Platelet Aggregation Inhibitors|Reproductive Effect|Vasodilator Agents|Cardiovascular Agents|Hematologic Agents,
Selexipag,Selective Non-prostanoid IP Prostacyclin Receptor Agonist|Antihypertensive Agents|Cardiovascular Agents,
Alprostadil,Fibrinolytic Agents|Hormone|Human Data|Mutation Data|Platelet Aggregation Inhibitors|Reproductive Effect|Vasodilator Agents|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents|Urological Agents,
thiotepa,"Alkylating Agents|Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Noxae",
MQX-503,,
Sensipar,"Calcimimetic Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
VDA-1102,,
maxacalcitol,Anticarcinogenic Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Reproductive Effect|Dermatologic Agents|Protective Agents,
cinacalcet,Treatment of Hyperthyroidism|Calcimimetic|Calcimimetic Agents|Calcium-Regulating Hormones and Agents|Hormone Antagonists,
cinacalcet,"Calcimimetic Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
Patidegib,,
propranolol,Adrenergic beta-Antagonists|Anti-Arrhythmia Agents|Antihypertensive Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Vasodilator Agents|Adrenergic Agents|Adrenergic Antagonists|Cardiovascular Agents|Neurotransmitter Agents,
ProCervix,,
CIGB300,,
AL101,,
TVI-Brain-1,,
tremelimumab+MEDI4736,,
allovectin-7,,
derazantinib,,
Rindopepimut,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
CDX-110,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Canfosfamide,,
ERIVEDGE,Antineoplastic Agents,
AA4500,,
ICVT,,
AM001,,
BF-200,Antacids|Skin / Eye Irritant|Gastrointestinal Agents,
MDNA55,,
DFD-07,,
comparator,,
Etarfolatide,,
ACT01,,
Comp01,,
Comp02,,
Comp03,,
Comp04,,
EISO,,
LAS41005,,
LAS41007,,
b.i.d,,
LAS106521,,
Telomelysin,,
Oleogel-S10,,
mg/g,,
Plasmids,,
Tamibarotene,,
MK3475,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Lactoferrin,,
MTG201,,
Capsules-,,
V501,Tumor Data|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
lidamycin,,
etiopurpurin,,
Picato®,,
Micafungin,,
CTA018,,
Idarubcin,,
olaratumab,Antineoplastic Agents,
TVGV-1,,
Calcifediol,Bone Density Conservation Agents|Growth Substances|Micronutrients|Vitamins,
Calcifediol,Bone Density Conservation Agents|Vitamins|Growth Substances|Micronutrients,
YIV-906+Sorafenib,,
131I-chTNT-1/B,,
Cotara,,
Cyclosporin,Antifungal Agents|Antirheumatic Agents|Dermatologic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Tumor Data|Anti-Infective Agents|Immunologic Factors|Calcineurin Inhibitors,
Cyclosporin,Drug / Therapeutic Agent|Human Data|Tumor Data,
CAMPATH-1H,"Antineoplastic Agents|Antirheumatic Agents|Antineoplastic Agents, Immunological",
SU5416,Tyrosine Kinase Inhibitors|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Protein Kinase Inhibitors,
SU5416,Angiogenesis Inhibitors|Protein Kinase Inhibitors,
ADP-A2M4,,
5-aza-2'deoxycytidine,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Reproductive Effect|Teratogens|Antimetabolites|Antineoplastic Agents|Noxae",
Tcelna,,
Afimoxifene,"Estrogen Antagonists|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Antineoplastic Agents|Selective Estrogen Receptor Modulators",
WT-1-vaccine,,
DFD07,,
CC-100004,,
VP-102,,
applicator,,
PS341,Antineoplastic Agents|Protease Inhibitors|Enzyme Inhibitors,
infigratinib,,
Temo,,
VP-16,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|DNA Topoisomerase II Inhibitors|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
ondansetron,Anti-Anxiety Agents|Antiemetics|Antipsychotic Agents|Drug / Therapeutic Agent|Human Data|Serotonin Antagonists|Antipruritics|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dermatologic Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Psychotropic Drugs|Serotonin Agents|Tranquilizing Agents,
Yallaferon®,,
SUN-131,,
TK-112690,,
SKLB1028,,
treatment-free,,
ACE-536,,
KRN321,Hematinics|Hematologic Agents,
bemcentinib,,
IDEA-070,,
troxacitabine,Treatment of Refractory Myeloid Leukemias|Anti-HIV Agents|Anti-Infective Agents|Antineoplastic Agents|Anti-Retroviral Agents|Antiviral Agents,
standard-dose,,
FG-4592,,
Deferasirox,Iron Chelator|Chelating Agent|Chelating Agents|Iron Chelating Agents|Sequestering Agents,
NC-503,,
Anti-amyloidotic,,
BB-401,,
Docetaxel-PM,,
Cisplatin-gemcitabine,,
Cisplatin/Carboplatin,,
Proellex,,
GL-0817,,
telepristone,,
Proellex®,,
BMS-734016,,
Ipilimumab+,,
Budesonide,"Bronchodilator Agents|Drug / Therapeutic Agent|Hormone|Human Data|Reproductive Effect|Adrenal Cortex Hormones|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Autonomic Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents|Respiratory System Agents",
2-times,,
5-times,,
Asoprisnil,Progesterone Receptor Modulator,
Eicosapentaenoic,,
IDN-6556,,
Alitretinoin,Antineoplastic Agents|Dermatologic Agents,
Camidanlumab,,
ulipristal,,
KL-A167,,
Peg-asparaginase,Antineoplastic Agents,
6-mercaptopurine,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Antineoplastic Agents|Enzyme Inhibitors|Immunologic Factors|Noxae",
Spectrila®,,
Erwinia,,
Chrysanthemi,,
CLT-008,,
MOR00208,,
cycolophosphamide,,
vacristine,,
pednisone,,
chrysanthemi,,
Versus,"Anti-Inflammatory Agents, Non-Steroidal|Drug / Therapeutic Agent|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antirheumatic Agents|Peripheral Nervous System Agents|Sensory System Agents",
Versus,,
Chemotherapy-Relapsed/Refractory,,
Low-Grade,,
Non-Hodgkin,,
timolol,Adrenergic beta-Antagonists|Anti-Arrhythmia Agents|Antihypertensive Agents|Adrenergic Agents|Adrenergic Antagonists|Cardiovascular Agents|Neurotransmitter Agents,
timolol,Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Anti-Arrhythmia Agents|Antihypertensive Agents|Cardiovascular Agents|Neurotransmitter Agents,
anti-B1,,
BuCyE,,
Fludara,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
HLX10+HLX04,,
BCD-217,,
KRT-232,,
ATG-008,,
BAY86-5128,,
ONTAK,Antineoplastic Agents,
ONTAK,,
Para-Toluenesulfonamide,Drug / Therapeutic Agent|Mutation Data,
MPB-1523,,
Milciclib,,
maleate,,
Immuncell-LC,,
immunoglobulin,Human Data|Natural Product|Immunologic Factors,
immunoglobulin,Natural Product|Reproductive Effect|Immunologic Factors,
idiotype-KLH,,
SDX-105,"Drug / Therapeutic Agent|Reproductive Effect|Tumor Data|Antineoplastic Agents|Alkylating Agents|Antineoplastic Agents, Alkylating|Noxae",
SDX-105,"Antineoplastic Agents|Alkylating Agents|Antineoplastic Agents, Alkylating|Noxae",
VCL-CB01,,
ZGN-440,Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances,
diluent,,
isotretinoin,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Teratogens|Dermatologic Agents|Noxae,
Sunscreen,,
gallium,Mutation Data,
V3-Myoma,,
BGG492,,
PACOX,,
Cemiplimab-Rwlc,,
L19IL2+L19TNF,,
BCR-ABL,,
HyperAcute®-Melanoma,,
OSI-461,,
5-aminolevulinic,,
PT2385,,
Intranasal,,
Naxitamab,,
AOP2014,,
Pegylated-Proline-interferon,,
Racotumomab,,
P03277,,
Plasmid,,
INTERLEUKIN-12,"Antiasthmatic|Adjuvants, Immunologic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Immunologic Factors",
INTERLEUKIN-12,,
LCI699,,
AMG386,Growth Substances|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors,
Bimiralisib,,
Bosentan,Antihypertensive Agents|Reproductive Effect|Antihypertensive|Cardiovascular Agents,
Bosentan,Antihypertensive Agents|Cardiovascular Agents|Endothelin Receptor Antagonists,
PTG-300,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Chemoembolisation,,
Osilodrostat,,
Thymosin-alpha-1,,
IMA901,,
Palovarotene,,
CY-503,,
intra,,
nodal,,
4-1BB,,
OPC-18,,
GV1001,,
nimotuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
CNTX-4975,,
monohydrate,,
tasisulam,,
Taxoprexin,Antineoplastic Agents,
ICT-107,,
Histone,,
Deacetylase,,
MS-275,Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors,
Elagolix,,
Sofosbuvir,Antiviral Agents|Anti-Infective Agents,
PA101,,
ABT-510/Thrombospondin-1,,
SUBA-Itraconazole,,
alpha-1,,
mifepristone,"Abortifacient Agents, Steroidal|Contraceptives, Oral, Synthetic|Contraceptives, Postcoital, Synthetic|Hormone|Hormone Antagonists|Human Data|Luteolytic Agents|Menstruation-Inducing Agents|Reproductive Effect|Abortifacient Agents|Contraceptive Agents|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Postcoital|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents",
vaginal,,
59-8862,,
elagolix,,
cyclical,,
progesterone,"Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Progestins",
UltratraceTM,,
Integrin,Drug / Therapeutic Agent,
CTLA-4,,
Lipid,,
Talampanel,Drug / Therapeutic Agent,
PRM-151,,
GIVINOSTAT,,
AUTO,,
lestaurtinib,,
SGN-00101,,
Anti-tumor,,
ALGRX,,
CHEP,,
24-7429,,
Vesnarinone,"Adjuvants, Immunologic|Antineoplastic Agents|Antiviral Agents|Cardiotonic Agents|Drug / Therapeutic Agent|Reproductive Effect|Anti-Infective Agents|Cardiovascular Agents|Enzyme Inhibitors|Immunologic Factors|Phosphodiesterase Inhibitors|Protective Agents",
PEG-asp,,
AraC,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
ibritumomab,,
Mozobil,,
VSLI,,
Solu-Medrol,Drug / Therapeutic Agent|Hormone|Human Data|Reproductive Effect,
Ozogamycin,,
PEG-l-asparaginase,Antineoplastic Agents,
Decadron,"Antiemetics|Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Immunomodulator|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents",
CEEP,,
R+CVP+IFN,,
mesna,Drug / Therapeutic Agent|Protective Agents|Reproductive Effect,
Isophosphamide,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Interleukin-11,,
Interleukin-11,Antineoplastic Agents,
IL-11,Drug / Therapeutic Agent,
IL-11,Antineoplastic Agents,
Neumega,Antineoplastic Agents,
SHR-1210+Paclitaxel+nedaplatin,,
Zevalin-BuCyE,,
Tiuxetan,,
Elsamitrusin,,
89Zirconium-labeled,,
Doxorubin,,
pp65-LAMP,,
mRNA-pulsed,,
111In-labeled,,
HIV-Gag,,
BRAF,,
Fotemustine,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data,
Definity,Contrast Media|Diagnostic Uses of Chemicals,
Dactinomycin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Enzyme Inhibitors",
HDIL-2,,
AZD4017,,
Etirinotecan,,
Propranolol,Adrenergic beta-Antagonists|Anti-Arrhythmia Agents|Antihypertensive Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Vasodilator Agents|Adrenergic Agents|Adrenergic Antagonists|Cardiovascular Agents|Neurotransmitter Agents,
Anti-CTLA4,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
ZK-EPO,Antineoplastic Agents,
4-peptide,,
Ontak,Antineoplastic Agents,
Ontak,,
ontak,Antineoplastic Agents,
ontak,,
bupivacaine,"Anesthetics, Local|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
Nifurtimox,Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents|Trypanocidal Agents,
abexinostat,Enzyme Inhibitors|Histone Deacetylase Inhibitors,
VT-EBV-N,,
tisagenlecleucel,,
HS006+CHOP,,
Rituximab+CHOP,,
CD11301,,
CD24Fc,,
GemOx,,
NM-IL-12,,
TSEBT,,
Fenretinide,Anticarcinogenic Agents|Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Protective Agents,
ABT199,Antineoplastic Agents,
Oncoquest-L,,
chlorambucil,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
GSK1841157,Antineoplastic Agents,
Estrogens/Bazedoxifene,,
Lupron,Reproductive Effect,
VCAP/AMP/VECP,,
mLSG15,,
bafetinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
vial,,
Aplidin®,,
A-dmDT390-bisFv,,
UCHT1,,
SY-1425,,
tamibarotene,,
arginase,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Forodesine,,
alvocidib,Antineoplastic|Cyclin-Dependent Kinase (CDK) Inhibitors|Antineoplastic Agents|Growth Inhibitors|Kinase Inhibitors,
alvocidib,Antineoplastic Agents|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Protein Kinase Inhibitors,
Glasdegib,,
CPOP-R,,
CHOP-R,,
Nipent,Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Reproductive Effect|Antineoplastic Agents|Adenosine Deaminase Inhibitors,
Potassium,,
Iodide,,
depsipeptide,,
Elsamitrucin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Antineoplastic Agents",
Sotatercept,,
tumor-derived,,
nelarabine,Antineoplastic,
anti-CD30,,
pentostatin,Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Reproductive Effect|Antineoplastic Agents|Adenosine Deaminase Inhibitors,
Dalfampridine,"Acaricide|Agricultural Chemical|Avicide|Human Data|Insect Attractant, Repellent and Chemosterilant|Cardiovascular Agents|Membrane Transport Modulators|Potassium Channel Blockers",
resminostat,,
Emapalumab-Lzsg,,
Mitoguazone,Antineoplastic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Mutation Data|Reproductive Effect,
MDX-060,,
Timolol,Adrenergic beta-Antagonists|Anti-Arrhythmia Agents|Antihypertensive Agents|Adrenergic Agents|Adrenergic Antagonists|Cardiovascular Agents|Neurotransmitter Agents,
Timolol,Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Anti-Arrhythmia Agents|Antihypertensive Agents|Cardiovascular Agents|Neurotransmitter Agents,
MOR208,,
Mechlorethamine,"Alkylating Agents|Antineoplastic Agents, Alkylating|Chemical Warfare Agents|Drug / Therapeutic Agent|Human Data|Irritants|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Blister Agent|Antineoplastic Agents|Noxae|Poisons|Riot Control Agents, Chemical",
mechlorethamine-MCH,,
nitrogen,,
IBI305,,
Alfa-2a,,
PD-L2,,
cabiralizumab,,
Siroquine,,
R-CHOEP,,
Gazyva,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Lenali,,
Ibrutinib-RICE,,
IBRUTINIB,Antineoplastic Agents,
HIDAC,,
Diphtheria,,
Toxoid/Tetanus,,
Toxoid/Acellular,,
Pertussis,,
Adsorbed,,
Pneumococcal,,
13-valent,,
O-ICE,,
ABR-217620/naptumomab,,
IFN-alpha,,
IFN-alpha,Human Data,
R-CHOEP14x6+HD-AraC+HD-Mtx,,
Reduced_intensity,,
Ofatumumab/HDMP,,
Methoxsalen,Drug / Therapeutic Agent|Mutation Data|Photosensitizing Agents|Reproductive Effect|Tumor Data|Cross-Linking Reagents|Dermatologic Agents|Indicators and Reagents|Radiation-Sensitizing Agents,
ESHAP,,
R-EPOCH,,
ZBEAM,,
Aracytine,,
mechlorethamine,"Alkylating Agents|Antineoplastic Agents, Alkylating|Chemical Warfare Agents|Drug / Therapeutic Agent|Human Data|Irritants|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Blister Agent|Antineoplastic Agents|Noxae|Poisons|Riot Control Agents, Chemical",
Interferon-2A,,
Velban,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data,
Adriblastin,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Adriblastin,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data,
alkeran,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Alkylating Agents|Antineoplastic Agents|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Noxae",
alkeran,Human Data|Tumor Data,
CAMPTH-1H,,
Doxorubicine,"Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Natural Product|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antibiotics, Antineoplastic|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
ACVBP,,
Vindesine,"Antineoplastic Agents, Phytogenic|Mutation Data|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
Yttrium-ibritumomab,,
DexaBEAM,,
5-aza,,
SC-PEG,,
Oncaspar,Antineoplastic Agents,
Talacotuzumab,,
AZACITIDINE,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
pracinostat,,
I+VEN,,
keyhole,,
hemocyanin,,
cell-based,,
VINORELBINE,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Antineoplastic Agents|Antimitotic Agents|Tubulin Modulators",
PALO,,
CC-1088,,
HDMP,,
propionate,,
2-CdA,Antineoplastic Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Immunologic Factors,
2-CdA,"Antimetabolites, Antineoplastic|Antimetabolites|Antineoplastic Agents|Noxae",
PVX-2,,
Letermovir,,
anti-GD2,,
Ciprofloxacin,Drug / Therapeutic Agent|Human Data|Mutation Data|Anti-Infective Agents|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Anti-Bacterial Agents|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors|Metabolic Side Effects of Drugs and Substances,
procarbazine,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data,
LIK066,,
AZD4901,,
nucleic,,
deferasirox,Iron Chelator|Chelating Agent|Chelating Agents|Iron Chelating Agents|Sequestering Agents,
Cytomegalovirus,,
Gemcitabine-Oxaliplatin,,
R-GEMOX,,
DFD05,,
Active01,,
DPCP,,
2014-ALC-919-US,,
Vehicle-Control,,
CANDIN,,
VIR007,,
Erwinase®,,
Immunochemotherapy,,
metformin,Drug / Therapeutic Agent|Hypoglycemic Agents|Mutation Data|Reproductive Effect,
exenatide,"Antidiabetic|GLP-1 Receptor Agonist|Hypoglycemic Agents|Incretins|Hormones, Hormone Substitutes, and Hormone Antagonists|Hormone Antagonists|Hormones|Anti-Obesity Agents",
PEGASYS,Antiviral Agents|Anti-Infective Agents,
abacavir/3TC/zidovudine,,
abacavir,Nucleoside Reverse Transcriptase|Antiretroviral,
/3TC,,
ritonavir,Protease Inhibitor|Antiretroviral|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|HIV Protease Inhibitors|Protease Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Metabolic Side Effects of Drugs and Substances,
lopinavir,Antiviral|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|HIV Protease Inhibitors|Protease Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Metabolic Side Effects of Drugs and Substances,
D-chiro-inositol,,
Myoinositol,Drug / Therapeutic Agent|Growth Substances|Micronutrients|Vitamin B Complex|Vitamins|To Increase Survival and Prevent the Need for Surgical Intervention in Late Stage Retinopathy of Prematurity (ROP),
Mifamurtide,"Adjuvants, Immunologic|Immunologic Factors",
Linsitinib,,
Progesterone,"Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Progestins",
Vaginal,,
R-DHAP,,
BR-DHAP,,
6-MP,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Antineoplastic Agents|Enzyme Inhibitors|Immunologic Factors|Noxae",
Armodafinil,Central Nervous System Agents|Central Nervous System Stimulants|Wakefulness-Promoting Agents,
RiBVD,,
Temodal,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Mutation Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Temodal/radiotherapy,,
Bosulif,Antineoplastic (Src Kinase Inhibitor)|Antineoplastic Agents,
Bosulif,Antineoplastic Agents,
ABIRATERONE,,
S-1/Cisplatin,,
5-FU/cisplatin,,
Nanosomal,,
Ado-trastuzumab,,
Hexaminolevulinate,,
TAS-118,,
Prednisone/Prednisolone,,
Docetaxel/Paclitaxel,,
Carboplatin+Paclitaxel,,
anastrazole,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Enzyme Inhibitors|Aromatase Inhibitors|Antineoplastic Agents|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
Arimidex®,,
Calmangafodipir,,
Tanezumab,Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents,
Prasterone,"Adjuvants, Immunologic|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Immunologic Factors",
DHEA,"Adjuvants, Immunologic|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Immunologic Factors",
Sulijia,,
REGN2810/chemo/ipi,,
MIL60,,
REGN2810/ipi,,
RPR116258,,
Physician's-Choice,,
ECDG,,
Ethylenedicysteine-Deoxyglucose,,
uracil,Mutation Data|Reproductive Effect|Tumor Data,
tegafur,"Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antimetabolites|Antineoplastic Agents|Noxae",
THERATOPE,,
STn-KLH,,
MetMab,,
NK105,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
Pamrevlumab,,
ProstAtak®,,
Piperacillin/Tazobactam,,
Piperacillin/Tazobactam,Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors|beta-Lactamase Inhibitors,
Piperacillin/Tazobactam,Drug / Therapeutic Agent|Reproductive Effect,
Tazocin,,
Tazocin,Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors|beta-Lactamase Inhibitors,
Decapeptyl®,,
14-day,,
triptorelin,"Antineoplastic Agents, Hormonal|Luteolytic Agents|Antineoplastic Agents|Contraceptive Agents|Contraceptive Agents, Female|Reproductive Control Agents",
embonate,,
LY353381,,
BAY73-,"Agricultural Chemical|Insect Attractant, Repellent and Chemosterilant|Molluscicide|Reproductive Effect|Tumor Data",
HyperAcute-Pancreas,,
endocrine-modulating,,
Rivaroxaban,Anticoagulants|Hematologic Agents|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Protease Inhibitors|Serine Proteinase Inhibitors,
Larotaxel,,
levo-,,
11C-choline,,
Radioactive,,
Hexvix,,
SAR390530,,
LightPath®,,
68Ga-RM2,,
ZD9393,,
Abarelix,"Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
Cisplatin/Gemcitabine,,
Pemetrexed/Cisplatin,,
Pemetrexed/Carboplatin,,
Nasalfent,,
trastuzuamb,,
marimastat,Enzyme Inhibitors,
MYL-,,
EG12014,,
Cisplatin/,,
Carboplatin/,,
Pemetrexed/,,
RPR109881,,
hCRF,,
Nissle,,
HLX02,,
HD201,,
UTD1,,
Paraplatin®,,
Trastuzumab-EU,,
pegcyte,,
Neulastim,,
Non-steroidal,,
aromatase,,
64Cu-DOTATATE,,
Prednisone/prednisolone,,
Neo-adjuvant,,
GEMZAR,"Reproductive Effect|Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antiviral Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Noxae|Radiation-Sensitizing Agents",
GP-Pharm,,
vic-,,
duocarmazine,,
HYCAMTIN,,
HYCAMTIN,Antineoplastic Agents|Enzyme Inhibitors|Antineoplastic|Topoisomerase I Inhibitors|Topoisomerase Inhibitors,
faslodex,"Antineoplastic Agents|Estrogen Antagonists|Antineoplastic Agents, Hormonal|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Estrogen Receptor Antagonists",
arimidex,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Enzyme Inhibitors|Aromatase Inhibitors|Antineoplastic Agents|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
Dose-dense,,
dose-dense,,
adagloxad,,
simolenin,,
OBI-821,,
Phosphate-buffered,,
porfiromycin,"Antibiotics, Antineoplastic|Drug / Therapeutic Agent|Human Data|Mutation Data|Antineoplastic Agents",
SR259075,,
20-minute,,
farletuzumab,Antineoplastic Agents,
177Lu-PSMA-617,,
tibolone,"Antineoplastic Agents, Hormonal|Anabolic Agents|Androgen Antagonists|Antihypertensive Agents|Antineoplastic Agents|Cardiovascular Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
MODAFINIL,Central Nervous System Stimulants|Central Nervous System Agents|Neuroprotective Agents|Protective Agents|Cytochrome P-450 CYP3A Inducers|Wakefulness-Promoting Agents|Metabolic Side Effects of Drugs and Substances,
Dostarlimab,,
Carboplatin-paclitaxel,,
ASP-1929,,
SIBP-01,,
Taxane-based,,
Peg-Filgrastim,Antineoplastic Agents|Pegylated Protein,
sublingual,,
epidoxorubicine,,
ciclophosphamide,"Agricultural Chemical|Alkylating Agents|Antineoplastic Agents, Alkylating|Antirheumatic Agents|Drug / Therapeutic Agent|Experimental Pesticide|Human Data|Immunosuppressive Agents|Mutagens|Mutation Data|Reproductive Effect|Tumor Data|Unspecified / Unclassified Pesticide|Antineoplastic Agents|Immunologic Factors|Myeloablative Agonists|Noxae",
fluorouracile,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
Normale,,
histrelin,Natural Product|Reproductive Effect|Antineoplastic Agents,
Z-100,"Drug / Therapeutic Agent|Adjuvants, Immunologic|Antineoplastic Agents|Immunologic Factors",
Z-100,"Adjuvants, Immunologic|Antineoplastic Agents|Immunologic Factors",
zoptarelin,,
"docetaxel,0xaliplatin",,
#NAME?,,
Arfolitixorin,,
TAP-144-SR,Reproductive Effect,
2-tetrahydrofuryl,,
#NAME?,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
CDHP,,
Gemeracil,,
Oteracil,,
Buprenorphine,"Analgesics, Opioid|Human Data|Narcotic Antagonists|Narcotics|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
Sustained-Release,,
Paclical®,,
Taxol®,,
Nadroparin,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
Uridine,Drug / Therapeutic Agent|Mutation Data|Natural Product,
5'-Triphosphate,,
HD204,,
FOLFIRI-3,,
OncoVAX,,
NeuVax,,
Leukine®,,
rofecoxib,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Cyclooxygenase 2 Inhibitors|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Antirheumatic Agents",
Calmette-Guerin,,
TAXOTERE®,,
ELIGARD®,,
Nirapairb,,
FOLFIRI-cetuximab,,
mFOLFOX6-bevacizumab,,
OPTIMOX-bevacizumab,,
irinotecan-based,,
chemo,,
DWJ1319,,
GW-2000-02,,
Fluoropyrimidine-based,,
Thyrogen,Thyroid Hormone,
thyrotropin,Drug / Therapeutic Agent|Hormone|Reproductive Effect,
Tetrodotoxin,"Natural Product|Anesthetics|Anesthetics, Local|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Membrane Transport Modulators|Noxae|Peripheral Nervous System Agents|Poisons|Sensory System Agents|Sodium Channel Blockers",
hydrocloride,,
ETOPOSIDE,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|DNA Topoisomerase II Inhibitors|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors",
Histrelin,Natural Product|Reproductive Effect|Antineoplastic Agents,
hydrogel,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
/Cisplatin,,
bemarituzumab,,
Talactoferrin,Antineoplastic Agents,
topotecan/cisplatin,,
Isovorin,,
Ibandronate,Bone Density Conservation Agents,
Docetaxel/DDP,,
docetaxel/gemcitabine,,
Paxlitaxel,,
Nab-paxlitaxel,,
cyproterone,"Androgen Antagonists|Hormone|Reproductive Effect|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
MB02,,
EU-approved,,
SCT510,,
BAT1706,,
nirapairb,,
Ixempra,Antineoplastic|Antineoplastic Agents,
BSoC,,
Lymphoseek,,
triacetyluridine,,
Eurofarma,,
Granulokine,Drug / Therapeutic Agent|Human Data|Natural Product|Hematologic Agents,
Amgen,,
QL1101,,
S95005,,
LMIS,,
virus-like,,
particle/AS04,,
hepatitis,,
LY01008,,
Efaproxiral,Antisickling Agents|Hematologic Agents|Radiation-Sensitizing Agents,
Efaproxiral,,
leuprorelin,"Antineoplastic Agents, Hormonal|Fertility Agents, Female|Hormone|Human Data|Reproductive Effect|Antineoplastic Agents|Fertility Agents|Reproductive Control Agents",
Etoposide-Cisplatin,,
LA-EP2006,,
SPY-PHI,,
Gadobutrol,Contrast Media|Diagnostic Uses of Chemicals,
Gadavist,Contrast Media|Diagnostic Uses of Chemicals,
Gadovist,Contrast Media|Diagnostic Uses of Chemicals,
BAY86-4875,,
sulphate,,
Systemic,,
tamsulosin,Adrenergic alpha-Antagonists|Adrenergic Agents|Adrenergic Antagonists|Neurotransmitter Agents,
tamsulosin,Adrenergic alpha-Antagonists|Adrenergic Agents|Adrenergic Antagonists|Antineoplastic Agents|Neurotransmitter Agents|Adrenergic alpha-1 Receptor Antagonists|Urological Agents,
atamestane,Enzyme Inhibitors,
toremifene,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
anti-CTLA4,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
BRN01,,
FOLFOX6m,,
TX05,,
Cocculine®,,
Matrifen,"Adjuvants, Anesthesia|Analgesics, Opioid|Anesthetics, Intravenous|Drug / Therapeutic Agent|Human Data|Narcotics|Analgesics|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
cevimeline,Parasympathomimetics|Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Muscarinic Agonists|Neurotransmitter Agents|Peripheral Nervous System Agents,
buserelin,"Drug / Therapeutic Agent|Fertility Agents, Female|Hormone|Human Data|Reproductive Effect|Fertility Agents|Reproductive Control Agents",
flutamide,"Androgen Antagonists|Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
PPP011,,
Virulizin®,,
nolatrexed,"Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Folic Acid Antagonists|Noxae",
dihydrochloride,Tumor Data,
Docetaxel/Taxotere,,
Anastozole,,
Nolvadex,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Estrogen Antagonists|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
Nolvadex,"Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Selective Estrogen Receptor Modulators|Antineoplastic Agents, Hormonal|Bone Density Conservation Agents|Estrogen Antagonists|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
SID530,Antineoplastic Agents|Drug / Therapeutic Agent|Antimitotic Agents|Mitosis Modulators|Tubulin Modulators,
177Lu-edotreotide,,
PRRT,,
cisplatinum,Antineoplastic Agents|Cross-Linking Reagents|Drug / Therapeutic Agent|Human Data|Mutation Data|Radiation-Sensitizing Agents|Reproductive Effect|Tumor Data|Indicators and Reagents,
e.g.etoposide,,
e.g.etoposide+enoxaparin,,
Toremifene,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
girentuximab,,
MYL-1401H,,
ARIMIDEX,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Enzyme Inhibitors|Aromatase Inhibitors|Antineoplastic Agents|Estrogen Antagonists|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors",
NOLVADEX,"Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Estrogen Antagonists|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
NOLVADEX,"Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Selective Estrogen Receptor Modulators|Antineoplastic Agents, Hormonal|Bone Density Conservation Agents|Estrogen Antagonists|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists",
risedronate,Calcium Channel Blockers|Bone Density Conservation Agents|Cardiovascular Agents|Membrane Transport Modulators|Calcium-Regulating Hormones and Agents,
Qapzola,Drug / Therapeutic Agent|Antineoplastic Agents,
XELOXA,,
XELOXA-A,,
pre-,,
post-medication,,
Nanoxel®M,,
BEMA,,
BNP7787,,
BEMA,,
SPARC1507,,
Reference1507,,
Lucanix,,
L-carnitine,Drug / Therapeutic Agent|Natural Product|Antihyperlipoproteinemic|Growth Substances|Micronutrients|Vitamin B Complex|Vitamins,
OraVescent,,
Magnevist,,
Ethypharm,,
Roferon,,
cCRT,,
miFL,,
Lipoxomal,,
Abivertinib,,
Nirogacestat,,
Glutamine,Drug / Therapeutic Agent|Human Data|Mutation Data|Dietary Supplement,
Glutamine,,
Magnesium,,
Transdermal,,
dexpantenol,Drug / Therapeutic Agent|Skin / Eye Irritant,
Bepantol,Drug / Therapeutic Agent|Skin / Eye Irritant,
Capsaicin,Mutation Data|Natural Product|Tumor Data|Antipruritics|Dermatologic Agents|Peripheral Nervous System Agents|Sensory System Agents,
Pregabalin,Anticonvulsant|Anticonvulsants|Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Calcium Channel Blockers|Cardiovascular Agents|Membrane Transport Modulators|Anti-Anxiety Agents|Central Nervous System Depressants|Psychotropic Drugs|Tranquilizing Agents|Calcium-Regulating Hormones and Agents,
INFS,,
#NAME?,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Antineoplastic Agents|Antimitotic Agents|Tubulin Modulators",
armodafinil,Central Nervous System Agents|Central Nervous System Stimulants|Wakefulness-Promoting Agents,
Injectafer,,
Injectafer,Hematinics|Hematologic Agents,
Bevacizumab-Pfizer,,
Bevacizumab-EU,,
Alendronate,Reproductive Effect|Bone Density Conservation Agents,
Alendronate,Drug / Therapeutic Agent|Human Data|Reproductive Effect,
EP2006,,
fusidic,,
Verutex,,
erythromycin,Drug / Therapeutic Agent|Gastrointestinal Agents|Human Data|Mutation Data|Natural Product|Protein Synthesis Inhibitors|Reproductive Effect|Anti-Bacterial Agents|Anti-Infective Agents|Enzyme Inhibitors,
Eritex,,
Fisiogel,,
Cross-over,,
PTC+Pertuzumab,,
FEC-T+Pertuzumab,,
Bupivacaine,"Anesthetics, Local|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
Edoxaban,Enzyme Inhibitors|Protease Inhibitors|Serine Proteinase Inhibitors|Antithrombins|Factor Xa Inhibitors|Hematologic Agents|Anticoagulants,
heparin,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
H1N1,,
non-adjuvanted,,
rivaroxaban,Anticoagulants|Hematologic Agents|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Protease Inhibitors|Serine Proteinase Inhibitors,
Low-molecular-weight,,
Sativex®,,
Lipofundin,,
EN3267,,
Semuloparin,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
Cebranopadol,,
Immunogen,,
hydromorphone,"Analgesics, Opioid|Drug / Therapeutic Agent|Human Data|Narcotics|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
cisplatin+capecitabine,,
epirubicin+cisplatin+capecitabine,,
Raloxifene,"Estrogen Antagonists|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
mg/40,,
morphine,"Analgesics, Opioid|Drug / Therapeutic Agent|Human Data|Mutation Data|Narcotics|Reproductive Effect|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
Oxymorphone,"Adjuvants, Anesthesia|Analgesics, Opioid|Drug / Therapeutic Agent|Narcotics|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
R331333,,
JNS024,,
CG5503,"Adrenergic Agents|Adrenergic Uptake Inhibitors|Analgesics|Analgesics, Opioid|Central Nervous System Agents|Central Nervous System Depressants|Membrane Transport Modulators|Narcotics|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Sensory System Agents",
XERECEPT,Natural Product|Reproductive Effect,
corticorelin,,
corticorelin,Natural Product|Reproductive Effect,
CYP2D6*10,,
SonoVue®,,
SonoVue-enhanced,,
Synergo®,,
BEC2,,
Ropivacaine,"Anesthetics, Local|Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
Epinephrine,Adrenergic Agonists|Bronchodilator Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Mydriatics|Reproductive Effect|Sympathomimetics|Vasoconstrictor Agents|Adrenergic Agents|Adrenergic alpha-Agonists|Adrenergic beta-Agonists|Anti-Asthmatic Agents|Autonomic Agents|Cardiovascular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents,
Propofol,"Anesthetics, Intravenous|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives",
MMX®,,
HX575,Hematinics|Hematologic Agents,
ERYPO®,,
Janssen-Cilag,,
KL-140,,
tarceva,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
#NAME?,,
Anti-PDL1,,
5-Fluoro-3-Pyridinecarboxylic,,
Xaliproden,Neurotransmitter Agents|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists,
SR57746A,,
dabepoetin,,
Telcyta,,
mFolfirinox,,
Folfirinox,,
SAR240550/BSI-201,,
HPV-16/18,,
Havrix,,
MEDI4736+Tremelimumab,,
Radioiodine,,
APF530,Antiemetics|Serotonin Antagonists|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin Agents,
Bemiparin,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
SAIT101,,
MabThera®,,
long-acting,,
Alvimopan,,
Alvimopan,Drug / Therapeutic Agent|Opioid Antagonist|Peripherally Restricted mu Opioid Receptor Antagonist|Gastrointestinal Agents,
ABLC,,
Icosapent,,
Cetuximab/Erbitux,,
Cisplatin/Platinol,,
Carboplatin/Paraplatin,,
Fluorouracil/Adrucil,,
raloxifene,"Estrogen Antagonists|Bone Density Conservation Agents|Estrogen Receptor Modulators|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators",
Donepezil,Cholinesterase Inhibitors|Nootropic Agents|Central Nervous System Agents|Cholinergic Agents|Enzyme Inhibitors|Neurotransmitter Agents,
5-FLUOROURACIL,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
methylphenidate,Central Nervous System Stimulants|Dopamine Agents|Dopamine Uptake Inhibitors|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Central Nervous System Agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Membrane Transport Modulators,
124-Iodine-cG250,,
low-molecular,,
heparine,Anticoagulants|Drug / Therapeutic Agent|Fibrinolytic Agents|Human Data|Mutation Data|Natural Product|Reproductive Effect|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents,
Trisulfate,,
V503,,
2-Day,,
Split-Dosing,,
"NER1006,1-Day",,
Before-Only,,
SP+MS,,
avapritinib,,
sucrose,Mutation Data|Reproductive Effect|Flavoring Agents|Food Additives|Sweetening Agents,
IMC-1211B,,
PegIntron,Antiviral Agents|Anti-Infective Agents,
intron,,
fosnetupitant/,,
palonosetron,Serotonin Antagonists|Neurotransmitter Agents|Serotonin Agents|Antiemetics|Central Nervous System Agents|Gastrointestinal Agents|Peripheral Nervous System Agents|Serotonin 5-HT3 Receptor Antagonists,
netupitant/palonosetron,,
Varenicline,Cholinergic Agents|Cholinergic Agonists|Neurotransmitter Agents|Nicotinic Agonists|Smoking Cessation Agents,
Bioseal,,
Olokizumab,,
CT-16,,
Alectnib,,
zoster,,
CT-P10,,
unexpanded,,
PF-05280586,"Antineoplastic Agents|Antirheumatic Agents|Immunologic Factors|Antineoplastic Agents, Immunological",
gemcitabine/Eloxatin,,
Investigator´s,,
Hetrombopag,,
Avatrombopag,,
r-HuEPO,Hematinics|Hematologic Agents,
TULY,,
GK567,,
capecitabine-irinotecan,,
capecitabine+irinotecan,,
Omega-3,,
Omegaven,,
long-chain,,
triglyceride,,
Arzoxifene,,
Innohep®,,
transmucosal,,
Macrogol,Drug / Therapeutic Agent|Mutation Data|Skin / Eye Irritant|Tumor Data|Solvents|Surface-Active Agents|Excipients|Pharmaceutic Aids|Pharmaceutical Vehicles|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
Ascorbate,Antioxidants|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Growth Substances|Micronutrients|Protective Agents|Vitamins,
Ascorbate,,
Tavocept,,
Micelles,,
BLI850,,
bowel,,
5-ALA,Photosensitizing Agents|Dermatologic Agents|Radiation-Sensitizing Agents,
Multihance,Drug / Therapeutic Agent|Paramagnetic,
Dapsone,Anti-Infective Agents|Antimalarials|Drug / Therapeutic Agent|Folic Acid Antagonists|Human Data|Leprostatic Agents|Mutation Data|Reproductive Effect|Tumor Data|Antibacterial (Tuberculostatic)|Dermatitis Herpetiformis Suppressant|Anti-Bacterial Agents|Antiparasitic Agents|Antiprotozoal Agents|Enzyme Inhibitors,
anthracycline-based,,
Keratinocyte,,
dimeglumine,,
amphotericin,,
deoxycholate,,
Havrix-based,,
investigational,,
MK0869,Substance P Antagonist|Antiemetic (in Chemotherapy-Induced Emesis)|Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Peripheral Nervous System Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents,
UGN-101,,
dronabinol,"Analgesics, Non-Narcotic|Drug / Therapeutic Agent|Hallucinogens|Mutation Data|Natural Product|Psychotropic Drugs|Reproductive Effect|Tumor Data|Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Cannabinoid Receptor Agonists|Cannabinoid Receptor Modulators|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents",
carboxymaltose,,
Cavilon,,
Sorbolene,,
omidubicel,,
STZ-5FU,,
PROBIO-FIX,,
INUM®,,
FKB238,,
candesartan,Angiotensin II Type 1 Receptor Blockers|Antihypertensive Agents|Cardiovascular Agents|Angiotensin Receptor Antagonists,
IBI303,,
TQB2450+cisplatin,,
ProHance,Contrast Media|Drug / Therapeutic Agent|Diagnostic Uses of Chemicals,
Gemcitabine+Cisplatin,,
pembroliziumab,,
linezolid,Antibacterial|Anti-Infective Agents|Protein Synthesis Inhibitors|Enzyme Inhibitors|Anti-Bacterial Agents,
vancomycin,Drug / Therapeutic Agent|Human Data|Natural Product|Anti-Bacterial Agents|Anti-Infective Agents,
Benzydamine,Drug / Therapeutic Agent|Anti-Inflammatory Agents,
ustekinumab,Dermatologic Agents,
Trovax,,
Ra223,,
Secukinumab,,
AIN457,,
EPA-FFA,,
D2E7,Monoclonal Antibody|Anti-Inflammatory Agents|Antirheumatic Agents,
Benralizumab,Anti-Asthmatic Agents|Respiratory System Agents,
Mometasone,Anti-Allergic Agents|Anti-Inflammatory Agents,
Furoate,,
Etrozulimab,,
etrolizumab,Gastrointestinal Agents|Immunologic Factors,
Etrolizumab,Gastrointestinal Agents|Immunologic Factors,
Propionate,,
AndroGel,"Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Androgens|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antineoplastic Agents|Antirheumatic Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents",
"CP-690,550",Enzyme Inhibitors|Protein Kinase Inhibitors,
tocilizumab,,
RoActemra/Actemra,,
Venlafaxine,"Antidepressive Agents, Second-Generation|Serotonin Uptake Inhibitors|Antidepressant|Antidepressive Agents|Central Nervous System Agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Serotonin Agents|Membrane Transport Modulators",
"PN-152,243",,
"/PN-196,444",,
FEC-DocGemzar,,
FEC-Doc,,
paracetamol,"Analgesics, Non-Narcotic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Antipyretics",
Dara,,
plitidepsin,,
Melphalan+Prednisolone,,
comedication,,
dabigatran,Thrombin Inhibitor|Anticoagulants|Antithrombins|Enzyme Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Proteinase Inhibitors,
four-week,,
Acetylcarnitine,Central Nervous System Agents|Growth Substances|Micronutrients|Nootropic Agents|Vitamin B Complex|Vitamins,
Acetylcarnitine,Nootropic Agents|Central Nervous System Agents|Growth Substances|Micronutrients|Vitamin B Complex|Vitamins,
Baricitinib,,
cDMARD,,
Fibrinogen,TSCA UVCB,
thrombin,Mutation Data|Hemostatics|Coagulants|Hematologic Agents|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
TachoSil,,
Shantha,,
Biotechnics,,
DMARDs,,
Certolizumab,Immunologic Factors|Immunosuppressive Agents|Antirheumatic Agents,
CDP870,,
certolizumab,Immunologic Factors|Immunosuppressive Agents|Antirheumatic Agents,
Casopitant,Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents,
PBSCT,,
M-VTD-PACE,,
TT3-LITE,,
L-TT3,,
Fibrin,,
Sealant,,
Brivaracetam,Anticonvulsants|Central Nervous System Agents,
Dextrose,Human Data|Mutation Data|Reproductive Effect|Tumor Data|Flavoring Agents|Food Additives|Sweetening Agents,
Dextrose,,
Fotemustin,,
DFP-10917,,
Uproleselan,,
glasdegib,,
LoDAC,,
guadecitabine,,
Low-dose,,
Intermediate-dose,,
IDAC,,
FLAG-IDA,,
Granulocyte-Colony,,
ASCT-con,,
ASCT-aug,,
Bortezomib-Melphalan,,
GARDASIL,,
histamine,Mutation Data|Natural Product|Reproductive Effect|Histamine Agents|Histamine Agonists|Neurotransmitter Agents,
Busilvex,,
CCRD,,
non-intensive,,
CRDa,,
CTDa,,
MDX-1379,,
InjectionGemcitabine,,
MitoGel,,
Darcabazine,,
BAF312,,
palifosfamide-tris,,
PAZOPANIB,,
methyl-aminolevulinate,,
ozogamycin,,
FEDRATINIB,Antineoplastic,
ponatinib,Antineoplastic Agents|Protein Kinase Inhibitors|Enzyme Inhibitors,
5-fluorouracil/salicylic,,
GZ427397,,
OFATUMUMAB,Antineoplastic Agents,
RITUXIMAB,"Antineoplastic Agents|Antirheumatic Agents|Immunologic Factors|Antineoplastic Agents, Immunological",
Polycap,,
Hextend,,
ALA-PDT,,
Ameluz®-PDT,,
eLOOP,,
Cisplatin/carboplatin,,
allovectin-7/dacarbazine,,
Twinrix,Vaccines,
Paediatric,,
Engerix,,
Efudex®,,
Carac®,,
LEO43204,,
Perrigo,,
Iomab-B,,
NDL-PDT,,
c-PDT,,
metabute,,
Metvix,Dermatologic Agents|Photosensitizing Agents|Radiation-Sensitizing Agents,
Metvix,,
Carac,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
LASW1510,,
Aldara,,
Canada,,
prolifespan,,
GLIADEL®,,
HSV-Tk,,
depatuxizumab,,
mafodotin,,
Vasoconstrictor,,
Afinitor,Immunosuppressant|Immunologic Factors|Immunosuppressive Agents|Antineoplastic Agents,
Virus-Like,,
REPEVAX,,
Non-concomitant,,
Gardasil®,,
Gardasil,,
Metvix®,,
rAd-IFN,,
Gadopentetate,,
Gadopentetate,Contrast Media|Diagnostic Uses of Chemicals,
Dimeglumine,,
BAY86-4882,,
Votrient,,
Nonavalent,,
Thromboreductin,Drug / Therapeutic Agent|Cardiovascular Agents|Fibrinolytic Agents|Hematologic Agents|Platelet Aggregation Inhibitors,
CervarixTM,,
MK0966,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Cyclooxygenase 2 Inhibitors|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Antirheumatic Agents",
Rofecoxib,"Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Cyclooxygenase 2 Inhibitors|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Antirheumatic Agents",
mg/day,,
Peg-alpha,,
Peg-Intron,Antiviral Agents|Anti-Infective Agents,
epacadostat,,
GARDASIL,Vaccine,
PGL4001,,
Abnoba,,
Viscum,,
SmPC,,
Amphotericin,,
AFATINIB,Antineoplastic Agents|Radiation-Sensitizing Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Engerix,,
zanubrutinib,,
lymphodepleting,,
immunochemotherapy,,
HSCT,,
DRL_RI,,
Chemoimmunotherapy,,
pasudotox,,
Protectant,,
Hydroxydaunorubicin,,
Oncovin,Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data,
interferon-a-2a,,
Mabthera/Rituxan,,
Post-Chlorambucil,,
Second-line,,
Anticancer,,
Anti-cancer,,
hydroxydaunorubicin,,
Analgesic/antipyretic,,
antihistamine,,
Gemcitabine/Cisplatin,,
Y-ibritumomab,,
Daromun,,
pixantrone,Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
pixantrone,Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors,
Oxalplatin,,
Ifosfasmide,,
Mitoxatrone,,
POL-103A,,
arginine,Mutation Data,
deiminase,,
Levoketoconazole,,
NPC-12G,,
NPC-07,,
E2/NETA,,
OBE2109,,
Add-back,,
osilodrostat,,
loperamide,Antidiarrheals|Drug / Therapeutic Agent|Gastrointestinal Agents,
D961H,,
M-Vax-,,
hapten-modified,,
Civacir®,,
Pegylated-Proline-Interferon,,
Pre-filled,,
Interferon-alfa,,
Peg-P-IFN-alpha-2b,,
Semustine,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Skin / Eye Irritant|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
123I-mIBG,,
meta-iodobenzylguanidine,Antineoplastic Agents|Enzyme Inhibitors|Indicators and Reagents|Radiopharmaceuticals|Diagnostic Uses of Chemicals,
magnesium,,
Nexium,,
XIAFLEX,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
XIAPEX,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
CCNU,"Antineoplastic Agents, Alkylating|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Alkylating Agents|Antineoplastic Agents|Noxae",
Xiapex,TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
INC424/INCB018424,,
CYTARABINE,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
DASATINIB,Antineoplastic|Enzyme Inhibitors|Protein Kinase Inhibitors,
DASATINIB,Protein Kinase Inhibitors|Enzyme Inhibitors|Antineoplastic Agents,
DEXAMETHASONE,"Antiemetics|Antineoplastic Agents, Hormonal|Drug / Therapeutic Agent|Hormone|Human Data|Mutation Data|Reproductive Effect|Immunomodulator|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents",
HYDROCORTISONE,Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Anti-Inflammatory Agents,
LEUCOVORIN,Growth Substances|Micronutrients|Vitamin B Complex|Vitamins|Antidotes|Protective Agents,
CALCIUM,Calcium-Regulating Hormones and Agents,
MERCAPTOPURINE,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Tumor Data|Antineoplastic Agents|Enzyme Inhibitors|Immunologic Factors|Noxae",
MERCAPTOPURINE,"Mutation Data|Reproductive Effect|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors",
METHOTREXATE,"Abortifacient Agents, Nonsteroidal|Agricultural Chemical|Antimetabolites, Antineoplastic|Antirheumatic Agents|Dermatologic Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Folic Acid Antagonists|Human Data|Immunosuppressive Agents|Insecticide|Mutation Data|Nucleic Acid Synthesis Inhibitors|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Abortifacient Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae|Reproductive Control Agents",
NELARABINE,Antineoplastic,
pegaspargase,Antineoplastic Agents,
IU/m2,,
IM862,"Immunomodulator|Adjuvants, Immunologic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Arrhythmia Agents|Antidotes|Antineoplastic Agents|Cardiovascular Agents|Growth Inhibitors|Growth Substances|Immunologic Factors|Protective Agents",
IM862,,
Amifampridine,,
amifampridine,,
Methyl-Prednisolone,"Antiemetics|Drug / Therapeutic Agent|Human Data|Neuroprotective Agents|Anti-Inflammatory|Immunosuppressant|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents|Protective Agents",
Procarbazine,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data,
GWP42003-P,,
VLP/AS04,,
Antiepileptic,,
post-extension,,
RTXM83,,
Interferon-alpha2b,Drug / Therapeutic Agent|Human Data,
G-CHOP,,
Platinum-containing,,
zosuquidar,,
trihydrochloride,,
SGX301,,
hypericin,Antidepressive Agents|Antineoplastic Agents|Antiviral Agents|Enzyme Inhibitors|Radiation-Sensitizing Agents|Anti-Infective Agents|Central Nervous System Agents|Immunologic Factors|Immunosuppressive Agents|Psychotropic Drugs,
lipegfilgrastim,,
Rituximab-CHOP,,
Rituximab-CVP,,
Rituximab-Bendamustine,,
CMAB304,,
SCT400,,
interferon-alpha,,
interferon-alpha,Drug / Therapeutic Agent|Human Data,
INF-a,,
FluCAM,,
Flumatinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
US-ATG-F,,
"PN-196,444",,
Actonel,Drug / Therapeutic Agent|Human Data|Bone Density Conservation Agents|Calcium Channel Blockers|Cardiovascular Agents|Membrane Transport Modulators,
Risedronate,Calcium Channel Blockers|Bone Density Conservation Agents|Cardiovascular Agents|Membrane Transport Modulators|Calcium-Regulating Hormones and Agents,
HYDROXYUREA,Antineoplastic Agents|Antisickling Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Hematologic Agents|Nucleic Acid Synthesis Inhibitors,
Procrit,,
Cetrorelix,"Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Fertility Agents|Fertility Agents, Female|Reproductive Control Agents",
Cetrorelix,Drug / Therapeutic Agent|Human Data|Reproductive Effect,
Cetrorelix,,
Choriogonadotropin,Hormone|Human Data|Mutation Data|Reproductive Effect|Reproductive Control Agents,
r-hCG,,
follicle,,
r-hFSH,,
MSJ-0011,,
u-hCG,,
Follitropin,"Hormone|Reproductive Effect|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
Marizomib,,
Peg-Interferon,,
Ricover-scheme,,
rituximab-schedule,,
standard-of-care,,
DLBS3233,,
vitamin,,
Podofilox,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Keratolytic Agents|Mutation Data|Natural Product|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Dermatologic Agents|Mitosis Modulators|Tubulin Modulators",
Condylox,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Keratolytic Agents|Mutation Data|Natural Product|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Dermatologic Agents|Mitosis Modulators|Tubulin Modulators",
CLS006,,
Saxagliptin,,
Saxagliptin,"Dipeptidyl-Peptidase IV Inhibitors|Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemic Agents|Incretins|Protease Inhibitors",
Saxagliptin-Metformin,,
Liraglutide,"Antidiabetic|Peptides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemic Agents|Incretins",
Injector,,
Saxenda,"Antidiabetic|Peptides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemic Agents|Incretins",
Corifollitropin,,
Marvelon,"Contraceptive Agents|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Combined|Reproductive Control Agents",
Exenatide,"Antidiabetic|GLP-1 Receptor Agonist|Hypoglycemic Agents|Incretins|Hormones, Hormone Substitutes, and Hormone Antagonists|Hormone Antagonists|Hormones|Anti-Obesity Agents",
Dapagliflozin,Hypoglycemic Agents|Sodium-Glucose Transporter 2 Inhibitors,
DAPA,"Agricultural Chemical|Fungicide, Bactericide, Wood Preservative|Mutation Data|Reproductive Effect|Rodenticide|Tumor Data|Fungicides, Industrial|Pesticides",
Glucophage,Drug / Therapeutic Agent|Skin / Eye Irritant,
Phentermine,Adrenergic Agents|Appetite Depressants|Central Nervous System Stimulants|Human Data|Mutation Data|Sympathomimetics|Anti-Obesity Agents|Autonomic Agents|Central Nervous System Agents|Neurotransmitter Agents|Peripheral Nervous System Agents,
/Topiramate,,
PHEN/,,
Novartis,,
Meningococcal,,
ACWY,,
Tdap,,
Polyphenon,,
PEG-L-asparaginase,Antineoplastic Agents,
Cardiovascular,,
Polypill,,
Prevention,,
Tretinoin,Antineoplastic Agents|Drug / Therapeutic Agent|Keratolytic Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Dermatologic Agents,
Contrast-enhanced,,
Dotarem®,,
Gadovist®/Gadavist®,,
Lupin,,
Medpulser,,
Tramadol,"Analgesics, Opioid|Drug / Therapeutic Agent|Human Data|Narcotics|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
HCI/acetaminophen,,
Dexchlorpheniramine,Histamine H1 Antagonists|Antihistaminic|Histamine Agents|Histamine Antagonists|Neurotransmitter Agents,
Metoclopramide,Antiemetics|Dopamine Antagonists|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Autonomic Agents|Central Nervous System Agents|Dopamine Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Dopamine D2 Receptor Antagonists,
Metoclopramide,Drug / Therapeutic Agent|Human Data,
HER2-neu,,
5-Fluouracil,,
#NAME?,"Adjuvants, Anesthesia|Analgesics, Opioid|Anesthetics, Intravenous|Drug / Therapeutic Agent|Human Data|Narcotics|Analgesics|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
doublet,,
Oxygen/50,,
Nitrous,,
premix,Agricultural Chemical|Growth Regulator / Fertilizer|Human Data|Mutation Data|Skin / Eye Irritant|Tumor Data|Growth Substances|Plant Growth Regulators,
Kalinox,"Anesthetics, Combined|Anesthetics|Central Nervous System Agents|Central Nervous System Depressants",
Nitrogen,,
Pamidronate,Bone Resorption Inhibitor|Bone Density Conservation Agents,
pamoate,,
Docetaxel-Carboplatin,,
fluciclovine,,
avodart,"Enzyme Inhibitors|5-alpha Reductase Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Urological Agents|Steroid Synthesis Inhibitors",
doxifluridine,"Antineoplastic Agents|Drug / Therapeutic Agent|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Antimetabolites|Antimetabolites, Antineoplastic|Appetite Stimulants|Central Nervous System Agents|Central Nervous System Stimulants|Immunologic Factors|Noxae",
Eligard,"Antineoplastic Agents, Hormonal|Fertility Agents, Female|Hormone|Human Data|Reproductive Effect|Antineoplastic Agents|Fertility Agents|Reproductive Control Agents",
Eligard,Reproductive Effect,
hemostatic,,
iliac,,
MedPulser,,
Wellbutrin,Drug / Therapeutic Agent|Human Data,
fosaprepitant,Neurokinin-1 Antagonists|Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents,
DepoCyt,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
ara-C,"Antimetabolites, Antineoplastic|Antiviral Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Immunologic Factors|Noxae",
LENOGRASTIM,"Adjuvants, Immunologic|Drug / Therapeutic Agent|Human Data|Natural Product|Immunologic Factors|Hematologic Agents",
GRANOGYTE,,
Ki-67,,
urate,Mutation Data|Reproductive Effect|Antioxidants|Protective Agents,
urate,,
oxidase,,
Tolvaptan,Vasopressin V2 Receptor Antagonist|Antidiuretic Hormone Receptor Antagonists|Natriuretic Agents,
IU/kg,,
nutritional,,
eicosapentanoic,,
Rocuronium,Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Agents|Peripheral Nervous System Agents,
Sugammadex,,
Neostigmine,Cholinesterase Inhibitors|Parasympathomimetics|Autonomic Agents|Cholinergic Agents|Enzyme Inhibitors|Neurotransmitter Agents|Peripheral Nervous System Agents,
Glycopyrrolate,"Adjuvants, Anesthesia|Drug / Therapeutic Agent|Muscarinic Antagonists|Reproductive Effect|Central Nervous System Agents|Cholinergic Agents|Cholinergic Antagonists|Neurotransmitter Agents",
CitraFleet,,
Elunate®,,
Fentanyl-TTS,,
Sitagliptin,"Dipeptidyl-Peptidase IV Inhibitors|Enzyme Inhibitors|Protease Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemic Agents|Incretins",
Chlorhydrate,,
Dexmedetomidine,"Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Analgesics|Analgesics, Non-Narcotic|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Adrenergic alpha-2 Receptor Agonists",
TACHOSIL,,
Drotrecogin,,
FEC100,,
Desvenlafaxine,Antidepressive Agents|Neurotransmitter Uptake Inhibitors|Central Nervous System Agents|Neurotransmitter Agents|Psychotropic Drugs|Membrane Transport Modulators,
tramadol,"Analgesics, Opioid|Drug / Therapeutic Agent|Human Data|Narcotics|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents",
acetaminophen,"Analgesics, Non-Narcotic|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Antipyretics",
ferric,,
ferrous,Mutation Data,
Targin,,
tofacitinib,Enzyme Inhibitors|Protein Kinase Inhibitors,
etanercept,"Anti-Inflammatory Agents, Non-Steroidal|Gastrointestinal Agents|Immunosuppressive Agents|Antirheumatic Agents|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Immunologic Factors|Peripheral Nervous System Agents|Sensory System Agents",
amnion/chorion,,
Clevidipine,Calcium Channel Blockers|Cardiovascular Agents|Membrane Transport Modulators|Calcium-Regulating Hormones and Agents,
Neuromuscular,,
Prevacid,Anti-Infective Agents|Anti-Ulcer Agents|Drug / Therapeutic Agent|Enzyme Inhibitors|Reproductive Effect|Gastrointestinal Agents|Proton Pump Inhibitors,
Ferrous,Mutation Data,
Gardasil9,Vaccine,
ZYDENA,Phosphodiesterase 5 Inhibitors|Enzyme Inhibitors|Phosphodiesterase Inhibitors,
TAB.75mg,,
Udenafil,Phosphodiesterase 5 Inhibitors|Enzyme Inhibitors|Phosphodiesterase Inhibitors,
ramosetron,Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin Agents|Serotonin Antagonists,
naturopathic,,
5-a-day,,
Cesamet,,
nabilone,Drug / Therapeutic Agent|Reproductive Effect|Anti-Anxiety Agents|Antiemetics|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Gastrointestinal Agents|Peripheral Nervous System Agents|Psychotropic Drugs|Tranquilizing Agents,
Cabergoline,Antineoplastic Agents|Antiparkinson Agents|Dopamine Agonists|Drug / Therapeutic Agent|Anti-Dyskinesia Agents|Central Nervous System Agents|Dopamine Agents|Neurotransmitter Agents,
SARILUMAB,,
Azathioprine,"Antimetabolites|Antimetabolites, Antineoplastic|Antirheumatic Agents|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
Chloroquine,Amebicides|Antimalarials|Antirheumatic Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents,
Leflunomide,Drug / Therapeutic Agent|Enzyme Inhibitors|Immunosuppressive Agents|Antirheumatic Agents|Immunologic Factors,
Sulfasalazine,"Anti-Infective Agents|Anti-Inflammatory Agents, Non-Steroidal|Antirheumatic Agents|Drug / Therapeutic Agent|Gastrointestinal Agents|Human Data|Mutation Data|Reproductive Effect|Tumor Data|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Peripheral Nervous System Agents|Sensory System Agents",
dolasetron,Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin Agents|Serotonin Antagonists,
tropisetron,Antiemetics|Serotonin Antagonists|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin Agents|Serotonin 5-HT3 Receptor Antagonists,
PROMETRIUM®,,
iso-osmolar,,
non-ionic,,
Bicarbonate,Buffers,
Olanzapine,Antipsychotic Agents|Antiemetics|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Gastrointestinal Agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Psychotropic Drugs|Serotonin Agents|Serotonin Uptake Inhibitors|Tranquilizing Agents|Membrane Transport Modulators,
Inggenol,,
Huaier,,
Granule,,
Hectorol,Bone Density Conservation Agents|Growth Substances|Micronutrients|Vitamins,
Zemplar,,
Sensipar®,,
Ambisome,Amebicides|Antiprotozoal Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Anti-Bacterial Agents|Antifungal Agents|Anti-Infective Agents|Antiparasitic Agents,
Ambisome,"Drug / Therapeutic Agent|Antibiotics, Antifungal|Antifungal Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoal Agents|Drug Carriers|Liposomes",
Cholecalciferol,Human Data|Reproductive Effect|Rodenticide|Bone Density Conservation Agents|Growth Substances|Micronutrients|Vitamins|Calcium-Regulating Hormones and Agents,
Botox,Natural Product|Neurotoxins|Acetylcholine Release Inhibitors|Cholinergic Agents|Membrane Transport Modulators|Neuromuscular Agents|Neurotransmitter Agents|Noxae|Peripheral Nervous System Agents,
MYOBLOC,Natural Product|Acetylcholine Release Inhibitors|Anti-Dyskinesia Agents|Central Nervous System Agents|Cholinergic Agents|Membrane Transport Modulators|Neurotransmitter Agents,
Nedaplatin,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect,
Kepivance,,
Gardasil-9,Vaccine,
Methyl,,
Aminolaevulinate,,
rabeprazole,Anti-Ulcer Agents|Enzyme Inhibitors|Gastrointestinal Agents,
Retapamulin,Anti-Bacterial Agents|Anti-Infective Agents,
Ergocalciferol,Agricultural Chemical|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Rodenticide|Bone Density Conservation Agents|Growth Substances|Micronutrients|Vitamins|Calcium-Regulating Hormones and Agents,
Teicoplanin,Drug / Therapeutic Agent|Human Data|Anti-Bacterial Agents|Anti-Infective Agents,
lipiodol,,
Xiaoai,,
Jiedu,,
Decoction,,
ozogamicin-dose,,
Weight-Based,,
Zevalin®,,
Zelboraf,Antineoplastic Agents|Enzyme Inhibitors|Protein Kinase Inhibitors,
Xenetix-CT,,
clevudine,Anti-Infective Agents|Antiviral Agents,
Adefovir,Antiviral Agents|Mutation Data|Anti-Infective Agents|Anti-Retroviral Agents|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Reverse Transcriptase Inhibitors,
Nerison,,
#NAME?,,
Lipiodol®,,
Insulin,Hypoglycemic Agents,
Insulin,Human Data|Mutation Data|Reproductive Effect|Hypoglycemic Agents,
Insulin,Drug / Therapeutic Agent|Hypoglycemic Agents,
Insulin,Drug / Therapeutic Agent|Human Data|Mutation Data|Hypoglycemic Agents,
Prospective,,
difitox,,
DAB389IL-2,,
Hemoporfin,,
Urea,Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data,
Ibuprofen,"Analgesics, Non-Narcotic|Anti-Inflammatory Agents, Non-Steroidal|Cyclooxygenase Inhibitors|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Nonsteroidal Anti-Inflammatory|Analgesics|Anti-Inflammatory Agents|Antirheumatic Agents|Central Nervous System Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents",
cabergoline/Octrotide,,
Somavert,,
Tisseel,Coagulants|Hematologic Agents|Hemostatics|Surgical Fixation Devices|Tissue Adhesives,
Tisseel,,
Prednisone/Prednisolone/Methylprednisolone,,
Humira,Monoclonal Antibody|Anti-Inflammatory Agents|Antirheumatic Agents,
Engerix-B,,
Entecavir,Antiviral Agents,
Entecavir,Anti-Infective Agents|Antiviral Agents,
entecavir,Antiviral Agents,
entecavir,Anti-Infective Agents|Antiviral Agents,
micafungin,,
Vedolizumab,Treatment of Crohn's Disease|Gastrointestinal Agents,
Colchicine,Agricultural Chemical|Drug / Therapeutic Agent|Gout Suppressants|Human Data|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Antimitotic Agents|Antirheumatic Agents|Mitosis Modulators|Tubulin Modulators,
loteprednol,,
opthalmic,,
Menotropin,"Drug / Therapeutic Agent|Fertility Agents, Female|Human Data|Natural Product|Reproductive Effect|Fertility Agents|Reproductive Control Agents",
ICL670/Deferasirox,,
DRSP/20,,
tredaptive,,
nicotinic,,
acid/,,
laropiprant,,
Lopinavir/ritonavir,Protease Inhibitor,
Emtricitabine/Tenofovir,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Reverse Transcriptase Inhibitors|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors,
Efavirenz,Non-Nucleoside Reverse Transcriptase Inhibitor|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Reverse Transcriptase Inhibitors|Metabolic Side Effects of Drugs and Substances,
HAART,,
Triomune,,
Methoxsalen+ECP,,
Elemene,,
Injection/Elemene,,
Emulusion,,
EPCAM-targeted,,
Colloid,,
Isosulfan,,
OncoCare,,
carcinoma,,
IG-001,"Antineoplastic Agents, Phytogenic|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Tubulin Modulators",
mRNA,,
CART-meso,,
Protein-Type,,
Microspheres,,
Pronase,Drug / Therapeutic Agent|Natural Product,
TS-1/Cisplatin,,
PEG-filgrastim,Antineoplastic Agents|Pegylated Protein,
Duloxetine,Antidepressant|Adrenergic Agents|Adrenergic Uptake Inhibitors|Antidepressive Agents|Central Nervous System Agents|Dopamine Agents|Dopamine Uptake Inhibitors|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Serotonin Agents|Serotonin Uptake Inhibitors|Analgesics|Membrane Transport Modulators|Peripheral Nervous System Agents|Sensory System Agents,
Duloxetine,,
Zolderonic,,
Innohep,Drug / Therapeutic Agent|Human Data|Anticoagulants|Cardiovascular Agents|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|TSCA Flag XU (Exempt from Reporting under Chemical Data Reporting Rule),
FBSF,,
QBX258,,
AGS-006,,
hENT1,,
Sheng,,
Alpharadin,Antineoplastic Agents,
Thrombopoietin,,
Indocyanine,,
vaccine-KLH,,
Senna,Drug / Therapeutic Agent|Mutation Data|Natural Product|Cathartics|Gastrointestinal Agents,
SUPREP,,
Bisacodyl,Cathartics|Gastrointestinal Agents|Laxatives,
Gastrografin,Contrast Media|Drug / Therapeutic Agent|Human Data|Diagnostic Uses of Chemicals,
Gastrografin,Contrast Media|Drug / Therapeutic Agent|Diagnostic Uses of Chemicals,
IADT,,
gadobenate,Contrast Media|Diagnostic Uses of Chemicals,
MultiHance,Drug / Therapeutic Agent|Paramagnetic,
Lidocaine,"Anesthetics, Local|Anti-Arrhythmia Agents|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Anesthetics|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Peripheral Nervous System Agents|Sensory System Agents|Membrane Transport Modulators|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers",
nonmyeloablative,,
simethicone,Antifoaming Agents|Emollients|Dermatologic Agents|Surface-Active Agents,
Lutetium-177,,
Octreotate,,
Targretin,Anticarcinogenic Agents|Antineoplastic Agents|Protective Agents,
urine,,
microbiota,,
CD19-targeted,,
varenicline,Cholinergic Agents|Cholinergic Agonists|Neurotransmitter Agents|Nicotinic Agonists|Smoking Cessation Agents,
EVICEL,,
CAR-CLD18,,
124I-Humanized,,
shenqifuzheng,,
Lutrate,,
Enantone,,
Tivo,,
Papavarine,,
Phentholamine,,
Prostaglandin,,
mcg/mmL,,
Hydrophor,,
MediHoney,,
Bupivicaine,,
desflurane,"Anesthetics, Inhalation|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants",
propofol,"Anesthetics, Intravenous|Drug / Therapeutic Agent|Human Data|Reproductive Effect|Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives",
saliva,,
CD19-UCART,,
RoACTEMRA®,,
BCMA-UCART,,
BCMA-CART,,
Lymphodepletion,,
MabCampath,,
Low-Molecular-Weight,,
Platelet,,
Ifosfamide-based,,
Levulan,Mutation Data|Photosensitizing Agents|Dermatologic Agents|Radiation-Sensitizing Agents,
Kerastick,,
Vesicare,Cholinergic Agents|Cholinergic Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Urological Agents,
Antihistamine,,
Cetirizine,"Anti-Allergic Agents|Drug / Therapeutic Agent|Histamine H1 Antagonists|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents",
Efudex,"Antimetabolites|Antimetabolites, Antineoplastic|Drug / Therapeutic Agent|Human Data|Immunosuppressive Agents|Mutation Data|Reproductive Effect|Skin / Eye Irritant|Tumor Data|Antineoplastic Agents|Immunologic Factors|Noxae",
Zinecard,,
DS-1001b,,
Welgenaleucel,,
Anti-Thymocyte,,
DC-TC+GM-CSF,,
GD2-targeted,,
ABVD,,
Id-KLH,,
CHOP/Rituximab,,
INTRON,,
on-time,,
Natulan,Antineoplastic Agents|Drug / Therapeutic Agent|Mutation Data|Reproductive Effect|Tumor Data,
Bortezomib/Dexamethasone,,
Maraviroc,Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|CCR5 Receptor Antagonists|HIV Fusion Inhibitors,
Zidovudine,Anti-HIV Agents|Antimetabolites|Drug / Therapeutic Agent|Human Data|Mutation Data|Reproductive Effect|Reverse Transcriptase Inhibitors|Tumor Data|Antiretroviral|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Noxae|Nucleic Acid Synthesis Inhibitors,
Epratuzumab,"Antineoplastic Agents|Antineoplastic Agents, Immunological",
Inosine,Drug / Therapeutic Agent|Mutation Data,
pranobex,,
valproic,,
Fluocinonide,"Anti-Allergic Agents|Drug / Therapeutic Agent|Hormone|Mutation Data|Reproductive Effect|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists",
Cryotherapy,,
Glycolic,,
Polypectomy,,
